Please wait...
| ID | PMID | YEAR | Sequence | MAP | Name | C-ter MOD | N-ter MOD | Linear/Cyclic | Stereo-Chemistry | Modified | Length | Fuction | Activity | RBCs Source | Origin | Experimental structure | Non-Hemolytic |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17067722 | 2006 | MKLGLLVVLAVAVLVPSLSEGQNVPSCQLKDPNQTPVEAGNMRNKREADDSSEESDLAEI | Pp B | Free | Free | Linear | L | None | 60 | Antibacterial | 3.2 HU/mg | Horse | Grammistins (Pogonoperca punctata) | NA | NA | ||
| 17067722 | 2006 | IGGIISFFKRLF | Gs B | Free | Free | Linear | L | None | 12 | Antibacterial | <10 HU/mg | Horse | Grammistins (Pogonoperca punctata) | NA | NA | ||
| 17067722 | 2006 | MKLGLLVVLAVAVLVPSLSEQDFPSCQLKEPNQTPVEAGNMRNKREADESSEEFDLAEM | Pp l | Free | Free | Linear | L | None | 60 | Antibacterial | 79 HU/mg | Horse | Grammistins (Pogonoperca punctata) | NA | NA | ||
| 17067722 | 2006 | VKRALSALKPKNKRFIGGIISFFKRLFG | Pp 2b | Free | Free | Linear | L | None | 28 | Antibacterial | 63 HU/mg | Horse | Grammistins (Pogonoperca punctata) | NA | NA | ||
| 22484288 | 2012 | FLFSLIPHAIGGLISAFK | AamAP1 | Free | Free | Linear | L | None | 18 | Antimicrobial | 0% hemolysis at 10µM | Horse | AamAP1 from the venom of the North African scorpion, Androctonus amoreuxi | NA | NA | ||
| 22484288 | 2012 | FLFSLIPHAIGGLISAFK | AamAP1 | Free | Free | Linear | L | None | 18 | Antimicrobial | 100% hemolysis at 100µM | Horse | AamAP1 from the venom of the North African scorpion, Androctonus amoreuxi | NA | NA | ||
| 22484288 | 2012 | FPFSLIPHAIGGLISAIK | AamAP2 | Free | Free | Linear | L | None | 18 | Antimicrobial | 19% hemolysis at 10µM | Horse | AamAP2 from the venom of the North African scorpion, Androctonus amoreuxi | NA | NA | ||
| 22484288 | 2012 | FPFSLIPHAIGGLISAIK | AamAP2 | Free | Free | Linear | L | None | 18 | Antimicrobial | 75% hemolysis at 100µM | Horse | AamAP2 from the venom of the North African scorpion, Androctonus amoreuxi | NA | NA | ||
| 22484288 | 2012 | FLFSLIPKAIGGLISAFK | AamAP-S1 | Free | Free | Linear | L | None | 18 | Antimicrobial | 17.8% hemolysis at 10µM | Horse | AamAP1 analog (Androctonus amoreuxi) | NA | NA | ||
| 22484288 | 2012 | FLFSLIPKAIGGLISAFK | AamAP-S1 | Free | Free | Linear | L | None | 18 | Antimicrobial | 53% hemolysis at 100µM | Horse | AamAP1 analog (Androctonus amoreuxi) | NA | NA | ||
| 11279030 | 2001 | WLGSALKIGAKLLPSVVGLFKKKKQ | Ponericin-W1 | Free | Free | Linear | L | None | 25 | Antimicrobial and Insecticidal | zone of inhibition (2 mm) at 0.4-0.5mM | Horse | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | GIWGTLAKIGIKAVPRVISMLKKKKQ | Ponericin-W3 | Free | Free | Linear | L | None | 26 | Antimicrobial and Insecticidal | zone of inhibition (1 mm) at 0.4-0.5mM | Horse | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | GIWGTALKWGVKLLPKLVGMAQTKKQ | Ponericin-W4 | Free | Free | Linear | L | None | 26 | Antimicrobial and Insecticidal | zone of inhibition (2 mm) at 0.4-0.5mM | Horse | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | FWGALIKGAAKLIPSVVGLFKKKQ | Ponericin-W5 | Free | Free | Linear | L | None | 24 | Antimicrobial and Insecticidal | zone of inhibition (4 mm) at 0.4-0.5mM | Horse | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | FIGTALGIASAIPAIVKLFK{ct:Amid} | Ponericin-W6 | Amidation | Free | Linear | L | None | 20 | Antimicrobial and Insecticidal | zone of inhibition (3 mm) at 0.4-0.5mM | Horse | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | GWKDWAKKAGGWLKKKGPGMAKAALKAAMQ | Ponericin-G1 | Free | Free | Linear | L | None | 30 | Antimicrobial and Insecticidal | zone of inhibition not detected at 0.4-0.5mM | Horse | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | GWKDWLNKGKEWLKKKGPGIMKAALKAATQ | Ponericin-G3 | Free | Free | Linear | L | None | 30 | Antimicrobial and Insecticidal | zone of inhibition not detected at 0.4-0.5mM | Horse | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | DFKDWMKTAGEWLKKKGPGILKAAMAAAT | Ponericin-G4 | Free | Free | Linear | L | None | 29 | Antimicrobial and Insecticidal | zone of inhibition not detected at 0.4-0.5mM | Horse | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | GLVDVLGKVGGLIKKLLP{ct:Amid} | Ponericin-G6 | Amidation | Free | Linear | L | None | 18 | Antimicrobial and Insecticidal | zone of inhibition not detected at 0.4-0.5mM | Horse | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 11279030 | 2001 | LLKELWTKIKGAGKAVLGKIKGLL{ct:Amid} | Ponericin-L2 | Amidation | Free | Linear | L | None | 24 | Antimicrobial and Insecticidal | zone of inhibition not detected at 0.4-0.5mM | Horse | Synthetic peptide (Pachycondyla goeldii venom) | NA | NA | ||
| 10669014 | 1999 | LFGFLIKLIPSLFGALSNIGRNRNQ | Gs1 | Free | Free | Linear | L | None | 25 | Hemolytic and Ichthyotoxic | LC50 =1.9μM | Horse | Grammistins peptide (Grammistes sexlineatus) | NA | NA | ||
| 10669014 | 1999 | LFGFLIPLLPHIIGAIPQVIGAIR | Gs2 | Free | Free | Linear | L | None | 24 | Hemolytic and Ichthyotoxic | LC50 = 0.19μM | Horse | Grammistins peptide (Grammistes sexlineatus) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-A | Free | Formylation | Linear | L | None | 26 | Cytolytic | 73% hemolysis at 25μg | Horse | δ-toxin (Staphylococcus aurezis) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-A | Free | Formylation | Linear | L | None | 26 | Cytolytic | 85% hemolysis at 75μg | Horse | δ-toxin (Staphylococcus aurezis) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-B | Free | Formylation | Linear | L | None | 26 | Cytolytic | 34% hemolysis at 25μg | Horse | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation} | Peptide-B | Free | Formylation | Linear | L | None | 26 | Cytolytic | 43% hemolysis at 75μg | Horse | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGDLVKWIIDTVNKFPKK | Peptide-C | Free | Free | Linear | L | None | 26 | Cytolytic | 50% hemolysis at 75μg | Horse | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | DLVKWIIDTVNKFTKK | Peptide-D | Free | Free | Linear | L | None | 16 | Cytolytic | 0% hemolysis at 75μg | Horse | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | DLVKWIIDTVNKFTKK | Peptide-D | Free | Free | Linear | L | None | 16 | Cytolytic | 20% hemolysis at 250μg | Horse | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | DLVKWIIDTVNKFTKK | Peptide-D | Free | Free | Linear | L | None | 16 | Cytolytic | 19% hemolysis at 500μg | Horse | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MAQDIISTIGD{nt:Formylation} | Peptide-E | Free | Formylation | Linear | L | None | 11 | Cytolytic | 0% hemolysis at 1000μg (non hemolytic) | Horse | δ-toxin derivative (Synthetic peptide) | NA | Non-hemolytic | ||
| 2474443 | 1989 | MLQDLLSSLGDLLKSWLDTLNKFTKK{nt:Formylation} | Peptide-F | Free | Formylation | Linear | L | None | 26 | Cytolytic | 12% hemolysis at 75μg | Horse | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MLQDLLSSLGDLLKSWLDTLNKFTKK | Peptide-G | Free | Free | Linear | L | None | 26 | Cytolytic | 31% hemolysis at 75μg | Horse | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MLQDWLSSLGDLLKSLLDTVNKFTKK{nt:Fmoc} | Peptide-H | Free | Fmoc | Linear | L | None | 26 | Cytolytic | 25% hemolysis at 75μg | Horse | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 2474443 | 1989 | MLQDWLSSLGDLLKSLLDTVNKFTKK | Peptide-I | Free | Free | Linear | L | None | 26 | Cytolytic | 11% hemolysis at 75μg | Horse | δ-toxin derivative (Synthetic peptide) | NA | NA | ||
| 19427345 | 2009 | FLGAIAAALPHVINAVTNAL{ct:Amid} | Kassinatuerin-2Ma | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 45-50% hemolysis at 120μM | Horse | Kassinatuerin 2 (skin secretion of the African hyperoliid frog Kassina maculata) | NA | NA | ||
| 19427345 | 2009 | FFGAIAAALPHVISAIKNAL{ct:Amid} | Kassinatuerin-2Mb | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 45-50% hemolysis at 120μM | Horse | Kassinatuerin 2 (skin secretion of the African hyperoliid frog Kassina maculata) | NA | NA | ||
| 19427345 | 2009 | FVGAIAAALPHVISAIKNAL{ct:Amid} | Kassinatuerin-2Mc | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 45-50% hemolysis at 120μM | Horse | Kassinatuerin 2 (skin secretion of the African hyperoliid frog Kassina maculata) | NA | NA | ||
| 19427345 | 2009 | IIGAIAAALPHVINAIKNTF{ct:Amid} | Kassinatuerin-2Md | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 45-50% hemolysis at 120μM | Horse | Kassinatuerin 2 (skin secretion of the African hyperoliid frog Kassina maculata) | NA | NA | ||
| 19427345 | 2009 | FIQYLAPLIPHAVKAISDLI{ct:Amid} | Kassinatuerin-2S | Amidation | Free | Linear | L | None | 20 | Antimicrobial | 45-50% hemolysis at 120μM | Horse | Kassinatuerin 2 (skin secretion of the African hyperoliid frog Kassina maculata) | NA | NA | ||
| 19427345 | 2009 | GFMKYIGPLIPHAVKAISDLI{ct:Amid} | Kassinatuerin-1S | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 45-50% hemolysis at 120μM | Horse | Kassinatuerin 2 (skin secretion of the African hyperoliid frog Kassina maculata) | NA | NA | ||
| 23415652 | 2013 | LLGMIPLAISAISALSKL | Medusin-AC | Free | Free | Linear | L | None | 18 | Antimicrobial | 8.7% hemolysis at 32mg/ml | Horse | Medusin (Phyllomedusine frogs) | NA | NA | ||
| 23415652 | 2013 | LLGMIPVAISAISALSKL | Medusin-PH | Free | Free | Linear | L | None | 18 | Antimicrobial | 1.9% hemolysis at 128mg/ml | Horse | Medusin (Phyllomedusine frogs) | NA | NA | ||
| 23415652 | 2013 | LLGMIPLAISAISSLSKL | Medusin-PD | Free | Free | Linear | L | None | 18 | Antimicrobial | 6.9% hemolysis at 64mg/ml | Horse | Medusin (Phyllomedusine frogs) | NA | NA | ||
| 21396976 | 2011 | SFPFFPPGICKRLKRC | Limnonectin-1Fa | Free | Free | Linear | L | None | 16 | Antimicrobial | 0% hemolysis upto 160μM (Non hemolytic) | Horse | Limnonectin (Limnonectes fujianensis) | NA | Non-hemolytic | ||
| 21396976 | 2011 | SFHVFPPWMCKSLKKC | Limnonectin-1Fb | Free | Free | Linear | L | None | 16 | Antimicrobial | 0% hemolysis upto 160μM (Non hemolytic) | Horse | Limnonectin (Limnonectes fujianensis) | NA | Non-hemolytic | ||
| 11279030 | 2001 | WLGSALKIGAKLLPSVVGLFKKKKQ | W1 | Free | Free | Linear | L | None | 25 | Antimicrobial, Insecticidal | Zone of inhibition 2mm at 0.4-0.5mM | Horse | Ponericin | NA | NA | ||
| 11279030 | 2001 | WLGSALKIGAKLLPSVVGLFQKKKK | W2 | Free | Free | Linear | L | None | 25 | Antimicrobial, Insecticidal | Zone of inhibition 1mm at 0.4-0.5mM | Horse | Ponericin | NA | NA | ||
| 11279030 | 2001 | GIWGTALKWGVKLLPKLVGMAQTKKQ | W4 | Free | Free | Linear | L | None | 26 | Antimicrobial, Insecticidal | Zone of inhibition 2mm at 0.4-0.5mM | Horse | Ponericin | NA | NA | ||
| 11279030 | 2001 | FWGALIKGAAKLIPSVVGLFKKKQ | W5 | Free | Free | Linear | L | None | 24 | Antimicrobial, Insecticidal | Zone of inhibition 4mm at 0.4-0.5mM | Horse | Ponericin | NA | NA | ||
| 11279030 | 2001 | FIGTALGIASAIPAIVKLFK{ct:Amid} | W6 | Amidation | Free | Linear | L | None | 20 | Antimicrobial, Insecticidal | Zone of inhibition 3mm at 0.4-0.5mM | Horse | Ponericin | NA | NA | ||
| 23770440 | 2013 | FLSLIPSLVGGSISAFK{ct:Amid} | TsAP-1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 5 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | Non-hemolytic | ||
| 23770440 | 2013 | FLSLIPSLVGGSISAFK{ct:Amid} | TsAP-1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 10 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | Non-hemolytic | ||
| 23770440 | 2013 | FLSLIPSLVGGSISAFK{ct:Amid} | TsAP-1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 20 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | Non-hemolytic | ||
| 23770440 | 2013 | FLSLIPSLVGGSISAFK{ct:Amid} | TsAP-1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 40 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | Non-hemolytic | ||
| 23770440 | 2013 | FLSLIPSLVGGSISAFK{ct:Amid} | TsAP-1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | <10 % Hemolysis at 80 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLSLIPSLVGGSISAFK{ct:Amid} | TsAP-1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | <10 % Hemolysis at 120 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLSLIPSLVGGSISAFK{ct:Amid} | TsAP-1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 4 % Hemolysis at 160 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPGLIGGLISAFK{ct:Amid} | TsAP-2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 2.5 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | Non-hemolytic | ||
| 23770440 | 2013 | FLGMIPGLIGGLISAFK{ct:Amid} | TsAP-2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 5 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | Non-hemolytic | ||
| 23770440 | 2013 | FLGMIPGLIGGLISAFK{ct:Amid} | TsAP-2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 10 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | Non-hemolytic | ||
| 23770440 | 2013 | FLGMIPGLIGGLISAFK{ct:Amid} | TsAP-2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 0 % Hemolysis at 15 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | Non-hemolytic | ||
| 23770440 | 2013 | FLGMIPGLIGGLISAFK{ct:Amid} | TsAP-2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 18 % Hemolysis at 20 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPGLIGGLISAFK{ct:Amid} | TsAP-2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | ~90 % Hemolysis at 40 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPGLIGGLISAFK{ct:Amid} | TsAP-2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 80 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPGLIGGLISAFK{ct:Amid} | TsAP-2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 120 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPGLIGGLISAFK{ct:Amid} | TsAP-2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 160 µM | Horse | Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLSLIPKLVKKIIKAFK{ct:Amid} | TsAP-S1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 30 % Hemolysis at 5 µM | Horse | Analogue Of Tsap-1, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLSLIPKLVKKIIKAFK{ct:Amid} | TsAP-S1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | <90 % Hemolysis at 10 µM | Horse | Analogue Of Tsap-1, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLSLIPKLVKKIIKAFK{ct:Amid} | TsAP-S1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 20 µM | Horse | Analogue Of Tsap-1, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLSLIPKLVKKIIKAFK{ct:Amid} | TsAP-S1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 40 µM | Horse | Analogue Of Tsap-1, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLSLIPKLVKKIIKAFK{ct:Amid} | TsAP-S1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 80 µM | Horse | Analogue Of Tsap-1, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLSLIPKLVKKIIKAFK{ct:Amid} | TsAP-S1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 120 µM | Horse | Analogue Of Tsap-1, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLSLIPKLVKKIIKAFK{ct:Amid} | TsAP-S1 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 160 µM | Horse | Analogue Of Tsap-1, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPKLIKKLIKAFK{ct:Amid} | TsAP-S2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 30 % Hemolysis at 5 µM | Horse | Analogue Of Tsap-2, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPKLIKKLIKAFK{ct:Amid} | TsAP-S2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 80 % Hemolysis at 10 µM | Horse | Analogue Of Tsap-2, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPKLIKKLIKAFK{ct:Amid} | TsAP-S2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 20 µM | Horse | Analogue Of Tsap-2, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPKLIKKLIKAFK{ct:Amid} | TsAP-S2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 40 µM | Horse | Analogue Of Tsap-2, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPKLIKKLIKAFK{ct:Amid} | TsAP-S2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 80 µM | Horse | Analogue Of Tsap-2, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPKLIKKLIKAFK{ct:Amid} | TsAP-S2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 120 µM | Horse | Analogue Of Tsap-2, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 23770440 | 2013 | FLGMIPKLIKKLIKAFK{ct:Amid} | TsAP-S2 | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 100 % Hemolysis at 160 µM | Horse | Analogue Of Tsap-2, Venom Of The Brazilian Yellow Scorpion, Tityus Serrulatus | α-Helix | NA | ||
| 25003126 | 2014 | GIGGALLNVGKVALKGLAKGLAEHFAN{ct:Amid} | Bombinin | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 100 % Hemolysis at 64 mg/L | Horse | European Yellow-Bellied Toad (Bombina Variegata) | α-Helix | NA | ||
| 25003126 | 2014 | FLGLLGGLL{ct:Amid} | Feleucin-BV1 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 100 % Hemolysis at >512 mg/L | Horse | Skin Secretion-Derived (Bombina Variegata) | α-Helix | NA | ||
| 25003126 | 2014 | FLGLIGSLL{ct:Amid} | Feleucin-BV2 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 100 % Hemolysis at >512 mg/L | Horse | Skin Secretion-Derived(Bombina Variegata) | α-Helix | NA | ||
| 25054164 | 2014 | LRPAILVRIK{ct:Amid} | balteatide | Amidation | Free | Linear | L | None | 10 | Antimicrobial | <8 % Hemolysis at 512 mg/L | Horse | Purple-Sided Leaf Frog, Phyllomedusa Baltea | NA | Low hemolytic | ||
| 25054164 | 2014 | LRPAILVRTK{ct:Amid} | sauvatide | Amidation | Free | Linear | L | None | 10 | myotropic agent on rat | <8 % Hemolysis at 512 mg/L | Horse | Phyllomedusa Sauvagei Skin Secretion | NA | Low hemolytic | ||
| 24378871 | 2014 | GVLSAFKNALPGIMKIIV{ct:Amid} | hylaranin-L1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 3 % Hemolysis at 8 mg/L | Horse | Hylarana Latouchii | α-Helix | NA | ||
| 24378871 | 2014 | GVLSAFKNALPGIMKIIV{ct:Amid} | hylaranin-L1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 4.2 % Hemolysis at 16 mg/L | Horse | Hylarana Latouchii | α-Helix | NA | ||
| 24378871 | 2014 | GVLSAFKNALPGIMKIIV{ct:Amid} | hylaranin-L1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 22.9 % Hemolysis at 64 mg/L | Horse | Hylarana Latouchii | α-Helix | NA | ||
| 24378871 | 2014 | GVLSVIKNALPGIMRFIA{ct:Amid} | hylaranin-L2 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 5.8 % Hemolysis at 8 mg/L | Horse | Hylarana Latouchii | α-Helix | NA | ||
| 24378871 | 2014 | GVLSVIKNALPGIMRFIA{ct:Amid} | hylaranin-L2 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 58.6 % Hemolysis at 16 mg/L | Horse | Hylarana Latouchii | α-Helix | NA | ||
| 25332684 | 2014 | FLFSLIPHAISGLISAFK{ct:Amid} | AcrAP1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 100 % Hemolysis at 64 µM | Horse | Venom Of The Arabian Scorpion, Androctonus Crassicauda | α-Helix/Random coil | NA | ||
| 25332684 | 2014 | FLFSLIPNAISGLLSAFK{ct:Amid} | AcrAP2 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 100 % Hemolysis at 64 µM | Horse | Venom Of The Arabian Scorpion, Androctonus Crassicauda | α-Helix/Random coil | NA | ||
| 25332684 | 2014 | FLFKLIPKAIKGLIKAFK{ct:Amid} | AcrAP1a | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 100 % Hemolysis at 32 µM | Horse | Analogue Of Acrap1, Venom Of The Arabian Scorpion, Androctonus Crassicauda | α-Helix/Random coil | NA | ||
| 25332684 | 2014 | FLFKLIPKAIKGLLKAFK{ct:Amid} | AcrAP2a | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 100 % Hemolysis at 32 µM | Horse | Analogue Of Acrap2, Venom Of The Arabian Scorpion, Androctonus Crassicauda | α-Helix/Random coil | NA | ||
| 25056849 | 2015 | FLGLLGSLL{ct:Amid} | Feleucin-BO1 | Amidation | Free | Linear | L | None | 9 | Antibaterial | 100 % Hemolysis at 80 µM | Horse | Synthetic,Skin Secretion Of Bombina Orientalis | Random coil | NA | ||
| 25056849 | 2015 | FLKLLKKLL{ct:Amid} | Feleucin-K3 | Amidation | Free | Linear | L | None | 9 | Antibaterial, Antifungal | 100 % Hemolysis at >250 µM | Horse | Analogue Of Fpa-Bombinin-Bo, Skin Secretion Of Bombina Orientalis | α-Helix | NA | ||
| 25056849 | 2015 | GIGGALLSAKAALGLAKGLAEHFAN{ct:Amid} | FPA-Bombinin-BO | Amidation | Free | Linear | L | None | 25 | Antibaterial, Antifungal | 100 % Hemolysis at 125 µM | Horse | Synthetic, Skin Secretion Of Bombina Orientalis | α-Helix | NA | ||
| 26633506 | 2015 | FFSMIPKIAGGIASLVKNLG{ct:Amid} | Phylloseptin-PBa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 0 % Hemolysis at 0 mg/L | Horse | Leaf Frog (Phyllomedusa Baltea) | α-Helix | NA | ||
| 26633506 | 2015 | FFSMIPKIAGGIASLVKNLG{ct:Amid} | Phylloseptin-PBa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 0.2 % Hemolysis at 1 mg/L | Horse | Leaf Frog (Phyllomedusa Baltea) | α-Helix | NA | ||
| 26633506 | 2015 | FFSMIPKIAGGIASLVKNLG{ct:Amid} | Phylloseptin-PBa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 1.4 % Hemolysis at 2 mg/L | Horse | Leaf Frog (Phyllomedusa Baltea) | α-Helix | NA | ||
| 26633506 | 2015 | FFSMIPKIAGGIASLVKNLG{ct:Amid} | Phylloseptin-PBa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 1.3 % Hemolysis at 4 mg/L | Horse | Leaf Frog (Phyllomedusa Baltea) | α-Helix | NA | ||
| 26633506 | 2015 | FFSMIPKIAGGIASLVKNLG{ct:Amid} | Phylloseptin-PBa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 5 % Hemolysis at 8 mg/L | Horse | Leaf Frog (Phyllomedusa Baltea) | α-Helix | NA | ||
| 26633506 | 2015 | FFSMIPKIAGGIASLVKNLG{ct:Amid} | Phylloseptin-PBa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 9.5 % Hemolysis at 16 mg/L | Horse | Leaf Frog (Phyllomedusa Baltea) | α-Helix | NA | ||
| 26633506 | 2015 | FFSMIPKIAGGIASLVKNLG{ct:Amid} | Phylloseptin-PBa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 38.6 % Hemolysis at 32 mg/L | Horse | Leaf Frog (Phyllomedusa Baltea) | α-Helix | NA | ||
| 26633506 | 2015 | FFSMIPKIAGGIASLVKNLG{ct:Amid} | Phylloseptin-PBa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 79.6 % Hemolysis at 64 mg/L | Horse | Leaf Frog (Phyllomedusa Baltea) | α-Helix | NA | ||
| 26633506 | 2015 | FFSMIPKIAGGIASLVKNLG{ct:Amid} | Phylloseptin-PBa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 107.4 % Hemolysis at 128 mg/L | Horse | Leaf Frog (Phyllomedusa Baltea) | α-Helix | NA | ||
| 26633506 | 2015 | FFSMIPKIAGGIASLVKNLG{ct:Amid} | Phylloseptin-PBa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 104.1 % Hemolysis at 512 mg/L | Horse | Leaf Frog (Phyllomedusa Baltea) | α-Helix | NA | ||
| 26656394 | 2015 | GLRKKFRKTRKRIQKLGRKIGKTGRKVWKAWREYGQIPYPCRI | Cap11 | Free | Free | Linear | L | None | 43 | Antibacterial | 4 ± 0 % Hemolysis at 64 μg/ml | Horse | Mammalian, Guinea Pig, Neutrophils | α-Helical | NA | ||
| 26656394 | 2015 | KLRKLFRKLLKLIRKLLR | Cap11-1-18m2 | Free | Free | Linear | L | None | 18 | Antibacterial | 52 ± 6 % Hemolysis at 64 μg/ml | Horse | Truncated Derivative Of Cap11 | α-Helical | NA | ||
| 26656394 | 2015 | GLRKRLRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDY | Cap18 | Free | Free | Linear | L | None | 37 | Antibacterial | 1 ± 0 % Hemolysis at 64 μg/ml | Horse | Mammalian, Rabbit, Neutrophils | α-Helical | NA | ||
| 26656394 | 2015 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | Antibacterial | 110 ± 1 % Hemolysis at 128 μg/ml | Horse | Insects, Honey Bee | α-Helical | NA | ||
| 26656394 | 2015 | ILPWKWPWWPWR | Indolicidin | Free | Free | Linear | L | None | 12 | Antibacterial | 12 ± 0 % Hemolysis at 128 μg/ml | Horse | Mammalian, Bovine Neutrophils | Extended | NA | ||
| 26656394 | 2015 | SWLSKTAKKLENSAKKRISEGIAIAIQGGPR | Cecropin P1 | Free | Free | Linear | L | None | 31 | Antibacterial | 0 ± 0 % Hemolysis at 256 μg/ml | Horse | Mammalian, Pig, Small Intestine | α-Helical | Non-hemolytic | ||
| 26656394 | 2015 | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKALG{ct:Amid} | Cecropin B | Amidation | Free | Linear | L | None | 36 | Antibacterial | 0 ± 0 % Hemolysis at 256 μg/ml | Horse | Insects, Giant Silk Moth, Pupae | α-Helical | Non-hemolytic | ||
| 26656394 | 2015 | RLARIVVIRVAR | Bac2A | Free | Free | Linear | L | None | 12 | Antibacterial | 0 ± 0 % Hemolysis at 256 μg/ml | Horse | Non-Amidated Version Of Bac2A-Nh2 | α-Helical/β-Sheet | Non-hemolytic | ||
| 26656394 | 2015 | RLARIVVIRVAR{ct:Amid} | Bac2A-NH2 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 ± 0 % Hemolysis at 256 μg/ml | Horse | Linear Variant Of Bactenecin From Bovine Neutrophils | NA | Non-hemolytic | ||
| 26656394 | 2015 | RRWKIVVIRWRR{ct:Amid} | Sub5-NH2 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 ± 0 % Hemolysis at 256 μg/ml | Horse | Synthetic Variant Of Bac2A-Nh2 | NA | Non-hemolytic | ||
| 26656394 | 2015 | GIHDILKYGKPS | Myxinidin | Free | Free | Linear | L | None | 12 | Antibacterial | 0 ± 0 % Hemolysis at 256 μg/ml | Horse | Fish, Epidermal Mucus Of Hagfish | NA | Non-hemolytic | ||
| 26656394 | 2015 | GIHDILKYGKPS{ct:Amid} | Myxinidin-NH2 | Amidation | Free | Linear | L | None | 12 | Antibacterial | 0 ± 0 % Hemolysis at 256 μg/ml | Horse | Amidated Form Of Myxinidin | NA | Non-hemolytic | ||
| 26656394 | 2015 | VDKGSYLPRPTPPRPIYNRN | Pyrrhocoricin | Free | Free | Linear | L | None | 20 | Antibacterial | 0 ± 0 % Hemolysis at 256 μg/ml | Horse | Insects, Pyrrhocoris Apterus | NA | Non-hemolytic | ||
| 26656394 | 2015 | GNNRPVYIPQPRPPHPRI | Apidaecin IA | Free | Free | Linear | L | None | 18 | Antibacterial | 0 ± 0 % Hemolysis at 256 μg/ml | Horse | Insects, Honey Bee | Extended, proline rich | Non-hemolytic | ||
| 26656394 | 2015 | VDKPDYRPRPRPPNM | Metalnikowin I | Free | Free | Linear | L | None | 15 | Antibacterial | 0 ± 0 % Hemolysis at 256 μg/ml | Horse | Insects, Palomena Prasina | NA | Non-hemolytic | ||
| 27038545 | 2016 | GLPGPLGPAGPK | Collagencin | Free | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 7 µM | Horse | Fish Collagen | β-Sheet and β-Turn | NA | ||
| 27038545 | 2016 | GLPGPLGPAGPK | Collagencin | Free | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 15 µM | Horse | Fish Collagen | β-Sheet and β-Turn | NA | ||
| 27038545 | 2016 | GLPGPLGPAGPK | Collagencin | Free | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 29 µM | Horse | Fish Collagen | β-Sheet and β-Turn | NA | ||
| 27038545 | 2016 | GLPGPLGPAGPK | Collagencin | Free | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 59 µM | Horse | Fish Collagen | β-Sheet and β-Turn | NA | ||
| 27038545 | 2016 | GLPGPLGPAGPK | Collagencin | Free | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 118 µM | Horse | Fish Collagen | β-Sheet and β-Turn | NA | ||
| 27038545 | 2016 | GLPGPLGPAGPK | Collagencin | Free | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 235 µM | Horse | Fish Collagen | β-Sheet and β-Turn | NA | ||
| 27038545 | 2016 | GLPGPLGPAGPK | Collagencin | Free | Free | Linear | L | None | 12 | Antibacterial | <10 % Hemolysis at 470 µM | Horse | Fish Collagen | β-Sheet and β-Turn | NA | ||
| 27038545 | 2016 | GLPGPLGPAGPK | Collagencin | Free | Free | Linear | L | None | 12 | Antibacterial | <30 % Hemolysis at 940 µM | Horse | Fish Collagen | β-Sheet and β-Turn | NA | ||
| 27038545 | 2016 | GLPGPLGPAGPK | Collagencin | Free | Free | Linear | L | None | 12 | Antibacterial | <50 % Hemolysis at 1880 µM | Horse | Fish Collagen | β-Sheet and β-Turn | NA | ||
| 27187467 | 2016 | GMWSKIKETAMAAAKEAAKAAGKTISDMIKQ{ct:Amid} | Dermaseptin-PD-1 | Amidation | Free | Linear | L | None | 30 | Antibacterial, Antifungal, Anticancer | 100 % Hemolysis at >156.8 µM | Horse | Pachymedusa Dacnicolor | α-Helix | Low hemolytic | ||
| 27187467 | 2016 | GMWSKIKNAGKAAAKAAAKAAGKAALDAVSEAI{ct:Amid} | Dermaseptin-PD-2 | Amidation | Free | Linear | L | None | 32 | Antibacterial, Antifungal, Anticancer | 100 % Hemolysis at >161.6 µM | Horse | Pachymedusa Dacnicolor | α-Helix | Low hemolytic | ||
| 27311856 | 2016 | #ERROR! | Kunitzin-RE | Free | Free | Linear | L | None | 17 | Antibacterial | little hemolysis % at 120 µM | Horse | European Frog, Rana Esculenta | Loop | Low hemolytic | ||
| 27311856 | 2016 | AVNIPFKVHLRCKAAFC | Kunitzin-OS | Free | Free | Linear | L | None | 12 | Antibacterial | little hemolysis % at 120 µM | Horse | Chinese Frog, Odorrana Schmackeri | Loop | Low hemolytic | ||
| 27321580 | 2016 | GFLDIVKGVGKVALGAVSKLF{ct:Amid} | CZS-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 0 % Hemolysis at 2 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDIVKGVGKVALGAVSKLF{ct:Amid} | CZS-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 0 % Hemolysis at 4 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDIVKGVGKVALGAVSKLF{ct:Amid} | CZS-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 1 % Hemolysis at 8 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDIVKGVGKVALGAVSKLF{ct:Amid} | CZS-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 9 % Hemolysis at 16 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDIVKGVGKVALGAVSKLF{ct:Amid} | CZS-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 20 % Hemolysis at 32 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDIVKGVGKVALGAVSKLF{ct:Amid} | CZS-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 33 % Hemolysis at 64 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDIVKGVGKVALGAVSKLF{ct:Amid} | CZS-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 62 % Hemolysis at 128 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDIVKGVGKVALGAVSKLF{ct:Amid} | CZS-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 105 % Hemolysis at 256 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDIVKGVGKVALGAVSKLF{ct:Amid} | CZS-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 107 % Hemolysis at 512 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVIKHVGKAALGVVTHLINQ{ct:Amid} | CZS-1 | Amidation | Free | Linear | L | None | 21 | Antibacterial, Antifungal | 0 % Hemolysis at 2 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVIKHVGKAALGVVTHLINQ{ct:Amid} | CZS-2 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 1 % Hemolysis at 4 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVIKHVGKAALGVVTHLINQ{ct:Amid} | CZS-2 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 1 % Hemolysis at 8 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVIKHVGKAALGVVTHLINQ{ct:Amid} | CZS-2 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 6 % Hemolysis at 16 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVIKHVGKAALGVVTHLINQ{ct:Amid} | CZS-2 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 26 % Hemolysis at 32 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVIKHVGKAALGVVTHLINQ{ct:Amid} | CZS-2 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 54 % Hemolysis at 64 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVIKHVGKAALGVVTHLINQ{ct:Amid} | CZS-2 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 75 % Hemolysis at 128 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVIKHVGKAALGVVTHLINQ{ct:Amid} | CZS-2 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 93 % Hemolysis at 256 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVIKHVGKAALGVVTHLINQ{ct:Amid} | CZS-2 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 100 % Hemolysis at 512 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVVKHIGKAALGAVTHLINQ{ct:Amid} | CZS-2 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 0 % Hemolysis at 2 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVVKHIGKAALGAVTHLINQ{ct:Amid} | CZS-3 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 1 % Hemolysis at 4 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVVKHIGKAALGAVTHLINQ{ct:Amid} | CZS-3 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 1 % Hemolysis at 8 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVVKHIGKAALGAVTHLINQ{ct:Amid} | CZS-3 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 2 % Hemolysis at 16 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVVKHIGKAALGAVTHLINQ{ct:Amid} | CZS-3 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 6 % Hemolysis at 32 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVVKHIGKAALGAVTHLINQ{ct:Amid} | CZS-3 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 24 % Hemolysis at 64 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVVKHIGKAALGAVTHLINQ{ct:Amid} | CZS-3 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 59 % Hemolysis at 128 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVVKHIGKAALGAVTHLINQ{ct:Amid} | CZS-3 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 83 % Hemolysis at 256 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27321580 | 2016 | GFLDVVKHIGKAALGAVTHLINQ{ct:Amid} | CZS-3 | Amidation | Free | Linear | L | None | 23 | Antibacterial, Antifungal | 96 % Hemolysis at 512 mg/L | Horse | Splendid Leaf Frog Cruziohyla Calcarife | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 1 mg/L | Horse | Phyllomedusa Tarsius | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 128 mg/L | Horse | Phyllomedusa Tarsius | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 256 mg/L | Horse | Phyllomedusa Tarsius | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 512 mg/L | Horse | Phyllomedusa Tarsius | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 1 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 2 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 4 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 8 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 5 % Hemolysis at 16 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 5 % Hemolysis at 32 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 64 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 128 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 256 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPHAIKAVGVHAKHF{ct:Amid} | PS-PT1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <10 % Hemolysis at 512 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPKAIKAVGVKAKKF{ct:Amid} | PS-PT2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 5 % Hemolysis at 1 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPKAIKAVGVKAKKF{ct:Amid} | PS-PT2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 5 % Hemolysis at 2 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPKAIKAVGVKAKKF{ct:Amid} | PS-PT2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 5 % Hemolysis at 4 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPKAIKAVGVKAKKF{ct:Amid} | PS-PT2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <10 % Hemolysis at 8 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPKAIKAVGVKAKKF{ct:Amid} | PS-PT2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <10 % Hemolysis at 16 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPKAIKAVGVKAKKF{ct:Amid} | PS-PT2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 32 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPKAIKAVGVKAKKF{ct:Amid} | PS-PT2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 64 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPKAIKAVGVKAKKF{ct:Amid} | PS-PT2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <10 % Hemolysis at 128 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPKAIKAVGVKAKKF{ct:Amid} | PS-PT2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <10 % Hemolysis at 256 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPKAIKAVGVKAKKF{ct:Amid} | PS-PT2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | 5 % Hemolysis at 512 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid} | PS-PT2a | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 1 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid} | PS-PT2a | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 2 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid} | PS-PT2a | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 4 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid} | PS-PT2a | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 8 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid} | PS-PT2a | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 16 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid} | PS-PT2a | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 32 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid} | PS-PT2a | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 64 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid} | PS-PT2a | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 128 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid} | PS-PT2a | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 256 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIK{d}AVGVK{d}AK{d}K{d}F{ct:Amid} | PS-PT2a | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <10 % Hemolysis at 512 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIKAVGVKAKKF{ct:Amid} | PS-PT2b | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 2 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIKAVGVKAKKF{ct:Amid} | PS-PT2b | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 4 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIKAVGVKAKKF{ct:Amid} | PS-PT2b | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 8 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIKAVGVKAKKF{ct:Amid} | PS-PT2b | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 16 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIKAVGVKAKKF{ct:Amid} | PS-PT2b | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 32 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIKAVGVKAKKF{ct:Amid} | PS-PT2b | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 64 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIKAVGVKAKKF{ct:Amid} | PS-PT2b | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 128 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIKAVGVKAKKF{ct:Amid} | PS-PT2b | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 256 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27918477 | 2016 | FLSLIPK{d}AIKAVGVKAKKF{ct:Amid} | PS-PT2b | Amidation | Free | Linear | Mix | k = D-lysine | 19 | Antimicrobial | <5 % Hemolysis at 512 mg/L | Horse | Ps-Pt Analog | α-Helix | NA | ||
| 27008420 | 2016 | KKLKKFKKLQ{cyc:N-C} | BPC194 | Free | Free | Cyclic | L | None | 10 | Anti-plant-pathogenic bacteria and fungi | 4 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C7H15})FKKLQ{cyc:N-C} | BPC498 | Free | Free | Cyclic | L | CO-C7H15 = octanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 78 ± 4 % Hemolysis at 150 µM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C3H7})FKKLQ{cyc:N-C} | BPC500 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 28 ± 5 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C4H9})FKKLQ{cyc:N-C} | BPC526 | Free | Free | Cyclic | L | CO-C4H9 = pentanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 62 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-isoC5H11})FKKLQ{cyc:N-C} | BPC504 | Free | Free | Cyclic | L | CO-isoC5H11 = 4-methylpentanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 89 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-nC5H11})FKKLQ{cyc:N-C} | BPC528 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 98 ± 7 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK(LK-{nnr:CO-nC5H11})FKKLQ{cyc:N-C} | BPC596 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 12 | Anti-plant-pathogenic bacteria and fungi | 93 ± 5 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C6H13})FKKLQ{cyc:N-C} | BPC592 | Free | Free | Cyclic | L | CO-C6H13 = 2-methylhexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 100 ± 4 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C8H17})FKKLQ{cyc:N-C} | BPC594 | Free | Free | Cyclic | L | CO-C8H17 = 4-methyloctanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 93 ± 11 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C11H23})FKKLQ{cyc:N-C} | BPC530 | Free | Free | Cyclic | L | CO-C11H23 = lauroyl | 10 | Anti-plant-pathogenic bacteria and fungi | 89 ± 7 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C11H22OH})FKKLQ{cyc:N-C} | BPC524 | Free | Free | Cyclic | L | CO-C11H22OH = 12-hydroxylauroyl | 10 | Anti-plant-pathogenic bacteria and fungi | 100 ± 8 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C15H31})FKKLQ{cyc:N-C} | BPC502 | Free | Free | Cyclic | L | CO-C15H31 = palmitoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 78 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C17H33})FKKLQ{cyc:N-C} | BPC622 | Free | Free | Cyclic | L | CO-C17H33 = oleoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 91 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKKFKK({nnr:CO-nC5H11})LQ{cyc:N-C} | BPC582 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 92 ± 3 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKKFK({nnr:CO-nC5H11})KLQ{cyc:N-C} | BPC584 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 72 ± 5 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLK({nnr:CO-nC5H11})KFKKLQ{cyc:N-C} | BPC586 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 92 ± 9 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK({nnr:CO-nC5H11})LKKFKKLQ{cyc:N-C} | BPC588 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 95 ± 4 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK({nnr:CO-C3H7})LKKFKKLQ{cyc:N-C} | BPC708 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 2 ± 0.5 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K({nnr:CO-nC5H11})KLKKFKKLQ{cyc:N-C} | BPC590 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 100 ± 9 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K({nnr:CO-C3H7})KLKKFKKLQ{cyc:N-C} | BPC710 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 7 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{nnr:CO-C3H7}F{d}KKLQ{cyc:N-C} | BPC712 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 30 ± 4 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKKLK-{nnr:CO-C3H7}F{d}KKLQ{cyc:N-C} | BPC726 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, f = D-phenylalanine | 12 | Anti-plant-pathogenic bacteria and fungi | 0 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{nnr:CO-nC5H11}F{d}KKLQ{cyc:N-C} | BPC624 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 53 ± 5 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{nnr:CO-isoC5H11}F{d}KKLQ{cyc:N-C} | BPC626 | Free | Free | Cyclic | Mix | CO-isoC5H11 = 4-methylpentanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 51 ± 7 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKKLK-{nnr:CO-nC5H11}F{d}KKLQ{cyc:N-C} | BPC674 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, f = D-phenylalanine | 12 | Anti-plant-pathogenic bacteria and fungi | 51 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{nnr:CO-C7H15}F{d}KKLQ{cyc:N-C} | BPC668 | Free | Free | Cyclic | Mix | CO-C7H15 = octanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 79 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK{nnr:CO-C3H7}LKKF{d}KKLQ{cyc:N-C} | BPC714 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 3 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK{nnr:CO-nC5H11}LKKF{d}KKLQ{cyc:N-C} | BPC680 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 77 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K{nnr:CO-C3H7}KLKKF{d}KKLQ{cyc:N-C} | BPC716 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 2 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K{nnr:CO-nC5H11}KLKKF{d}KKLQ{cyc:N-C} | BPC686 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 10 ± 0.2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}{nnr:CO-C3H7}FKKLQ{cyc:N-C} | BPC702 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 1 ± 0.1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}LK-{nnr:CO-C3H7}FKKLQ{cyc:N-C} | BPC724 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, k = D-Lys | 12 | Anti-plant-pathogenic bacteria and fungi | 3 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}{nnr:CO-nC5H11}FKKLQ{cyc:N-C} | BPC628 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 19 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}{nnr:CO-isoC5H11}FKKLQ{cyc:N-C} | BPC630 | Free | Free | Cyclic | Mix | CO-isoC5H11 = 4-methylpentanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 22 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}LK-{nnr:CO-nC5H11}FKKLQ{cyc:N-C} | BPC672 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, k = D-Lys | 12 | Anti-plant-pathogenic bacteria and fungi | 33 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}{nnr:CO-C7H15}FKKLQ{cyc:N-C} | BPC666 | Free | Free | Cyclic | Mix | CO-C7H15 = octanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 61 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK{d}{nnr:CO-nC5H11}LKKFKKLQ{cyc:N-C} | BPC678 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 68 ± 3 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK{d}{nnr:CO-C3H7}LKKFKKLQ{cyc:N-C} | BPC704 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 9 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K{d}{nnr:CO-nC5H11}KLKKFKKLQ{cyc:N-C} | BPC684 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 8 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K{d}{nnr:CO-C3H7}KLKKFKKLQ{cyc:N-C} | BPC706 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 35 ± 3 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}{nnr:CO-nC5H11}F{d}KKLQ{cyc:N-C} | BPC632 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, f = D-phenylalanine, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 21 ± 13 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}{nnr:CO-isoC5H11}F{d}KKLQ{cyc:N-C} | BPC634 | Free | Free | Cyclic | Mix | CO-isoC5H11 = 4-methylpentanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 7 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C3H7})HKKLQ{cyc:N-C} | BPC718 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 3 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK(LK-{nnr:CO-C3H7})HKKLQ{cyc:N-C} | BPC728 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 12 | Anti-plant-pathogenic bacteria and fungi | 0 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Non-hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-nC5H11})HKKLQ{cyc:N-C} | BPC636 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 5 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-isoC5H11})HKKLQ{cyc:N-C} | BPC638 | Free | Free | Cyclic | L | CO-isoC5H11 = 4-methylpentanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 6 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK(LK-{nnr:CO-nC5H11})HKKLQ{cyc:N-C} | BPC676 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 12 | Anti-plant-pathogenic bacteria and fungi | 3 ± 0.3 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C7H15})HKKLQ{cyc:N-C} | BPC670 | Free | Free | Cyclic | L | CO-C7H15 = octanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 34 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK({nnr:CO-nC5H11})LKKHKKLQ{cyc:N-C} | BPC682 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 20 ± 3 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK({nnr:CO-C3H7})LKKHKKLQ{cyc:N-C} | BPC720 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 3 ± 1 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K({nnr:CO-nC5H11})KLKKHKKLQ{cyc:N-C} | BPC688 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 1 ± 2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K({nnr:CO-C3H7})KLKKHKKLQ{cyc:N-C} | BPC722 | Free | Free | Cyclic | L | CO-C3H7= butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 3 ± 0.2 % Hemolysis at 150 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKKFKKLQ{cyc:N-C} | BPC194 | Free | Free | Cyclic | L | None | 10 | Anti-plant-pathogenic bacteria and fungi | 6 ± 1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C7H15})FKKLQ{cyc:N-C} | BPC498 | Free | Free | Cyclic | L | CO-C7H15 = octanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 100 ± 12 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C3H7})FKKLQ{cyc:N-C} | BPC500 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 38 ± 4 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C4H9})FKKLQ{cyc:N-C} | BPC526 | Free | Free | Cyclic | L | CO-C4H9 = pentanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 78 ± 3 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-isoC5H11})FKKLQ{cyc:N-C} | BPC504 | Free | Free | Cyclic | L | CO-isoC5H11 = 4-methylpentanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 93 ± 3 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-nC5H11})FKKLQ{cyc:N-C} | BPC528 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 100 ± 1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK(LK-{nnr:CO-nC5H11})FKKLQ{cyc:N-C} | BPC596 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 12 | Anti-plant-pathogenic bacteria and fungi | 100 ± 11 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C6H13})FKKLQ{cyc:N-C} | BPC592 | Free | Free | Cyclic | L | CO-C6H13 = 2-methylhexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 98 ± 6 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C8H17})FKKLQ{cyc:N-C} | BPC594 | Free | Free | Cyclic | L | CO-C8H17 = 4-methyloctanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 96 ± 3 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C11H23})FKKLQ{cyc:N-C} | BPC530 | Free | Free | Cyclic | L | CO-C11H23 = lauroyl | 10 | Anti-plant-pathogenic bacteria and fungi | 91 ± 9 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C11H22OH})FKKLQ{cyc:N-C} | BPC524 | Free | Free | Cyclic | L | CO-C11H22OH = 12-hydroxylauroyl | 10 | Anti-plant-pathogenic bacteria and fungi | 100 ± 6 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C15H31})FKKLQ{cyc:N-C} | BPC502 | Free | Free | Cyclic | L | CO-C15H31 = palmitoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 99 ± 2 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C17H33})FKKLQ{cyc:N-C} | BPC622 | Free | Free | Cyclic | L | CO-C17H33 = oleoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 97 ± 3 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKKFKK({nnr:CO-nC5H11})LQ{cyc:N-C} | BPC582 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 96 ± 10 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKKFK({nnr:CO-nC5H11})KLQ{cyc:N-C} | BPC584 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 97 ± 12 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLK({nnr:CO-nC5H11})KFKKLQ{cyc:N-C} | BPC586 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 95 ± 20 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK({nnr:CO-nC5H11})LKKFKKLQ{cyc:N-C} | BPC588 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 92 ± 12 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK({nnr:CO-C3H7})LKKFKKLQ{cyc:N-C} | BPC708 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 3 ± 1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K({nnr:CO-nC5H11})KLKKFKKLQ{cyc:N-C} | BPC590 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 100 ± 9 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K({nnr:CO-C3H7})KLKKFKKLQ{cyc:N-C} | BPC710 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 13 ± 2 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{nnr:CO-C3H7}F{d}KKLQ{cyc:N-C} | BPC712 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 38 ± 7 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKKLK-{nnr:CO-C3H7}F{d}KKLQ{cyc:N-C} | BPC726 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, f = D-phenylalanine | 12 | Anti-plant-pathogenic bacteria and fungi | 4 ± 2 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{nnr:CO-nC5H11}F{d}KKLQ{cyc:N-C} | BPC624 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 64 ± 9 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{nnr:CO-isoC5H11}F{d}KKLQ{cyc:N-C} | BPC626 | Free | Free | Cyclic | Mix | CO-isoC5H11 = 4-methylpentanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 54 ± 4 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKKLK-{nnr:CO-nC5H11}F{d}KKLQ{cyc:N-C} | BPC674 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, f = D-phenylalanine | 12 | Anti-plant-pathogenic bacteria and fungi | 56 ± 2 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{nnr:CO-C7H15}F{d}KKLQ{cyc:N-C} | BPC668 | Free | Free | Cyclic | Mix | CO-C7H15 = octanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 79 ± 1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK{nnr:CO-C3H7}LKKF{d}KKLQ{cyc:N-C} | BPC714 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 3 ± 0.5 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK{nnr:CO-nC5H11}LKKF{d}KKLQ{cyc:N-C} | BPC680 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 81 ± 4 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K{nnr:CO-C3H7}KLKKF{d}KKLQ{cyc:N-C} | BPC716 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 4 ± 0.5 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K{nnr:CO-nC5H11}KLKKF{d}KKLQ{cyc:N-C} | BPC686 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, f = D-phenylalanine | 10 | Anti-plant-pathogenic bacteria and fungi | 14 ± 0.4 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}{nnr:CO-C3H7}FKKLQ{cyc:N-C} | BPC702 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 2 ± 0.3 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}LK-{nnr:CO-C3H7}FKKLQ{cyc:N-C} | BPC724 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, k = D-Lys | 12 | Anti-plant-pathogenic bacteria and fungi | 3 ± 0.5 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}{nnr:CO-nC5H11}FKKLQ{cyc:N-C} | BPC628 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 34 ± 3 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}{nnr:CO-isoC5H11}FKKLQ{cyc:N-C} | BPC630 | Free | Free | Cyclic | Mix | CO-isoC5H11 = 4-methylpentanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 28 ± 3 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}LK-{nnr:CO-nC5H11}FKKLQ{cyc:N-C} | BPC672 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, k = D-Lys | 12 | Anti-plant-pathogenic bacteria and fungi | 33 ± 2 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}{nnr:CO-C7H15}FKKLQ{cyc:N-C} | BPC666 | Free | Free | Cyclic | Mix | CO-C7H15 = octanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 73 ± 3 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK{d}{nnr:CO-nC5H11}LKKFKKLQ{cyc:N-C} | BPC678 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 73 ± 4 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK{d}{nnr:CO-C3H7}LKKFKKLQ{cyc:N-C} | BPC704 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 16 ± 2 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K{d}{nnr:CO-nC5H11}KLKKFKKLQ{cyc:N-C} | BPC684 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 13 ± 1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K{d}{nnr:CO-C3H7}KLKKFKKLQ{cyc:N-C} | BPC706 | Free | Free | Cyclic | Mix | CO-C3H7 = butanoyl, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 46 ± 3 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}{nnr:CO-nC5H11}F{d}KKLQ{cyc:N-C} | BPC632 | Free | Free | Cyclic | Mix | CO-nC5H11 = hexanoyl, f = D-phenylalanine, k = D-Lys | 10 | Anti-plant-pathogenic bacteria and fungi | 22 ± 10 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK{d}({nnr:CO-isoC5H11})F{d}KKLQ{cyc:N-C} | BPC634 | Free | Free | Cyclic | L | CO-isoC5H11 = 4-methylpentanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 17 ± 8 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C3H7})HKKLQ{cyc:N-C} | BPC718 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 4 ± 1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK(LK-{nnr:CO-C3H7})HKKLQ{cyc:N-C} | BPC728 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 12 | Anti-plant-pathogenic bacteria and fungi | 7 ± 1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-nC5H11})HKKLQ{cyc:N-C} | BPC636 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 16 ± 5 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-isoC5H11})HKKLQ{cyc:N-C} | BPC638 | Free | Free | Cyclic | L | CO-isoC5H11 = 4-methylpentanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 8 ± 5 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK(LK-{nnr:CO-nC5H11})HKKLQ{cyc:N-C} | BPC676 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 12 | Anti-plant-pathogenic bacteria and fungi | 3 ± 1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KKLKK({nnr:CO-C7H15})HKKLQ{cyc:N-C} | BPC670 | Free | Free | Cyclic | L | CO-C7H15 = octanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 40 ± 1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK({nnr:CO-nC5H11})LKKHKKLQ{cyc:N-C} | BPC682 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 27 ± 1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | KK({nnr:CO-C3H7})LKKHKKLQ{cyc:N-C} | BPC720 | Free | Free | Cyclic | L | CO-C3H7 = butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 4 ± 1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 27008420 | 2016 | K({nnr:CO-nC5H11})KLKKHKKLQ{cyc:N-C} | BPC688 | Free | Free | Cyclic | L | CO-nC5H11 = hexanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 1 ± 0.2 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Non-hemolytic | ||
| 27008420 | 2016 | K({nnr:CO-C3H7})KLKKHKKLQ{cyc:N-C} | BPC722 | Free | Free | Cyclic | L | CO-C3H7= butanoyl | 10 | Anti-plant-pathogenic bacteria and fungi | 3 ± 0.1 % Hemolysis at 250 µM | Horse | Synthetic Cyclolipopeptides | NA | Low hemolytic | ||
| 28122029 | 2017 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | moro-NH2 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 60 % Hemolysis at 25 µM | Horse | Hybrid Striped Bass | α-Helix | NA | ||
| 28122029 | 2017 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | moro-NH2 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 70 % Hemolysis at 50 µM | Horse | Hybrid Striped Bass | α-Helix | NA | ||
| 28122029 | 2017 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | moro-NH2 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 40 % Hemolysis at 6.25 µM | Horse | Hybrid Striped Bass | α-Helix | NA | ||
| 28122029 | 2017 | FFHHIFRGIVHVGKTIHKLVTG{ct:Amid} | moro-NH2 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 20 % Hemolysis at 5 µM | Horse | Hybrid Striped Bass | α-Helix | NA | ||
| 28122029 | 2017 | FFWHHIGHALDAAKRVHGMLSG{ct:Amid} | moroNC-NH2 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | ~10 % Hemolysis at 50 µM | Horse | Notothenia Coriiceps | α-Helix | NA | ||
| 28122029 | 2017 | FFWHHIGHALDAAKRVHGMLSG{ct:Amid} | moroNC-NH2 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | <1 % Hemolysis at 25 µM | Horse | Notothenia Coriiceps | α-Helix | NA | ||
| 28122029 | 2017 | FFGHLFRGIINVGKHIHGLLSG{ct:Amid} | moroPC-NH2 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 50 µM | Horse | Parachaenichthys Charcoti | α-Helix | NA | ||
| 28122029 | 2017 | FFGHLFRGIINVGKHIHGLLSG{ct:Amid} | moroPC-NH2 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | <10 % Hemolysis at 25 µM | Horse | Parachaenichthys Charcoti | α-Helix | NA | ||
| 28012857 | 2017 | FALALKALKKALKKLKKALKKAL | Hecate | Free | Free | Linear | L | None | 23 | Antimicrobial | 0 % Hemolysis at 0-25 µM | Horse | Synthetic, Derivate Of Melittin | α-Helix | NA | ||
| 28012857 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 50 % Hemolysis at 5 µM | Horse | Apis Mellifera | α-Helix | NA | ||
| 28012857 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 75 % Hemolysis at 10 µM | Horse | Apis Mellifera | α-Helix | NA | ||
| 28012857 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 15-25 µM | Horse | Apis Mellifera | α-Helix | NA | ||
| 28012857 | 2017 | ILGPVLGLVSDTLDDVLGIL | Maximin H5 | Free | Free | Linear | L | None | 20 | Antimicrobial | 0 % Hemolysis at 0-25 µM | Horse | Bombina Maxima Smap2 9 Rglrrlgrkiahgvkkygptvlriiri Ag 29 3256.0 0 12.3 1 +9 Derivative Of Ovispi | α-Helix | Non-hemolytic | ||
| 28012857 | 2017 | RGLRRLGRKIAHGVKKYGPTVLRIIRIAG | SMAP29 | Free | Free | Linear | L | None | 29 | Antimicrobial | 0 % Hemolysis at 0-25 µM | Horse | Derivative Of Ovispirin, Ovis Aries | α-Helix | Non-hemolytic | ||
| 28012857 | 2017 | KWKLWKKIEKWGQGIGAVLKWLTTWL | CAM-W | Free | Free | Linear | L | None | 26 | Antimicrobial | 80 % Hemolysis at 5 µM | Horse | Synthetic, Cecropin A / Melittin Hybrid | α-Helix | NA | ||
| 28012857 | 2017 | KWKLWKKIEKWGQGIGAVLKWLTTWL | CAM-W | Free | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 10 µM | Horse | Synthetic, Cecropin A / Melittin Hybrid | α-Helix | NA | ||
| 28012857 | 2017 | WEAALAEALAEALAEHLAEALAEALEALAA | GALA | Free | Free | Linear | L | None | 30 | Antimicrobial | 10 % Hemolysis at 25 µM | Horse | Synthetic, Cecropin A / Melittin Hybrid | α-Helix | NA | ||
| 28012857 | 2017 | WEAKLAKALAKALAKHLAKALAKALKACEA | KALA | Free | Free | Linear | L | None | 30 | Antimicrobial | <60 % Hemolysis at 25 µM | Horse | Synthetic | α-Helix | NA | ||
| 28012857 | 2017 | WEAKLAKALAKALAKHLAKALAKALKACEA | KALA | Free | Free | Linear | L | None | 30 | Antimicrobial | 50 % Hemolysis at 15 µM | Horse | Synthetic | α-Helix | NA | ||
| 28012857 | 2017 | WEAKLAKALAKALAKHLAKALAKALKACEA | KALA | Free | Free | Linear | L | None | 30 | Antimicrobial | 40 % Hemolysis at 10 µM | Horse | Synthetic | α-Helix | NA | ||
| 28850103 | 2017 | FLSLIPKIAGGIAALAKHL{ct:Amid} | Phylloseptin-PTa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 10 % Hemolysis at 7.79 µM | Horse | Phyllomedusa Tarsius | α-Helix | NA | ||
| 28850103 | 2017 | FLSLIPKIAGGIAALAKHL{ct:Amid} | Phylloseptin-PTa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 22.8 µM | Horse | Phyllomedusa Tarsius | α-Helix | NA | ||
| 28850103 | 2017 | FLSLIPAAISAVSALANHF{ct:Amid} | phylloseptin-PHa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 10 % Hemolysis at 76.5 µM | Horse | Phyllomedusa Hypochondrialis | α-Helix | NA | ||
| 28850103 | 2017 | FLSLIPAAISAVSALANHF{ct:Amid} | phylloseptin-PHa | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 109.5 µM | Horse | Phyllomedusa Hypochondrialis | α-Helix | NA | ||
| 28894024 | 2017 | GIGGALLSFGKSALKGLAKGLAEHF{ct:Amid} | BHL-bombinin | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 50 % Hemolysis at 64 mg/l | Horse | Bombina Orientalis | α-Helix | NA | ||
| 28894024 | 2017 | LLGPVLGLVSNVLGGLL{ct:Amid} | Bombinin HL | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 50 % Hemolysis at >512 mg/l | Horse | Bombina Orientalis | α-Helix | NA | ||
| 28894024 | 2017 | LLGPVLGLVSNVLGGLL{ct:Amid} | Bombinin HD | Amidation | Free | Linear | L | None | 17 | Antimicrobial | 50 % Hemolysis at >512 mg/l | Horse | Bombina Orientalis | α-Helix | NA | ||
| 28894024 | 2017 | GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid} | Melittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 50 % Hemolysis at 1 mg/l | Horse | Bee Venom | α-Helix | NA | ||
| 29112170 | 2017 | FLSLIPKIATGIAALAKHL | PSN-PC | Free | Free | Linear | L | None | 19 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 23 µM | Horse | Phyllomedusa Camba Skin Secretion | α-Helical | NA | ||
| 29112170 | 2017 | FLSLIPKIATGIAALAKHL | PSN-PC | Free | Free | Linear | L | None | 19 | Antimicrobial, Antibiofilm | ~100 % Hemolysis at 64 µM | Horse | Phyllomedusa Camba Skin Secretion | α-Helical | NA | ||
| 29112170 | 2017 | FLSLIPKIATGIAALAKHL | PSN-PC | Free | Free | Linear | L | None | 19 | Antimicrobial, Antibiofilm | ~100 % Hemolysis at 128 µM | Horse | Phyllomedusa Camba Skin Secretion | α-Helical | NA | ||
| 29112170 | 2017 | FLSLIPKIATGIAALAKHL | PSN-PC | Free | Free | Linear | L | None | 19 | Antimicrobial, Antibiofilm | ~100 % Hemolysis at 256 µM | Horse | Phyllomedusa Camba Skin Secretion | α-Helical | NA | ||
| 29112170 | 2017 | FLSLIPKIATGIAALAKHL | PSN-PC | Free | Free | Linear | L | None | 19 | Antimicrobial, Antibiofilm | ~100 % Hemolysis at 512 µM | Horse | Phyllomedusa Camba Skin Secretion | α-Helical | NA | ||
| 28026016 | 2017 | KKLKKFKKLQ{cyc:N-C} | BPC194 | Free | Free | Cyclic | L | None | 10 | Antimicrobial | 3 ± 0.6 % Hemolysis at 150 µM | Horse | Synthetic Peptidotriazoles | NA | NA | ||
| 28026016 | 2017 | KKLKKFKKLQ{cyc:N-C} | BPC194 | Free | Free | Cyclic | L | None | 10 | Antimicrobial | 3 ± 0.6 % Hemolysis at 250 µM | Horse | Synthetic Peptidotriazoles | NA | NA | ||
| 28026016 | 2017 | KKLKKFKKLQ{cyc:N-C} | BPC194 | Free | Free | Cyclic | L | None | 10 | Antimicrobial | 4 ± 0.7 % Hemolysis at 375 µM | Horse | Synthetic Peptidotriazoles | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:Tr-Bn}{cyc:N-C} | BPC458 | Free | Free | Cyclic | L | Tr-Bn = triazole bearing a benzyl group | 3 | Antimicrobial | 2 ± 0.3 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:Tr-Bn}{cyc:N-C} | BPC458 | Free | Free | Cyclic | L | Tr-Bn = triazole bearing a benzyl group | 3 | Antimicrobial | 3 ± 0.5 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:Tr-Bn}{cyc:N-C} | BPC458 | Free | Free | Cyclic | L | Tr-Bn = triazole bearing a benzyl group | 3 | Antimicrobial | 5 ± 0.2 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:Tr-Nle}{cyc:N-C} | BPC460 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid | 3 | Antimicrobial | 0 ± 0.3 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:Tr-Nle}{cyc:N-C} | BPC460 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid | 3 | Antimicrobial | 0 ± 0.3 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:Tr-Nle}{cyc:N-C} | BPC460 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid | 3 | Antimicrobial | 0 ± 0.1 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:TrPhNH2}{cyc:N-C} | BPC518 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety | 3 | Antimicrobial | 1 ± 0.1 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:TrPhNH2}{cyc:N-C} | BPC518 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety | 3 | Antimicrobial | 1 ± 0.1 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:TrPhNH2}{cyc:N-C} | BPC518 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety | 3 | Antimicrobial | 1 ± 0.1 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:TrPhMe}{cyc:N-C} | BPC540 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph-Me = triazole bearing a tolyl group | 3 | Antimicrobial | 2 ± 0.5 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:TrPhMe}{cyc:N-C} | BPC540 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph-Me = triazole bearing a tolyl group | 3 | Antimicrobial | 4 ± 0.4 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:TrPhMe}{cyc:N-C} | BPC540 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph-Me = triazole bearing a tolyl group | 3 | Antimicrobial | 6 ± 1 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:TrPhOMe}{cyc:N-C} | BPC542 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-PhOMe = triazole bearing an anisole moiety | 3 | Antimicrobial | 1 ± 0.6 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:TrPhOMe}{cyc:N-C} | BPC542 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-PhOMe = triazole bearing an anisole moiety | 3 | Antimicrobial | 2 ± 0.2 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:TrPhOMe}{cyc:N-C} | BPC542 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-PhOMe = triazole bearing an anisole moiety | 3 | Antimicrobial | 4 ± 0.4 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:TrPh}{cyc:N-C} | BPC544 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph = triazole bearing a phenyl group | 3 | Antimicrobial | 1 ± 0.4 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:TrPh}{cyc:N-C} | BPC544 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph = triazole bearing a phenyl group | 3 | Antimicrobial | 1 ± 0.3 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAA{nnr:TrPh}{cyc:N-C} | BPC544 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph = triazole bearing a phenyl group | 3 | Antimicrobial | 2 ± 0.4 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPh}{cyc:N-C} | BPC516 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph = triazole bearing a phenyl group | 3 | Antimicrobial | 5 ± 0.2 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPh}{cyc:N-C} | BPC516 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph = triazole bearing a phenyl group | 3 | Antimicrobial | 6 ± 0.4 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPh}{cyc:N-C} | BPC516 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph = triazole bearing a phenyl group | 3 | Antimicrobial | 8 ± 0.1 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhNH2}{cyc:N-C} | BPC538 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety | 3 | Antimicrobial | 1 ± 0.8 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhNH2}{cyc:N-C} | BPC538 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety | 3 | Antimicrobial | 1 ± 0.4 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhNH2}{cyc:N-C} | BPC538 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety | 3 | Antimicrobial | 2 ± 0.4 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhMe}{cyc:N-C} | BPC548 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph-Me = triazole bearing a tolyl group | 3 | Antimicrobial | 12 ± 0.3 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhMe}{cyc:N-C} | BPC548 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph-Me = triazole bearing a tolyl group | 3 | Antimicrobial | 24 ± 1 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhMe}{cyc:N-C} | BPC548 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph-Me = triazole bearing a tolyl group | 3 | Antimicrobial | 26 ± 4 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhOMe}{cyc:N-C} | BPC550 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-PhOMe = triazole bearing an anisole moiety | 3 | Antimicrobial | 7 ± 0.8 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhOMe}{cyc:N-C} | BPC550 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-PhOMe = triazole bearing an anisole moiety | 3 | Antimicrobial | 10 ± 0.8 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhOMe}{cyc:N-C} | BPC550 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-PhOMe = triazole bearing an anisole moiety | 3 | Antimicrobial | 19 ± 5 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKK{nnr:COTr}{cyc:N-C} | BPC692 | Free | Free | Cyclic | L | Tr = unsubsituted triazole | 3 | Antimicrobial | 5 ± 0.7 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKK{nnr:COTr}{cyc:N-C} | BPC692 | Free | Free | Cyclic | L | Tr = unsubsituted triazole | 3 | Antimicrobial | 5 ± 0.8 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKK{nnr:COTr}{cyc:N-C} | BPC692 | Free | Free | Cyclic | L | Tr = unsubsituted triazole | 3 | Antimicrobial | 7 ± 0.2 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKK{nnr:COTrBn}{cyc:N-C} | BPC696 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Bn = triazole bearing a benzyl group | 3 | Antimicrobial | 19 ± 4 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKK{nnr:COTrBn}{cyc:N-C} | BPC696 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Bn = triazole bearing a benzyl group | 3 | Antimicrobial | 20 ± 5 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKK{nnr:COTrBn}{cyc:N-C} | BPC696 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Bn = triazole bearing a benzyl group | 3 | Antimicrobial | 30 ± 4 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKK{nnr:COTrNle}{cyc:N-C} | BPC700 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid | 3 | Antimicrobial | 0 ± 2 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKK{nnr:COTrNle}{cyc:N-C} | BPC700 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid | 3 | Antimicrobial | 0 ± 0.4 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKK{nnr:COTrNle}{cyc:N-C} | BPC700 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid | 3 | Antimicrobial | 0 ± 0.1 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAAAA({nnr:TrBn}{cyc:N-C} | BPC510 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Bn = triazole bearing a benzyl group | 5 | Antimicrobial | 32 ± 2 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAAAA({nnr:TrBn}{cyc:N-C} | BPC510 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Bn = triazole bearing a benzyl group | 5 | Antimicrobial | 35 ± 3 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAAAA({nnr:TrBn}{cyc:N-C} | BPC510 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Bn = triazole bearing a benzyl group | 5 | Antimicrobial | 40 ± 4 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAAAA{nnr:Tr-Nle}{cyc:N-C} | BPC512 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid | 5 | Antimicrobial | 2 ± 0.1 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAAAA{nnr:Tr-Nle}{cyc:N-C} | BPC512 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid | 5 | Antimicrobial | 2 ± 0.2 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAAAA{nnr:Tr-Nle}{cyc:N-C} | BPC512 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid | 5 | Antimicrobial | 3 ± 0.4 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAAAA{nnr:TrPhNH2}{cyc:N-C} | BPC514 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety | 5 | Antimicrobial | 16 ± 0.9 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAAAA{nnr:TrPhNH2}{cyc:N-C} | BPC514 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety | 5 | Antimicrobial | 19 ± 0.8 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | AAAAA{nnr:TrPhNH2}{cyc:N-C} | BPC514 | Free | Free | Cyclic | L | Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety | 5 | Antimicrobial | 23 ± 2 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPh}{cyc:N-C} | BPC562 | Free | Free | Cyclic | L | Tr-Ph = triazole bearing a phenyl group | 5 | Antimicrobial | 42 ± 5 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPh}{cyc:N-C} | BPC562 | Free | Free | Cyclic | L | Tr-Ph = triazole bearing a phenyl group | 5 | Antimicrobial | 51 ± 3 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPh}{cyc:N-C} | BPC562 | Free | Free | Cyclic | L | Tr-Ph = triazole bearing a phenyl group | 5 | Antimicrobial | 58 ± 1 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhNH2}{cyc:N-C} | BPC572 | Free | Free | Cyclic | L | Tr-Ph-NH2 = triazole bearing an aniline moiety | 5 | Antimicrobial | 8 ± 0.2 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhNH2}{cyc:N-C} | BPC572 | Free | Free | Cyclic | L | Tr-Ph-NH2 = triazole bearing an aniline moiety | 5 | Antimicrobial | 13 ± 0.2 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhNH2}{cyc:N-C} | BPC572 | Free | Free | Cyclic | L | Tr-Ph-NH2 = triazole bearing an aniline moiety | 5 | Antimicrobial | 25 ± 5 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhOMe}{cyc:N-C} | BPC558 | Free | Free | Cyclic | L | Tr-PhOMe = triazole bearing an anisole moiety | 5 | Antimicrobial | 54 ± 4 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhOMe}{cyc:N-C} | BPC558 | Free | Free | Cyclic | L | Tr-PhOMe = triazole bearing an anisole moiety | 5 | Antimicrobial | 76 ± 8 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | {nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhOMe}{cyc:N-C} | BPC558 | Free | Free | Cyclic | L | Tr-PhOMe = triazole bearing an anisole moiety | 5 | Antimicrobial | 90 ± 8 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKKKK{nnr:COTr}){cyc:N-C} | BPC690 | Free | Free | Cyclic | L | Tr = unsubsituted triazole | 5 | Antimicrobial | 47 ± 7 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKKKK{nnr:COTr}){cyc:N-C} | BPC690 | Free | Free | Cyclic | L | Tr = unsubsituted triazole | 5 | Antimicrobial | 67 ± 8 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKKKK{nnr:COTr}){cyc:N-C} | BPC690 | Free | Free | Cyclic | L | Tr = unsubsituted triazole | 5 | Antimicrobial | 75 ± 7 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKKKK{nnr:COTrBn}{cyc:N-C} | BPC694 | Free | Free | Cyclic | L | Tr-Bn = triazole bearing a benzyl group | 5 | Antimicrobial | 57 ± 5 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKKKK{nnr:COTrBn}{cyc:N-C} | BPC694 | Free | Free | Cyclic | L | Tr-Bn = triazole bearing a benzyl group | 5 | Antimicrobial | 74 ± 15 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKKKK{nnr:COTrBn}{cyc:N-C} | BPC694 | Free | Free | Cyclic | L | Tr-Bn = triazole bearing a benzyl group | 5 | Antimicrobial | 93 ± 15 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKKKK{nnr:COTrNle}{cyc:N-C} | BPC698 | Free | Free | Cyclic | L | Tr-Bn = triazole bearing a benzyl group | 5 | Antimicrobial | 3 ± 0.5 % Hemolysis at 150 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKKKK{nnr:COTrNle}{cyc:N-C} | BPC698 | Free | Free | Cyclic | L | Tr-Bn = triazole bearing a benzyl group | 5 | Antimicrobial | 4 ± 1 % Hemolysis at 250 µM | Horse | Bpc194 Analog | NA | NA | ||
| 28026016 | 2017 | KKKKK{nnr:COTrNle}{cyc:N-C} | BPC698 | Free | Free | Cyclic | L | Tr-Bn = triazole bearing a benzyl group | 5 | Antimicrobial | 5 ± 0.7 % Hemolysis at 375 µM | Horse | Bpc194 Analog | NA | NA | ||
| 38794259 | 2024 | AVNIPFKVHFRCKAAFC | OSTI−1949 | Free | Free | Linear | L | None | 17 | Antimicrobial | 20 % Hemolysis at 287.8 µM | Horse | Kunitz-Type Inhibitor From Odorrana Schmackeri | α-Helical | NA | ||
| 38794259 | 2024 | VIFKVFWRCKAAFC | OSTI−1716 | Free | Free | Linear | L | None | 14 | Antimicrobial | 20 % Hemolysis at 270.4 µM | Horse | Osti−1949 Analogues | α-Helical | NA | ||
| 38794259 | 2024 | IKFKVHFRCKAAFC | OSTI−1696 | Free | Free | Linear | L | None | 14 | Antimicrobial | 20 % Hemolysis at 297.7 µM | Horse | Osti−1949 Analogues | β-Strand | NA | ||
| 38794259 | 2024 | AVKRAVKRFKVHFRCKAAFC | OSTI−2363 | Free | Free | Linear | L | None | 20 | Antimicrobial | 20 % Hemolysis at 555.4 µM | Horse | Osti−1949 Analogues | β-Strand | NA | ||
| 38794259 | 2024 | AVNIPFKVHFKVHFRCKAAFC | OSTI−2461 | Free | Free | Linear | L | None | 20 | Antimicrobial | 20 % Hemolysis at 304.2 µM | Horse | Osti−1949 Analogues | α-Helical | NA | ||
| 38673786 | 2024 | KKPKPKPKPWWWW{ct:Amid} | K9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <10 % Hemolysis at 2 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPKPKPKPWWWW{ct:Amid} | K9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <10 % Hemolysis at 4 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPKPKPKPWWWW{ct:Amid} | K9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 8 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPKPKPKPWWWW{ct:Amid} | K9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 16 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPKPKPKPWWWW{ct:Amid} | K9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 32 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPKPKPKPWWWW{ct:Amid} | K9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 64 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPKPKPKPWWWW{ct:Amid} | K9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 128 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPRPRPRPWWWW{ct:Amid} | KR9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 2 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPRPRPRPWWWW{ct:Amid} | KR9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 4 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPRPRPRPWWWW{ct:Amid} | KR9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 8 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPRPRPRPWWWW{ct:Amid} | KR9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 16 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPRPRPRPWWWW{ct:Amid} | KR9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 32 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPRPRPRPWWWW{ct:Amid} | KR9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 64 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | KKPRPRPRPWWWW{ct:Amid} | KR9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <40 % Hemolysis at 128 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWW{ct:Amid} | R9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 2 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWW{ct:Amid} | R9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 4 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWW{ct:Amid} | R9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 8 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWW{ct:Amid} | R9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <20 % Hemolysis at 16 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWW{ct:Amid} | R9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <30 % Hemolysis at 32 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWW{ct:Amid} | R9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <50 % Hemolysis at 64 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWW{ct:Amid} | R9W4 | Amidation | Free | Linear | L | None | 13 | Antibacterial | <80 % Hemolysis at 128 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWWW{ct:Amid} | R9W5 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <20 % Hemolysis at 2 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWWW{ct:Amid} | R9W5 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <20 % Hemolysis at 4 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWWW{ct:Amid} | R9W5 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <40 % Hemolysis at 8 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWWW{ct:Amid} | R9W5 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <70 % Hemolysis at 16 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWWW{ct:Amid} | R9W5 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <120 % Hemolysis at 32 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWWW{ct:Amid} | R9W5 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <120 % Hemolysis at 64 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | RRPRPRPRPWWWWW{ct:Amid} | R9W5 | Amidation | Free | Linear | L | None | 14 | Antibacterial | <120 % Hemolysis at 128 µM | Horse | Synthetic | α-Helical | NA | ||
| 38673786 | 2024 | ILRWPWWPWRRK{ct:Amid} | Omiganan | Amidation | Free | Linear | L | None | 12 | Antibacterial | <20 % Hemolysis at 2 µM | Horse | Synthetic Analog To Indolicidin | α-Helical | NA | ||
| 38673786 | 2024 | ILRWPWWPWRRK{ct:Amid} | Omiganan | Amidation | Free | Linear | L | None | 12 | Antibacterial | <20 % Hemolysis at 4 µM | Horse | Synthetic Analog To Indolicidin | α-Helical | NA | ||
| 38673786 | 2024 | ILRWPWWPWRRK{ct:Amid} | Omiganan | Amidation | Free | Linear | L | None | 12 | Antibacterial | <20 % Hemolysis at 8 µM | Horse | Synthetic Analog To Indolicidin | α-Helical | NA | ||
| 38673786 | 2024 | ILRWPWWPWRRK{ct:Amid} | Omiganan | Amidation | Free | Linear | L | None | 12 | Antibacterial | <20 % Hemolysis at 16 µM | Horse | Synthetic Analog To Indolicidin | α-Helical | NA | ||
| 38673786 | 2024 | ILRWPWWPWRRK{ct:Amid} | Omiganan | Amidation | Free | Linear | L | None | 12 | Antibacterial | <40 % Hemolysis at 32 µM | Horse | Synthetic Analog To Indolicidin | α-Helical | NA | ||
| 38673786 | 2024 | ILRWPWWPWRRK{ct:Amid} | Omiganan | Amidation | Free | Linear | L | None | 12 | Antibacterial | <40 % Hemolysis at 64 µM | Horse | Synthetic Analog To Indolicidin | α-Helical | NA | ||
| 38673786 | 2024 | ILRWPWWPWRRK{ct:Amid} | Omiganan | Amidation | Free | Linear | L | None | 12 | Antibacterial | <40 % Hemolysis at 128 µM | Horse | Synthetic Analog To Indolicidin | α-Helical | NA | ||
| 38673786 | 2024 | FFHHIFRGIVHVGKTIHRLVTG{ct:Amid} | Piscidin 1 | Amidation | Free | Linear | L | None | 22 | Antibacterial | <20 % Hemolysis at 2 µM | Horse | Mast Cells Of Fish | α-Helical | NA | ||
| 38673786 | 2024 | FFHHIFRGIVHVGKTIHRLVTG{ct:Amid} | Piscidin 1 | Amidation | Free | Linear | L | None | 22 | Antibacterial | <40 % Hemolysis at 4 µM | Horse | Mast Cells Of Fish | α-Helical | NA | ||
| 38673786 | 2024 | FFHHIFRGIVHVGKTIHRLVTG{ct:Amid} | Piscidin 1 | Amidation | Free | Linear | L | None | 22 | Antibacterial | <70 % Hemolysis at 8 µM | Horse | Mast Cells Of Fish | α-Helical | NA | ||
| 38673786 | 2024 | FFHHIFRGIVHVGKTIHRLVTG{ct:Amid} | Piscidin 1 | Amidation | Free | Linear | L | None | 22 | Antibacterial | <120 % Hemolysis at 16 µM | Horse | Mast Cells Of Fish | α-Helical | NA | ||
| 38673786 | 2024 | FFHHIFRGIVHVGKTIHRLVTG{ct:Amid} | Piscidin 1 | Amidation | Free | Linear | L | None | 22 | Antibacterial | <120 % Hemolysis at 32 µM | Horse | Mast Cells Of Fish | α-Helical | NA | ||
| 38673786 | 2024 | FFHHIFRGIVHVGKTIHRLVTG{ct:Amid} | Piscidin 1 | Amidation | Free | Linear | L | None | 22 | Antibacterial | <120 % Hemolysis at 64 µM | Horse | Mast Cells Of Fish | α-Helical | NA | ||
| 38673786 | 2024 | FFHHIFRGIVHVGKTIHRLVTG{ct:Amid} | Piscidin 1 | Amidation | Free | Linear | L | None | 22 | Antibacterial | <120 % Hemolysis at 128 µM | Horse | Mast Cells Of Fish | α-Helical | NA | ||
| 37760707 | 2024 | VKVGINGFGRIGRLVTRAAFHGKKVAIVAINA{ct:Amid} | Analog 5 | Amidation | Free | Linear | L | None | 33 | Antimicrobial | 14.1 % Hemolysis at 1024 μg/mL | Horse | Analog Of Sjgap | α-Helical | NA | ||
| 37760707 | 2024 | VKVGINGFGRIGRLVTRAAFHGKKVAIVAINA{ct:Amid} | Analog 5 | Amidation | Free | Linear | L | None | 33 | Antimicrobial | 11.8 % Hemolysis at 512 μg/mL | Horse | Analog Of Sjgap | α-Helical | NA | ||
| 37760707 | 2024 | VKVGINGFGRIGRLVTRAAFHGKKVEIVAIND{ct:Amid} | Analog 1(SJGAP) | Amidation | Free | Linear | L | None | 33 | Antimicrobial | <4 % Hemolysis at 1024 μg/mL | Horse | Skipjack Tuna Glyceraldehyde-3-Phosphate Dehydrogenase (Gapdh)-Related Peptide (Sjgap) | α-Helical | NA | ||
| 37760707 | 2024 | VKVGINGFGRIGRLVTRAAFHGKKVKIVAINK{ct:Amid} | Analog 6 | Amidation | Free | Linear | L | None | 33 | Antimicrobial | 10 % Hemolysis at 1024 μg/mL | Horse | Analog Of Sjgap | α-Helical | NA | ||
| 37760707 | 2024 | VKVGINGFGRIGRLVTRAAFHGKKVKIVAINK{ct:Amid} | Analog 6 | Amidation | Free | Linear | L | None | 33 | Antimicrobial | <10 % Hemolysis at 512 μg/mL | Horse | Analog Of Sjgap | α-Helical | NA | ||
| 37760707 | 2024 | VKVGINGFGRIGRLVTRLLFHGKKVEIVLIND{ct:Amid} | Analog 7 | Amidation | Free | Linear | L | None | 33 | Antimicrobial | <10 % Hemolysis at 1024 μg/mL | Horse | Analog Of Sjgap | α-Helical | NA | ||
| 37760707 | 2024 | VKVGINGFGRIGRLVTRLLFHGKKVEIVLIND{ct:Amid} | Analog 7 | Amidation | Free | Linear | L | None | 33 | Antimicrobial | <6 % Hemolysis at 512 μg/mL | Horse | Analog Of Sjgap | α-Helical | NA | ||
| 37760707 | 2024 | VKVGINGFGRIGRLVTRAAFHGKKVEIVAIND{ct:Amid} | Analog 8 | Amidation | Free | Linear | L | None | 33 | Antimicrobial | <6 % Hemolysis at 1024 μg/mL | Horse | Analog Of Sjgap | α-Helical | NA | ||
| 37760707 | 2024 | VKVGINGFGRIGRLVTRAAFHGKKVEIVAIND{ct:Amid} | Analog 8 | Amidation | Free | Linear | L | None | 33 | Antimicrobial | 4 % Hemolysis at 512 μg/mL | Horse | Analog Of Sjgap | α-Helical | NA | ||
| 29219046 | 2017 | FFGSTIGALANFLPSLISKIRN{ct:Amid} | brevinin-1ULf | Amidation | Free | Linear | L | None | 22 | Antimicrobial Peptides | 13.1 % Hemolysis at 32 μg/ml | Horse | Brown Frog Rana Ulma | NA | NA | ||
| 29219046 | 2017 | FFGSTIGALANFLPSLISKIRN{ct:Amid} | brevinin-1ULf | Amidation | Free | Linear | L | None | 22 | Antimicrobial Peptides | 54.7 % Hemolysis at 64 μg/ml | Horse | Brown Frog Rana Ulma | NA | NA | ||
| 29219046 | 2017 | FFGSTIGALANFLPSLISKIRN{ct:Amid} | brevinin-1ULf | Amidation | Free | Linear | L | None | 22 | Antimicrobial Peptides | 90.1 % Hemolysis at 128 μg/ml | Horse | Brown Frog Rana Ulma | NA | NA | ||
| 29219046 | 2017 | LALRTAGWLRLLGFRDKKKN | Ulmin-1ULa | Free | Free | Linear | L | None | 20 | Antimicrobial Peptides | 4 % Hemolysis at 32 μg/ml | Horse | Brown Frog Rana Ulma | NA | NA | ||
| 29219046 | 2017 | LALRTAGWLRLLGFRDKKKN | Ulmin-1ULa | Free | Free | Linear | L | None | 20 | Antimicrobial Peptides | 5 % Hemolysis at 64 μg/ml | Horse | Brown Frog Rana Ulma | NA | NA | ||
| 29219046 | 2017 | LALRTAGWLRLLGFRDKKKN | Ulmin-1ULa | Free | Free | Linear | L | None | 20 | Antimicrobial Peptides | 8 % Hemolysis at 128 μg/ml | Horse | Brown Frog Rana Ulma | NA | NA | ||
| 29191658 | 2018 | FLPIVAKLLSGLL{ct:Amid} | Temporin-PE | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 39.64 μM | Horse | Frog(Pelophylax Kl. Esculentus) | α-Helical | NA | ||
| 29191658 | 2018 | FLYIVAKLLSGLL{ct:Amid} | Temporin-PEa | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at 531.7 μM | Horse | Frog(Pelophylax Kl. Esculentus) | α-Helical | NA | ||
| 29191658 | 2018 | FLPIVAKLLSGLLGRKKRRQRRR{ct:Amid} | Temporin-PEb | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 50 % Hemolysis at 44.64 μM | Horse | Frog(Pelophylax Kl. Esculentus) | α-Helical | NA | ||
| 29643444 | 2018 | TVLRGCWTFSFPPKPCI{ct:Amid} | HECI | Amidation | Free | Linear | L | None | 17 | Anticancer | <15 % Hemolysis at 128 µM | Horse | Frogs (Hylarana Erythraea Chymotrypsin Inhibitor) | NA | NA | ||
| 29643444 | 2018 | TVLRGCWTKSFPPKPCI{ct:Amid} | K9-HECI | Amidation | Free | Linear | L | None | 17 | Anti-proliferation of cancer cells | ~5 % Hemolysis at 128 µM | Horse | Analogue Of Heci | NA | Low hemolytic | ||
| 29904274 | 2018 | LNLKALLAVAKKIL{ct:Amid} | MP-C | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 50 % Hemolysis at 40.11 µM | Horse | European Hornet (Vespa Crabro) | Random-coil at aq, α-Helical at membrane mimic solution | NA | ||
| 29904274 | 2018 | CLNLKALLAVAKKILC{cyc:N-C}{ct:Amid} | cMP-C | Amidation | Free | Cyclic | L | None | 16 | Antimicrobial | 50 % Hemolysis at 9.19 µM | Horse | Modifcation In Mp-C A Skeleton-Based Cyclization By Two Cysteine Residues | α-Helical at aq, α-Helical at membrane mimic solution | NA | ||
| 29904274 | 2018 | RKKRRQRRRLNLKALLAVAKKIL{ct:Amid} | tMP-C | Amidation | Free | Linear | L | None | 23 | Anticancer | 50 % Hemolysis at 77.94 µM | Horse | Modifcation In Mp-N-Terminal Extension Via Tat-Linked | Random-coil at aq, α-Helical at membrane mimic solution | NA | ||
| 30674824 | 2018 | {nnr:Nap}FFKK-{nnr:OH}{nt:(Naphthalene-2-ly)-Acetylation}{ct:OH} | (naphthalene-2-ly)-acetyl-diphenylalanine-dilysine-OH | OH | (Naphthalene-2-ly)-Acetylation | Linear | L | OH = Hydroxy, Nap = (Naphthalene-2-ly)-acetyl | 4 | Antifungal and hydrogel forming properties | <2 % Hemolysis at 500 µM | Horse | Synthetic Ultrashort Peptide | β-Sheet | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDY | Cap18 - pure | Free | Free | Linear | L | None | 37 | Antimicrobial | 1 ± 1 % Hemolysis at 64 μg/ml | Horse | Rabbit Neutrophils | α-Helical | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDY | Cap18 - library | Free | Free | Linear | L | None | 37 | Antimicrobial | 2 ± 1 % Hemolysis at 32 μg/ml | Horse | Rabbit Neutrophils | α-Helical | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRPRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDY | Peptide 1 | Free | Free | Linear | L | None | 37 | Antimicrobial | 1 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFLNKIKEKLKKIGQKIQGLLPKLAPRTDY | Peptide 2 | Free | Free | Linear | L | None | 37 | Antimicrobial | 6 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | NA | ||
| 29852015 | 2018 | GLRKRLRKFRNKDKEKLKKIGQKIQGLLPKLAPRTDY | Peptide 3 | Free | Free | Linear | L | None | 37 | NA | 1 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKFKEKLKKIGQKIQGLLPKLAPRTDY | Peptide 4 | Free | Free | Linear | L | None | 37 | Antimicrobial | 2 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKHKEKLKKIGQKIQGLLPKLAPRTDY | Peptide 5 | Free | Free | Linear | L | None | 37 | Antimicrobial | 1 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKMKEKLKKIGQKIQGLLPKLAPRTDY | Peptide 6 | Free | Free | Linear | L | None | 37 | Antimicrobial | 2 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKQKEKLKKIGQKIQGLLPKLAPRTDY | Peptide 7 | Free | Free | Linear | L | None | 37 | Antimicrobial | 1 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKSKEKLKKIGQKIQGLLPKLAPRTDY | Peptide 8 | Free | Free | Linear | L | None | 37 | Antimicrobial | 1 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKECLKKIGQKIQGLLPKLAPRTDY | Peptide 9 | Free | Free | Linear | L | None | 37 | Antimicrobial | 4 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Low hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEDLKKIGQKIQGLLPKLAPRTDY | Peptide 10 | Free | Free | Linear | L | None | 37 | Antimicrobial | 1 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEFLKKIGQKIQGLLPKLAPRTDY | Peptide 11 | Free | Free | Linear | L | None | 37 | Antimicrobial | 9 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | NA | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEILKKIGQKIQGLLPKLAPRTDY | Peptide 12 | Free | Free | Linear | L | None | 37 | Antimicrobial | 10 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | NA | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKELLKKIGQKIQGLLPKLAPRTDY | Peptide 13 | Free | Free | Linear | L | None | 37 | Antimicrobial | 14 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | NA | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEMLKKIGQKIQGLLPKLAPRTDY | Peptide 14 | Free | Free | Linear | L | None | 37 | Antimicrobial | 8 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | NA | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEYLKKIGQKIQGLLPKLAPRTDY | Peptide 15 | Free | Free | Linear | L | None | 37 | Antimicrobial | 9 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | NA | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKDKKIGQKIQGLLPKLAPRTDY | Peptide 16 | Free | Free | Linear | L | None | 37 | NA | 0 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKKKKIGQKIQGLLPKLAPRTDY | Peptide 17 | Free | Free | Linear | L | None | 37 | Antimicrobial | 1 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKPKKIGQKIQGLLPKLAPRTDY | Peptide 18 | Free | Free | Linear | L | None | 37 | NA | 0 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLPKIGQKIQGLLPKLAPRTDY | Peptide 19 | Free | Free | Linear | L | None | 37 | Antimicrobial | 1 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKEGQKIQGLLPKLAPRTDY | Peptide 20 | Free | Free | Linear | L | None | 37 | Antimicrobial | 1 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKHGQKIQGLLPKLAPRTDY | Peptide 21 | Free | Free | Linear | L | None | 37 | Antimicrobial | 1 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKNGQKIQGLLPKLAPRTDY | Peptide 22 | Free | Free | Linear | L | None | 37 | Antimicrobial | 0 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKICQKIQGLLPKLAPRTDY | Peptide 23 | Free | Free | Linear | L | None | 37 | Antimicrobial | 4 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Low hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKILQKIQGLLPKLAPRTDY | Peptide 24 | Free | Free | Linear | L | None | 37 | Antimicrobial | 7 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | NA | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKIGQKCQGLLPKLAPRTDY | Peptide 25 | Free | Free | Linear | L | None | 37 | Antimicrobial | 2 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKIGQKDQGLLPKLAPRTDY | Peptide 26 | Free | Free | Linear | L | None | 37 | NA | 0 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKIGQKGQGLLPKLAPRTDY | Peptide 27 | Free | Free | Linear | L | None | 37 | Antimicrobial | 1 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKIGQKNQGLLPKLAPRTDY | Peptide 28 | Free | Free | Linear | L | None | 37 | NA | 1 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKIGQKSQGLLPKLAPRTDY | Peptide 29 | Free | Free | Linear | L | None | 37 | Antimicrobial | 1 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKIGQKIQTLLPKLAPRTDY | Peptide 30 | Free | Free | Linear | L | None | 37 | Antimicrobial | 2 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKIGQKIQGPLPKLAPRTDY | Peptide 31 | Free | Free | Linear | L | None | 37 | Antimicrobial | 1 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Non-hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKIGQKIQGLLAKLAPRTDY | Peptide 32 | Free | Free | Linear | L | None | 37 | Antimicrobial | 4 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Low hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKIGQKIQGLLDKLAPRTDY | Peptide 33 | Free | Free | Linear | L | None | 37 | Antimicrobial | 3 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Low hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKIGQKIQGLLFKLAPRTDY | Peptide 34 | Free | Free | Linear | L | None | 37 | Antimicrobial | 7 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | NA | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKIGQKIQGLLHKLAPRTDY | Peptide 35 | Free | Free | Linear | L | None | 37 | Antimicrobial | 3 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Low hemolytic | ||
| 29852015 | 2018 | GLRKRLRKFRNKIKEKLKKIGQKIQGLLSKLAPRTDY | Peptide 36 | Free | Free | Linear | L | None | 37 | Antimicrobial | 4 % Hemolysis at 64 μg/ml | Horse | Cap18 Derivatives | NA | Low hemolytic | ||
| 30108987 | 2018 | {nnr:KP}FF{nnr:KP}FF{nnr:KP}FFK{nt:H}{ct:Amid} | CAP11 | Amidation | H | Linear | L | KP = phosphonium isostere of (trimethyl)lysine | 10 | Antimicrobial | 1.5 ± 0.1 % Hemolysis at 512 μM | Horse | Phosphonium Based Cationic Amphiphilic Peptides | NA | Non-hemolytic | ||
| 30108987 | 2018 | {nnr:RP}FF{nnr:RP}FF{nnr:RP}FF{nnr:RP}{nt:H}{ct:Amid} | CAP12 | Amidation | H | Linear | L | RP = phosphonium side chain length comparable o that of arginine | 10 | Antimicrobial | 3.1 ± 0.1 % Hemolysis at 512 μM | Horse | Phosphonium Based Cationic Amphiphilic Peptides | NA | Low hemolytic | ||
| 30108987 | 2018 | {nnr:KP}WW{nnr:KP}WW{nnr:KP}WW{nnr:KP}{nt:H}{ct:Amid} | CAP13 | Amidation | H | Linear | L | KP = phosphonium isostere of (trimethyl)lysine | 10 | NA | 11.0 ± 1.6 % Hemolysis at 512 μM | Horse | Phosphonium Based Cationic Amphiphilic Peptides | NA | NA | ||
| 30108987 | 2018 | {nnr:RP}WW{nnr:RP}WW{nnr:RP}WW{nnr:RP}{nt:H}{ct:Amid} | CAP14 | Amidation | H | Linear | L | RP = phosphonium side chain length comparable o that of arginine | 10 | NA | 5.8 ± 1.0 % Hemolysis at 512 μM | Horse | Phosphonium Based Cationic Amphiphilic Peptides | NA | NA | ||
| 30108987 | 2018 | {nnr:KP}LL{nnr:KP}LL{nnr:KP}LL{nnr:KP}{nt:H}{ct:Amid} | CAP15 | Amidation | H | Linear | L | KP = phosphonium isostere of (trimethyl)lysine | 10 | NA | 2.1 ± 0.5 % Hemolysis at 512 μM | Horse | Phosphonium Based Cationic Amphiphilic Peptides | NA | Low hemolytic | ||
| 30108987 | 2018 | {nnr:RP}LL{nnr:RP}LL{nnr:RP}LL{nnr:RP}{nt:H}{ct:Amid} | CAP16 | Amidation | H | Linear | L | RP = phosphonium side chain length comparable o that of arginine | 10 | NA | 0.6 ± 0.2 % Hemolysis at 512 μM | Horse | Phosphonium Based Cationic Amphiphilic Peptides | NA | Non-hemolytic | ||
| 30108987 | 2018 | {nnr:KP}II{nnr:KP}II{nnr:KP}II{nnr:KP}{nt:H}{ct:Amid} | CAP17 | Amidation | H | Linear | L | KP = phosphonium isostere of (trimethyl)lysine | 10 | NA | 2.3 ± 1.5 % Hemolysis at 512 μM | Horse | Phosphonium Based Cationic Amphiphilic Peptides | NA | Low hemolytic | ||
| 30108987 | 2018 | {nnr:RP}II{nnr:RP}II{nnr:RP}II{nnr:RP}{nt:H}{ct:Amid} | CAP18 | Amidation | H | Linear | L | RP = phosphonium side chain length comparable o that of arginine | 10 | NA | 3.9 ± 0.7 % Hemolysis at 512 μM | Horse | Phosphonium Based Cationic Amphiphilic Peptides | NA | Low hemolytic | ||
| 30108987 | 2018 | KRWWKWIRW{nt:H}{ct:Amid} | HHC10 | Amidation | H | Linear | L | None | 9 | Antimicrobial | 14.3 ± 3.6 % Hemolysis at 512 μM | Horse | Phosphonium Based Cationic Amphiphilic Peptides | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKYL{ct:Amid} | BP100 | Amidation | Free | Linear | L | None | 11 | Antibacterial | 43 ± 1.4 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | C5H11CO-KKLFKKILKYL{nt:hexanoyl}{ct:Amid} | BP367 | Amidation | hexanoyl | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 83 ± 6 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | K({nnr:COC5H11})KLFKKILKYL{nt:Acet}{ct:Amid} | BP368 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 96 ± 0.9 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KK({nnr:COC5H11})LFKKILKYL{nt:Acet}{ct:Amid} | BP369 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 84 ± 8 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKK({nnr:COC5H11})FKKILKYL{nt:Acet}{ct:Amid} | BP370 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antimicrobial | 11 ± 2 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLK({nnr:COC5H11})KKILKYL{nt:Acet}{ct:Amid} | BP371 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 75 ± 4 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFK({nnr:COC5H11})KILKYL{nt:Acet}{ct:Amid} | BP372 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 97 ± 2 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKK({nnr:COC5H11})ILKYL{nt:Acet}{ct:Amid} | BP373 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 92 ± 1 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKK({nnr:COC5H11})LKYL{nt:Acet}{ct:Amid} | BP374 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 19 ± 3 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKIK({nnr:COC5H11})KYL{nt:Acet}{ct:Amid} | BP375 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 70 ± 6 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILK({nnr:COC5H11})YL{nt:Acet}{ct:Amid} | BP376 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 90 ± 4 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKK({nnr:COC5H11})L{nt:Acet}{ct:Amid} | BP377 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 92 ± 5 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKYK({nnr:COC5H11}){nt:Acet}{ct:Amid} | BP378 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antimicrobial | 26 ± 0.4 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | C3H7CO-KKLFKKILKYL{nt:butanoyl}{ct:Amid} | BP379 | Amidation | butanoyl | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 93 ± 0.8 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | K({nnr:COC3H7})KLFKKILKYL{nt:Acet}{ct:Amid} | BP380 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 93 ± 6 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KK({nnr:COC3H7})LFKKILKYL{nt:Acet}{ct:Amid} | BP381 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antimicrobial | 54 ± 6 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKK({nnr:COC3H7})FKKILKYL{nt:Acet}{ct:Amid} | BP382 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 100 ± 0.9 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLK({nnr:COC3H7})KKILKYL{nt:Acet}{ct:Amid} | BP383 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 22 ± 4 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFK({nnr:COC3H7})KILKYL{nt:Acet}{ct:Amid} | BP384 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 100 ± 4 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKK({nnr:COC3H7})ILKYL{nt:Acet}{ct:Amid} | BP385 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 100 ± 3 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKK({nnr:COC3H7})LKYL{nt:Acet}{ct:Amid} | BP386 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | NA | 1 ± 0.1 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | Non-hemolytic | ||
| 30052685 | 2018 | KKLFKKIK({nnr:COC3H7})KYL{nt:Acet}{ct:Amid} | BP387 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antimicrobial | 14 ± 0.5 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILK({nnr:COC3H7})YL{nt:Acet}{ct:Amid} | BP388 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 38 ± 4 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKK({nnr:COC3H7})L{nt:Acet}{ct:Amid} | BP389 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antimicrobial | 22 ± 2 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKYK({nnr:COC3H7}){nt:Acet}{ct:Amid} | BP390 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 5 ± 0.3 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | Low hemolytic | ||
| 30052685 | 2018 | C11H23CO-KKLFKKILKYL{nt:lauroyl}{ct:Amid} | BP391 | Amidation | lauroyl | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 0.9 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | K({nnr:COC11H23})KLFKKILKYL{nt:Acet}{ct:Amid} | BP392 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 0.9 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KK({nnr:COC11H23})LFKKILKYL{nt:Acet}{ct:Amid} | BP393 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 97 ± 0.6 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKK({nnr:COC11H23})FKKILKYL{nt:Acet}{ct:Amid} | BP394 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 1 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLK({nnr:COC11H23})KKILKYL{nt:Acet}{ct:Amid} | BP395 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 2 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFK({nnr:COC11H23})KILKYL{nt:Acet}{ct:Amid} | BP396 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 4 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKK({nnr:COC11H23})ILKYL{nt:Acet}{ct:Amid} | BP397 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 4 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKK({nnr:COC11H23})LKYL{nt:Acet}{ct:Amid} | BP398 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 3 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKIK({nnr:COC11H23})KYL{nt:Acet}{ct:Amid} | BP399 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 5 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILK({nnr:COC11H23})YL{nt:Acet}{ct:Amid} | BP400 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 99 ± 0.4 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKK({nnr:COC11H23})L{nt:Acet}{ct:Amid} | BP401 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 1 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKYK({nnr:COC11H23}){nt:Acet}{ct:Amid} | BP402 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 4 % Hemolysis at 250 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKYL{ct:Amid} | BP100 | Amidation | Free | Linear | L | None | 11 | Antibacterial | 57 ± 4.6 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | C5H11CO-KKLFKKILKYL{nt:hexanoyl}{ct:Amid} | BP367 | Amidation | hexanoyl | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 95 ± 13 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | K({nnr:COC5H11})KLFKKILKYL{nt:Acet}{ct:Amid} | BP368 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 97 ± 3 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KK({nnr:COC5H11})LFKKILKYL{nt:Acet}{ct:Amid} | BP369 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 86 ± 8 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKK({nnr:COC5H11})FKKILKYL{nt:Acet}{ct:Amid} | BP370 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antimicrobial | 14 ± 3 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLK({nnr:COC5H11})KKILKYL{nt:Acet}{ct:Amid} | BP371 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 95 ± 3 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFK({nnr:COC5H11})KILKYL{nt:Acet}{ct:Amid} | BP372 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 100 ± 0.9 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKK({nnr:COC5H11})ILKYL{nt:Acet}{ct:Amid} | BP373 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 95 ± 6 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKK({nnr:COC5H11})LKYL{nt:Acet}{ct:Amid} | BP374 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 28 ± 2 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKIK({nnr:COC5H11})KYL{nt:Acet}{ct:Amid} | BP375 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 86 ± 3 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILK({nnr:COC5H11})YL{nt:Acet}{ct:Amid} | BP376 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 89 ± 2 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKK({nnr:COC5H11})L{nt:Acet}{ct:Amid} | BP377 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antibacterial | 89 ± 2 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKYK({nnr:COC5H11}){nt:Acet}{ct:Amid} | BP378 | Amidation | Acetylation | Linear | L | COC5H11 = hexanoyl | 11 | Antimicrobial | 52 ± 6 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | C3H7CO-KKLFKKILKYL{nt:butanoyl}{ct:Amid} | BP379 | Amidation | butanoyl | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 96 ± 1 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | K({nnr:COC3H7})KLFKKILKYL{nt:Acet}{ct:Amid} | BP380 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 97 ± 5 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KK({nnr:COC3H7})LFKKILKYL{nt:Acet}{ct:Amid} | BP381 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antimicrobial | 76 ± 2 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKK({nnr:COC3H7})FKKILKYL{nt:Acet}{ct:Amid} | BP382 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 100 ± 2 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLK({nnr:COC3H7})KKILKYL{nt:Acet}{ct:Amid} | BP383 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 40 ± 4 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFK({nnr:COC3H7})KILKYL{nt:Acet}{ct:Amid} | BP384 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 100 ± 2 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKK({nnr:COC3H7})ILKYL{nt:Acet}{ct:Amid} | BP385 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 100 ± 4 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKK({nnr:COC3H7})LKYL{nt:Acet}{ct:Amid} | BP386 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | NA | 3 ± 0 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | Non-hemolytic | ||
| 30052685 | 2018 | KKLFKKIK({nnr:COC3H7})KYL{nt:Acet}{ct:Amid} | BP387 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antimicrobial | 18 ± 1 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILK({nnr:COC3H7})YL{nt:Acet}{ct:Amid} | BP388 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 89 ± 10 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKK({nnr:COC3H7})L{nt:Acet}{ct:Amid} | BP389 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antimicrobial | 39 ± 3 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKYK({nnr:COC3H7}){nt:Acet}{ct:Amid} | BP390 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 11 | Antibacterial | 7 ± 0.9 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | Low hemolytic | ||
| 30052685 | 2018 | C11H23CO-KKLFKKILKYL{nt:lauroyl}{ct:Amid} | BP391 | Amidation | lauroyl | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 0.5 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | K({nnr:COC11H23})KLFKKILKYL{nt:Acet}{ct:Amid} | BP392 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 2 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KK({nnr:COC11H23})LFKKILKYL{nt:Acet}{ct:Amid} | BP393 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 99 ± 0.5 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKK({nnr:COC11H23})FKKILKYL{nt:Acet}{ct:Amid} | BP394 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 2 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLK({nnr:COC11H23})KKILKYL{nt:Acet}{ct:Amid} | BP395 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 2 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFK({nnr:COC11H23})KILKYL{nt:Acet}{ct:Amid} | BP396 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 7 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKK({nnr:COC11H23})ILKYL{nt:Acet}{ct:Amid} | BP397 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 5 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKK({nnr:COC11H23})LKYL{nt:Acet}{ct:Amid} | BP398 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 5 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKIK({nnr:COC11H23})KYL{nt:Acet}{ct:Amid} | BP399 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 6 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILK({nnr:COC11H23})YL{nt:Acet}{ct:Amid} | BP400 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 14 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKK({nnr:COC11H23})L{nt:Acet}{ct:Amid} | BP401 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 3 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30052685 | 2018 | KKLFKKILKYK({nnr:COC11H23}){nt:Acet}{ct:Amid} | BP402 | Amidation | Acetylation | Linear | L | COC11H23 = lauroyl | 11 | Antibacterial | 100 ± 0.5 % Hemolysis at 375 μM | Horse | Cecropin A-Melittin Hybrid Peptide | NA | NA | ||
| 30087268 | 2018 | ALWKDILKNAGKAALNEINQIVQ{ct:Amid} | DPS3 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 50 % Hemolysis at 138.1 μM | Horse | Frog Phyllomedusa Sauvagii | aqueous = Random coils, membrane-mimicking solution = α-Helical | NA | ||
| 30087268 | 2018 | ALWKKILKNAGKAALNKINQIVQ{ct:Amid} | K5, 17-DPS3 | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 50 % Hemolysis at 14.98 μM | Horse | Analogs Of Dermaseptin-Ps3 | aqueous = Random coils, membrane-mimicking solution = α-Helical | NA | ||
| 30087268 | 2018 | ALWKDILKNLLKAALNEINQIVQ{ct:Amid} | L10, 11-DPS3 | Amidation | Free | Linear | L | None | 23 | Antimicrobial, Anticancer | 50 % Hemolysis at 3.44 μM | Horse | Analogs Of Dermaseptin-Ps3 | aqueous = Random coils, membrane-mimicking solution = α-Helical | NA | ||
| 30258724 | 2018 | ALWKDLLKNVGKAAGKAVLNKVTDMVNQ{ct:Amid} | DRS-CA-1 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 50 % Hemolysis at 114.7 μM | Horse | Callimedusa Camba(Phyllomedusa) | α-Helical | NA | ||
| 30258724 | 2018 | ALWKSLLKNVGKAAGKAALNAVTDMVNQ{ct:Amid} | DRS-DU-1 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 50 % Hemolysis at 216.6 μM | Horse | Phyllomedusa Duellmani | α-Helical | NA | ||
| 30258724 | 2018 | ALWKSLLKNVGKA{ct:Amid} | DP-1 | Amidation | Free | Linear | L | None | 13 | Antimicrobial | 50 % Hemolysis at >512 μM | Horse | Truncated Analogue | α-Helical | NA | ||
| 30258724 | 2018 | GRKKRRQRRRGALWKSLLKNVGKA{ct:Amid} | DP-2 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 50 % Hemolysis at >512 μM | Horse | Tat-Fused Dp-1 | α-Helical | NA | ||
| 30322120 | 2018 | FLGAVLKVAGKLVPAAICKISKKC | Brevinin-1GHa | Free | Free | Linear | L | None | 24 | Antibiofilm, Antibacterial, Antifungal | 20 % Hemolysis at 16 µM | Horse | Frog Hylarana Guentheri | α-Helix | NA | ||
| 30322120 | 2018 | FLGAVLKVAGKLVPAAI | Brevinin-1GHb | Free | Free | Linear | L | None | 17 | Antibacterial | 20 % Hemolysis at 512 µM | Horse | Analogue Of Brevinin-1Gha | α-Helix | Low hemolytic | ||
| 30322120 | 2018 | FLGAVLKVCKISKKCAGKLVPAAI | Brevinin-1GHc | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal | 20 % Hemolysis at 128 µM | Horse | Analogue Of Brevinin-1Gha | α-Helix | NA | ||
| 30555431 | 2018 | GLLSGILGAGKKIVCGLSGLC | Nigrocin-HL | Free | Free | Linear | L | None | 21 | Antibacterial | 0 % Hemolysis at 2 µM | Horse | Frog Hylarana Latouchii | α-Helix | Non-hemolytic | ||
| 30555431 | 2018 | GLLSGILGAGKKIVCGLSGLC | Nigrocin-HL | Free | Free | Linear | L | None | 21 | Antibacterial | 1 % Hemolysis at 4 µM | Horse | Frog Hylarana Latouchii | α-Helix | Non-hemolytic | ||
| 30555431 | 2018 | GLLSGILGAGKKIVCGLSGLC | Nigrocin-HL | Free | Free | Linear | L | None | 21 | Antibacterial | 18.72 % Hemolysis at 16 µM | Horse | Frog Hylarana Latouchii | α-Helix | NA | ||
| 30555431 | 2018 | GLLSGILGAGKKIVCGLSGLC | Nigrocin-HL | Free | Free | Linear | L | None | 21 | Antibacterial | 32 % Hemolysis at 32 µM | Horse | Frog Hylarana Latouchii | α-Helix | NA | ||
| 30555431 | 2018 | GLLSGILGAGKKIVCGLSGLC | Nigrocin-HL | Free | Free | Linear | L | None | 21 | Antibacterial | 43 % Hemolysis at 64 µM | Horse | Frog Hylarana Latouchii | α-Helix | NA | ||
| 30555431 | 2018 | GLLSGILGAGKKIVCGLSGLC | Nigrocin-HL | Free | Free | Linear | L | None | 21 | Antibacterial | 67 % Hemolysis at 128 µM | Horse | Frog Hylarana Latouchii | α-Helix | NA | ||
| 30555431 | 2018 | GLLSGILGAGKKIVCGLSGLC | Nigrocin-HL | Free | Free | Linear | L | None | 21 | Antibacterial | 76 % Hemolysis at 256 µM | Horse | Frog Hylarana Latouchii | α-Helix | NA | ||
| 30555431 | 2018 | GLLSGILGAGKKIVCGLSGLC | Nigrocin-HL | Free | Free | Linear | L | None | 21 | Antibacterial | 85 % Hemolysis at 512 µM | Horse | Frog Hylarana Latouchii | α-Helix | NA | ||
| 30555431 | 2018 | GLLSGILGAGKKIVF{ct:Amid} | Nigrocin-HLM | Amidation | Free | Linear | L | None | 15 | Antibacterial | 0 % Hemolysis at 2 µM | Horse | Frog Hylarana Latouchii | α-Helix | Non-hemolytic | ||
| 30555431 | 2018 | GLLSGILGAGKKIVF{ct:Amid} | Nigrocin-HLM | Amidation | Free | Linear | L | None | 15 | Antibacterial | 0 % Hemolysis at 4 µM | Horse | Frog Hylarana Latouchii | α-Helix | Non-hemolytic | ||
| 30555431 | 2018 | GLLSGILGAGKKIVF{ct:Amid} | Nigrocin-HLM | Amidation | Free | Linear | L | None | 15 | Antibacterial | 0 % Hemolysis at 16 µM | Horse | Frog Hylarana Latouchii | α-Helix | Non-hemolytic | ||
| 30555431 | 2018 | GLLSGILGAGKKIVF{ct:Amid} | Nigrocin-HLM | Amidation | Free | Linear | L | None | 15 | Antibacterial | 0 % Hemolysis at 32 µM | Horse | Frog Hylarana Latouchii | α-Helix | Non-hemolytic | ||
| 30555431 | 2018 | GLLSGILGAGKKIVF{ct:Amid} | Nigrocin-HLM | Amidation | Free | Linear | L | None | 15 | Antibacterial | 1 % Hemolysis at 64 µM | Horse | Frog Hylarana Latouchii | α-Helix | Non-hemolytic | ||
| 30555431 | 2018 | GLLSGILGAGKKIVF{ct:Amid} | Nigrocin-HLM | Amidation | Free | Linear | L | None | 15 | Antibacterial | 4 % Hemolysis at 128 µM | Horse | Frog Hylarana Latouchii | α-Helix | NA | ||
| 30555431 | 2018 | GLLSGILGAGKKIVF{ct:Amid} | Nigrocin-HLM | Amidation | Free | Linear | L | None | 15 | Antibacterial | 11 % Hemolysis at 256 µM | Horse | Frog Hylarana Latouchii | α-Helix | NA | ||
| 30555431 | 2018 | GLLSGILGAGKKIVF{ct:Amid} | Nigrocin-HLM | Amidation | Free | Linear | L | None | 15 | Antibacterial | 35 % Hemolysis at 512 µM | Horse | Frog Hylarana Latouchii | α-Helix | NA | ||
| 30612735 | 2019 | FLSLIPHIASGIASLVKNF{ct:Amid} | Phylloseptin-PBa1 | Amidation | Free | Linear | L | None | 19 | Antimicrobial, Anticancer | 50 % Hemolysis at 18.6 µM | Horse | Leaf Forg (Phyllomedusa Burmeisteri) | α-Helix | NA | ||
| 30612735 | 2019 | FLSLLPHIASGIASLVSKF{ct:Amid} | Phylloseptin-PBa2 | Amidation | Free | Linear | L | None | 19 | Antimicrobial, Anticancer | 50 % Hemolysis at 15.82 µM | Horse | Leaf Forg (Phyllomedusa Burmeisteri) | α-Helix | NA | ||
| 30612735 | 2019 | FLSLIPHIVSGVAALANHL{ct:Amid} | Phylloseptin-PBa3 | Amidation | Free | Linear | L | None | 19 | Antimicrobial, Anticancer | 50 % Hemolysis at 52.98 µM | Horse | Leaf Forg (Phyllomedusa Burmeisteri) | α-Helix | NA | ||
| 30802593 | 2019 | MFTLKKPLLLLFFLGTINLSLCEEERNADEEERRDDPEERDVEVEKRFIVPSIFLLKKAFCIALKKC | Japonicin-2LF | Free | Free | Linear | L | None | 67 | Antibiofilm, Antimicrobial | > 80 % Hemolysis at 64 µM | Horse | Limnonectes Fujianensis (Fujian Large-Headed Frog) | aqueous = Random coil, membrane-mimic solutions = α-Helix | NA | ||
| 31242693 | 2019 | SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGCRT{ct:OH} | Ranatuerin-2Pb | OH | Free | Linear | L | None | 34 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 16.11 μM | Horse | Frog Rana Pipiens | 50% TFE/H2O = α-Helix, membrane mimicking liposomes(POPC/POPG 1:1, POPE/POPG 3:1 ) = α-Helix | NA | ||
| 31242693 | 2019 | SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGC{ct:OH} | RPa | OH | Free | Linear | L | None | 32 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 63.9 μM | Horse | Truncated Analogues Of Ranatuerin-2Pb | 50% TFE/H2O = α-Helix, membrane mimicking liposomes(POPC/POPG 1:1, POPE/POPG 3:1 ) = α-Helix | NA | ||
| 31242693 | 2019 | SFLTTVKKLVTNLAAL{ct:Amid} | RPb | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 178 μM | Horse | Truncated Analogues Of Ranatuerin-2Pb | 50% TFE/H2O = α-Helix, membrane mimicking liposomes(POPC/POPG 1:1, POPE/POPG 3:1 ) = α-Helix | NA | ||
| 31242693 | 2019 | SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGCRT{ct:OH} | Ranatuerin-2Pb | OH | Free | Linear | L | None | 34 | Antimicrobial, Antibiofilm | 20 % Hemolysis at 8 μM | Horse | Frog Rana Pipiens | 50% TFE/H2O = α-Helix, membrane mimicking liposomes(POPC/POPG 1:1, POPE/POPG 3:1 ) = α-Helix | NA | ||
| 31242693 | 2019 | SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGC{ct:OH} | RPa | OH | Free | Linear | L | None | 32 | Antimicrobial, Antibiofilm | 20 % Hemolysis at 32 μM | Horse | Truncated Analogues Of Ranatuerin-2Pb | 50% TFE/H2O = α-Helix, membrane mimicking liposomes(POPC/POPG 1:1, POPE/POPG 3:1 ) = α-Helix | NA | ||
| 31242693 | 2019 | SFLTTVKKLVTNLAAL{ct:Amid} | RPb | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibiofilm | 20 % Hemolysis at 64 μM | Horse | Truncated Analogues Of Ranatuerin-2Pb | 50% TFE/H2O = α-Helix, membrane mimicking liposomes(POPC/POPG 1:1, POPE/POPG 3:1 ) = α-Helix | NA | ||
| 31261655 | 2019 | MFTLKKSLLLLFFLGMVSLSLCEQERDADEDDNACEAKVENVKRVARPPGFTPFRVAPEIV | RVA-Thr6-BK | Free | Free | Linear | L | None | 61 | NA | 0 % Hemolysis at 256 μM | Horse | Frog Odorrana Hejiangensis | NA | Non-hemolytic | ||
| 31261655 | 2019 | MFTSKKSILLLFFLGAISLSLCEEERDADEDDTEGEAKVENVKRVALPPGFTPFRVAPEIV | RVA-Leu1, Thr6-BK | Free | Free | Linear | L | None | 61 | NA | 0 % Hemolysis at 256 μM | Horse | Frog Amolops Wuyiensis | NA | Non-hemolytic | ||
| 31426323 | 2019 | ALWKTLLKHVGKAAGKAALNAVTDMVNQ{ct:Amid} | Der-PS4 | Amidation | Free | Linear | L | None | 28 | Antimicrobial, Antibiofilm, Antiproliferative, Anticancer | 50 % Hemolysis at 128 μM | Horse | Waxy Monkey Tree Frog, Phyllomedusa Sauvagii | mimetic environment(DOPE, DOPC and DOPG, TFE) = α-Helix | NA | ||
| 31635388 | 2019 | GLWSKIKDAA-KTAGKAALGFVNEMV | DPT9 | Free | Free | Linear | L | None | 25 | Antimicrobial, Antibiofilm, Anticancer | 50 % Hemolysis at 210 μM | Horse | Derived From Frog Phyllomedusa Tarsius Dpt9 | NA | NA | ||
| 31635388 | 2019 | GLWSKIKKAA-KTAGKAALGFVNKMV | K8, 23-DPT9 | Free | Free | Linear | L | None | 25 | Antimicrobial, Antibiofilm, Anticancer | 50 % Hemolysis at 107 μM | Horse | Analogue And Modified Dtp9 | NA | Low hemolytic | ||
| 31653005 | 2019 | ALWKSILKNVGKAAGKAVLNAVTDMVNQ{ct:Amid} | DM-PC | Amidation | Free | Linear | L | None | 28 | Antimicrobial | >80 % Hemolysis at 256 μM | Horse | Frog Phyllomedusa Coelestis | aqueous = Random coil, 50% TFE buffer = Helical | NA | ||
| 31653005 | 2019 | ALWKSILKNVGKAAGKAVL{ct:Amid} | DMPC-19 | Amidation | Free | Linear | L | None | 19 | Antimicrobial | <5 % Hemolysis at 256 μM | Horse | Dm-Pc Designed Truncated Derivatives | aqueous = Random coil, 50% TFE buffer = Helical | Low hemolytic | ||
| 31653005 | 2019 | ALWKKLLKKA{ct:Amid} | DMPC-10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | <5 % Hemolysis at 256 μM | Horse | Dm-Pc Designed Truncated Derivatives | aqueous = Random coil, 50% TFE buffer = Helical | Low hemolytic | ||
| 31653005 | 2019 | ALWKKLLKK-{nnr:Cha}{ct:Amid} | DMPC-10A | Amidation | Free | Linear | L | Cha = cyclohexylalanine | 10 | Antimicrobial | >35 % Hemolysis at 256 μM | Horse | Dm-Pc Designed Truncated Derivatives | aqueous = Random coil, 50% TFE buffer = Helical | NA | ||
| 32397600 | 2020 | SLWGKLKEMAAAAGKAALNAVNGLVNQ{ct:Amid} | DRP-AC4 | Amidation | Free | Linear | L | None | 27 | Antimicrobial, Antibiofilm | 10 % Hemolysis at 26.25 μM | Horse | Frog Skin Agalychnis Callidryas(Dermaseptin) | aqueous = Random coil,50%(TFE) = α-Helix | NA | ||
| 32397600 | 2020 | SLWGKLKEMLAKAGKAVANAVNGLANQ{ct:Amid} | DRP-AC4a | Amidation | Free | Linear | L | None | 27 | Antimicrobial, Antibiofilm | 10 % Hemolysis at 14.49 μM | Horse | Analogue Of Drp-Ac4 | aqueous = Random coil,50%(TFE) = α-Helix | NA | ||
| 32397600 | 2020 | SLWGKLKEMLAAAGKAVANAVNGLANQ{ct:Amid} | DRP-AC4b | Amidation | Free | Linear | L | None | 27 | Antimicrobial, Antibiofilm | 10 % Hemolysis at 21.53 μM | Horse | Analogue Of Drp-Ac4 | aqueous = Random coil,50%(TFE) = α-Helix | NA | ||
| 32347293 | 2020 | FLGALFKVASKLVPAAICSISKKC | Brevinin-1GHd | Free | Free | Linear | L | None | 24 | Antimicrobial, Anticancer, Antibiotic, Antibiofilm | 13 % Hemolysis at 32 μM | Horse | Frog Skin, Hylarana Guenther | aqueous(10 mM NH4AC buffer) = Random coil, membrane-mimetic environment (50% TFE in 10 mM NH4AC)membrane-mimetic environment (50% TFE in 10 mM NH4AC) = α-Helix | NA | ||
| 32582642 | 2020 | ALWKDMLKGIGKLAGKAALGAVKTLV{ct:Amid} | Dermaseptin-PP | Amidation | Free | Linear | L | None | 26 | Antimicrobial, Antitumor | <20 % Hemolysis at 16 μM | Horse | Frog Phyllomedusa Palliata | 50% TFE-10 mmol/L NH4Ac solution (MME) = α-Helical | NA | ||
| 32582642 | 2020 | ALWKDMLKGIGKLAGKAALGAVKTLV{ct:Amid} | Dermaseptin-PP | Amidation | Free | Linear | L | None | 26 | Antimicrobial, Antitumor | 50 % Hemolysis at 38.77 μM | Horse | Frog Phyllomedusa Palliata | 50% TFE-10 mmol/L NH4Ac solution (MME) = α-Helical | NA | ||
| 32630734 | 2020 | FIQHLIPLIPHAIQGIKDIF{ct:Amid} | Kassiniatuerin-3 | Amidation | Free | Linear | L | None | 20 | Antimicrobial, Antibiofilm, Antiproliferation | ~2 % Hemolysis at 160 μM | Horse | Frog Kassina Senegalensis | aqueous = Random coil, 50% TFE = Helical | Low hemolytic | ||
| 32781587 | 2020 | FLPLIAGLAAKFLPKIFCAITKKC | B1A | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal | 10 % Hemolysis at 1.576 µM | Horse | Modified From Brevinin-1 (Lithobates Palustris (Rana Palustris)) Frog | aqueous, 1% SDS micelle solution = α-Helix | NA | ||
| 32781587 | 2020 | FLPLIAGLAAKCAITKKC | B1A1 | Free | Free | Linear | L | None | 18 | Antibacterial, Antifungal | 10 % Hemolysis at >512 µM | Horse | Truncated Analogue Of B1A | aqueous = Random coil, 1% SDS micelle solution = α-Helix | Low hemolytic | ||
| 32781587 | 2020 | FLPKIFCAITKKC | B1A2 | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal | 10 % Hemolysis at >512 µM | Horse | Truncated Analogue Of B1A | aqueous = Random coil, 1% SDS micelle solution = α-Helix | Low hemolytic | ||
| 32781587 | 2020 | KFLPKIFCAITKKC | KB2 | Free | Free | Linear | L | None | 14 | Antibacterial, Antifungal | 10 % Hemolysis at 154 µM | Horse | Derived From B1A2 | aqueous = Random coil, 1% SDS micelle solution = α-Helix | NA | ||
| 32781587 | 2020 | KKFLPKIFCAITKKC | KKB2 | Free | Free | Linear | L | None | 15 | Antibacterial, Antifungal | 10 % Hemolysis at 207 µM | Horse | Modification Of Kb2 | aqueous = Random coil, 1% SDS micelle solution = α-Helix | NA | ||
| 32781587 | 2020 | KFLPWKIFCAITKKC | KWB2 | Free | Free | Linear | L | None | 15 | Antibacterial, Antifungal | 10 % Hemolysis at 99.81 µM | Horse | Modified From Kb2 | aqueous = Random coil, 1% SDS micelle solution = α-Helix | NA | ||
| 32781587 | 2020 | KKFLPWKIFCAITKKC | KKWB2 | Free | Free | Linear | L | None | 16 | Antibacterial, Antifungal | 10 % Hemolysis at 140.04 µM | Horse | Modification Of Kwb | aqueous = Random coil, 1% SDS micelle solution = α-Helix | NA | ||
| 32781587 | 2020 | KFWPWKIFCAITKKC | KW3,5B2 | Free | Free | Linear | L | None | 15 | Antibacterial, Antifungal | 10 % Hemolysis at 32.07 µM | Horse | B1A Analogues | aqueous = Random coil, 1% SDS micelle solution = α-Helix | NA | ||
| 32781587 | 2020 | KFLPWKWFCAITKKC | KW5,7B2 | Free | Free | Linear | L | None | 15 | Antibacterial, Antifungal | 10 % Hemolysis at 58.42 µM | Horse | B1A Analogues | aqueous = Random coil, 1% SDS micelle solution = α-Helix | NA | ||
| 32872343 | 2020 | SALRGCWTKSYPPKPCL{ct:Amid} | SL-BBI | Amidation | Free | Linear | L | None | 17 | Antimicrobial | ≥5 % Hemolysis at 512 μM | Horse | Broad-Folded Frog (Sylvirana Latouchii) | NH4AC = β-Sheet and Random coil, 50%TFE/NH4AC = β-Sheet and Random coil | Non-hemolytic | ||
| 32872343 | 2020 | AALRGCWTKSIPPKPCK{ct:Amid} | K-SL | Amidation | Free | Linear | L | None | 17 | Antimicrobial | ≥5 % Hemolysis at 512 μM | Horse | Sl-Bbi Analogues | NH4AC = β-Sheet and Random coil, 50%TFE/NH4AC = β-Sheet, Random coil and Helix | Non-hemolytic | ||
| 32872343 | 2020 | SALRGCWTFSIPPKPCL{ct:Amid} | F-SL | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Anticancer | ≥10 % Hemolysis at 512 μM | Horse | Sl-Bbi Analogues | NH4AC = β-Sheet and Random coil, 50%TFE/NH4AC = β-Sheet and Random coil | Low hemolytic | ||
| 32967333 | 2020 | ALWKKLLKK-{nnr:Cha}{ct:Amid} | DMPC-10A | Amidation | Free | Linear | L | Cha = Cyclohexanylalanine | 10 | Antibacterial, Antibiofilm | ≥20 % Hemolysis at 128 μM | Horse | Derived From A Dermaseptin (Phyllomedusa Frogs) | amphipathic environment = α-Helix | NA | ||
| 32967333 | 2020 | AL{d}WK{d}K{d}L{d}L{d}K{d}K{d}-{nnr:Cha}{ct:Amid} | DMPC-10B | Amidation | Free | Linear | Mix | Cha = Cyclohexanylalanine | 10 | Antibacterial, Antibiofilm | 0 % Hemolysis at 128 μM | Horse | Modificaiton Of Dmpc-10A | TFE = α-Helix | Non-hemolytic | ||
| 33193152 | 2020 | FLSLIPKIAGGIAALVKNL{ct:Amid} | Phylloseptin-PV1 (PPV1) | Amidation | Free | Linear | L | None | 19 | Antimicrobial, Antiproliferative, Antibiofilm | ≥50 % Hemolysis at 32 μM | Horse | White-Lined Leaf Frog Phyllomedusa Vaillantii | aqueous = Random coil, 50% TFE = α-Helix | NA | ||
| 33193152 | 2020 | FLSLIPKIAGGIAALVKNL{ct:Amid} | Phylloseptin-PV1 (PPV1) | Amidation | Free | Linear | L | None | 19 | Antimicrobial, Antiproliferative, Antibiofilm | ≥95 % Hemolysis at 64 μM | Horse | White-Lined Leaf Frog Phyllomedusa Vaillantii | aqueous = Random coil, 50% TFE = α-Helix | NA | ||
| 33085895 | 2020 | F{d}{nnr:X}{nnr:X}L{nt:C16} | C16-fXXL | Free | C16 | Linear | Mix | X = L-2,4-diaminobutyric acid, f = D-phenylalanine | 4 | Antibacterial | ~10 % Hemolysis at 5 μg/mL | Horse | Synthetic Lipopeptide | NA | NA | ||
| 33085895 | 2020 | F{d}{nnr:X}{nnr:X}L{nt:C14} | C14-fXXL | Free | C14 | Linear | Mix | X = L-2,4-diaminobutyric acid, f = D-phenylalanine | 4 | Antibacterial | ~10 % Hemolysis at 5 μg/mL | Horse | Synthetic Lipopeptide | NA | NA | ||
| 33085895 | 2020 | F{d}{nnr:X}{nnr:X}{nnr:L}{nt:C12} | C12-fXXL | Free | C12 | Linear | Mix | X = L-2,4-diaminobutyric acid, f = D-phenylalanine, L = L-leucine | 4 | Antibacterial | <5 % Hemolysis at 5 μg/mL | Horse | Synthetic Lipopeptide | NA | NA | ||
| 32812694 | 2021 | FALGAVTKVLPKLFCLITRKC | Brevinin-1H | Free | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm, Antifungal | >20 % Hemolysis at 32 µM | Horse | Frog Amolops Hainanensis | Helix | NA | ||
| 32812694 | 2021 | FALGAVTKVLPKLFCLITRKC | Brevinin-1H | Free | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm, Antifungal | 50 % Hemolysis at 53.12 µM | Horse | Frog Amolops Hainanensis | Helix | NA | ||
| 32812694 | 2021 | FALGAVTKVLPKLFCLITRKC | Brevinin-1H | Free | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm, Antifungal | 9.49 % Hemolysis at 4 µM | Horse | Frog Amolops Hainanensis | Helix | NA | ||
| 32812694 | 2021 | FALGAVTCLIRTKCKVLPKLF | Brevinin-1Ha | Free | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm | 22.1 % Hemolysis at 128 µM | Horse | Brevinin-1H Analogues | NA | NA | ||
| 32812694 | 2021 | FALGAVTKVLYKLFCLITRKC | Brevinin-1HY | Free | Free | Linear | L | None | 21 | Antibacterial, Antibiofilm | 28.48 % Hemolysis at 4 µM | Horse | Brevinin-1H Analogues | Helix | NA | ||
| 33582221 | 2021 | ALWKDLLKNVGIAAGKAALNKVTDMVNQ{ct:Amid} | DRS-TO | Amidation | Free | Linear | L | None | 28 | Anticancer, Antimicrobial | 50 % Hemolysis at 436.7 µM | Horse | Leaf Frog Phyllomedusa Tomopterna | Helical | Low hemolytic | ||
| 33582221 | 2021 | ALWKTLLKNVGKAAGKAVLNAVTDMVNQ{ct:Amid} | DRS-PS2 | Amidation | Free | Linear | L | None | 28 | Antimicrobial | 50 % Hemolysis at 210.7 µM | Horse | Waxy Monkey Tree Frog Phyllomedusa Sauvagii | Helical | Low hemolytic | ||
| 34198776 | 2021 | KKLFKKILKKL{ct:Amid} | BP16 | Amidation | Free | Linear | L | None | 11 | Antibacterial | 3 ± 3.5 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34198776 | 2021 | RINSAKDDAAGLQIA{ct:OH} | flg15 | OH | Free | Linear | L | None | 15 | Antibacterial | 0 ± 0 % Hemolysis at 375 μM | Horse | Bacterial Flagellin | NA | Non-hemolytic | ||
| 34198776 | 2021 | RINSAKDDAAGLQIA-KKLFKKILKKL{ct:Amid} | BP358 (flg15-BP16) | Amidation | Free | Linear | L | None | 26 | Antibacterial | 5 ± 0.2 % Hemolysis at 375 μM | Horse | Combination Of Flg15 And Bp16 | NA | Low hemolytic | ||
| 34198776 | 2021 | KKLFKKILKKL-RINSAKDDAAGLQIA{ct:OH} | BP359 (BP16-flg15) | OH | Free | Linear | L | None | 26 | Antibacterial | 0.8 ± 0.5 % Hemolysis at 375 μM | Horse | Combination Of Bp16 And Flg15 | NA | Non-hemolytic | ||
| 34205705 | 2021 | KKLF{d}KKILKYL{nt:C5H11CO}{ct:Amid} | BP472 | Amidation | C5H11CO | Linear | Mix | None | 11 | Antifungal, Antibacterial | 78 ± 5 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 34205705 | 2021 | KKL{d}F{d}KK({nnr:COC3H7})IL{d}KYL{d}{nt:Acet}{ct:Amid} | BP473 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 11 | Antifungal, Antibacterial | 84 ± 11 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 34205705 | 2021 | KKL{d}F{d}KKIK({nnr:COC3H7})KYL{d}{nt:Acet}{ct:Amid} | BP474 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 11 | Antifungal, Antibacterial | 0 ± 0 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | Non-hemolytic | ||
| 34205705 | 2021 | KKL{d}F{d}KKIL{d}KK({nnr:COC3H7})L{d}{nt:Acet}{ct:Amid} | BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 11 | Antifungal, Antibacterial | 0 ± 0 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | α-Helical | Non-hemolytic | ||
| 34205705 | 2021 | KKL{d}F{d}KKIL{d}KYK({nnr:COC11H23}){nt:Acet}{ct:Amid} | BP476 | Amidation | Acetylation | Linear | Mix | COC11H23 = lauroyl | 11 | Antifungal, Antibacterial | 94 ± 10 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 34205705 | 2021 | KKL{d}k({nnr:COC5H11})KKIL{d}KYL{d}{nt:Acet}{ct:Amid} | BP484 | Amidation | Acetylation | Linear | Mix | COC5H11 = hexanoyl | 11 | Antifungal, Antibacterial | 10 ± 2 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | Non-hemolytic | ||
| 34205705 | 2021 | KKL{d}F{d}{d}KKIL{d}KYL{d}{nt:C3H7CO}{ct:Amid} | BP485 | Amidation | C3H7CO | Linear | Mix | None | 11 | Antifungal, Antibacterial | 24 ± 9 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 34205705 | 2021 | KK({nnr:COC3H7})L{d}F{d}KKIL{d}KYL{d}{nt:Acet}{ct:Amid} | BP486 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 11 | Antifungal, Antibacterial | 14 ± 5 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 34205705 | 2021 | KKL{d}k({nnr:COC11H23})KKIL{d}KYL{d}{nt:Acet}{ct:Amid} | BP488 | Amidation | Acetylation | Linear | Mix | COC11H23 = lauroyl | 11 | Antifungal, Antibacterial | 86 ± 14 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 34205705 | 2021 | KKL{d}F{d}KKK({nnr:COC11H23})L{d}KYL{d}{nt:Acet}{ct:Amid} | BP489 | Amidation | Acetylation | Linear | Mix | COC11H23 = lauroyl | 11 | Antifungal, Antibacterial | 100 ± 6 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 34205705 | 2021 | KKL{d}F{d}KKIK({nnr:COC11H23})KYL{d}{nt:Acet}{ct:Amid} | BP490 | Amidation | Acetylation | Linear | Mix | COC11H23 = lauroyl | 11 | Antifungal, Antibacterial | 100 ± 6 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 34205705 | 2021 | KKL{d}F{d}KKK({nnr:COC5H11})L{d}KYL{d}{nt:Acet}{ct:Amid} | BP494 | Amidation | Acetylation | Linear | Mix | COC5H11 = hexanoyl | 11 | Antifungal, Antibacterial | 0.2 ± 0.2 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | Non-hemolytic | ||
| 34205705 | 2021 | KKL{d}F{d}KKIL{d}KYK({nnr:COC5H11}){nt:Acet}{ct:Amid} | BP495 | Amidation | Acetylation | Linear | Mix | COC5H11 = hexanoyl | 11 | Antifungal, Antibacterial | 0.6 ± 1 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | Non-hemolytic | ||
| 34205705 | 2021 | KKL{d}F{d}KKIL{d}KYK({nnr:COC3H7}){nt:Acet}{ct:Amid} | BP496 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 11 | Antifungal, Antibacterial | 1 ± 1 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | Non-hemolytic | ||
| 34205705 | 2021 | KKL{d}F{d}KKIL{d}K({nnr:COC11H23})YL{d}{nt:Acet}{ct:Amid} | BP497 | Amidation | Acetylation | Linear | Mix | COC11H23 = lauroyl | 11 | Antifungal, Antibacterial | 100 ± 2 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 34205705 | 2021 | KKL{d}F{d}K({nnr:COC3H7})KIL{d}KYL{d}{nt:Acet}{ct:Amid} | BP498 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 11 | Antifungal, Antibacterial | 21 ± 3 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 34205705 | 2021 | KKL{d}F{d}KKIL{d}K({nnr:COC3H7})YL{d}{nt:Acet}{ct:Amid} | BP499 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 11 | Antifungal, Antibacterial | 11 ± 1 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 34205705 | 2021 | KKK({nnr:COC11H23})F{d}KKIL{d}KYL{d}{nt:Acet}{ct:Amid} | BP500 | Amidation | Acetylation | Linear | Mix | COC11H23 = lauroyl | 11 | Antifungal, Antibacterial | 71 ± 8 % Hemolysis at 256 μM | Horse | Synthetic Lipopeptides | NA | NA | ||
| 34342438 | 2021 | RPFTRAQWFAIQHISPRTIAMRAINNYRWR | hECP30 | Free | Free | Linear | L | None | 30 | Antimicrobial, Antibiofilm | 44 ± 4 % Hemolysis at 250 μM | Horse | Human Rnase 3 Eosinophil Cationic Protein (Ecp) Fragment | aqueous = Random coil, SDS micelles (1 mM) = α-Helical | NA | ||
| 34342438 | 2021 | {nnr:O}PFT{nnr:O}AQWFAIQHISP{nnr:O}TIAM{nnr:O}AINNY{nnr:O}W{nnr:O} | Orn analog | Free | Free | Linear | L | O = L-Ornithine | 30 | Antibacterial | 10 ± 2 % Hemolysis at 250 μM | Horse | Hecp30 Analogs | aqueous = Random coil, SDS micelles (1 mM) = α-Helical | NA | ||
| 34342438 | 2021 | {nnr:X}PFT{nnr:X}AQWFAIQHISP{nnr:X}TIAM{nnr:X}AINNY{nnr:X}W{nnr:X} | Dab analog | Free | Free | Linear | L | X = L-2,4-diaminobutyric acid | 30 | Antibacterial | 14 ± 6 % Hemolysis at 250 μM | Horse | Hecp30 Analogs | NA | NA | ||
| 34342438 | 2021 | {nnr:Z}PFT{nnr:Z}AQWFAIQHISP{nnr:Z}TIAM{nnr:Z}AINNY{nnr:Z}W{nnr:Z} | Har analog | Free | Free | Linear | L | Z = L-homoarginine | 30 | Antibacterial | 43 ± 1 % Hemolysis at 250 μM | Horse | Hecp30 Analogs | NA | NA | ||
| 34342438 | 2021 | FT{nnr:O}AQWFAIQHISP{nnr:O}TIAM{nnr:O}AINNY{nnr:O}W{nnr:O} | Des[Orn1-Pro2] analog | Free | Free | Linear | L | O = L-Ornithine | 28 | Antibacterial | 11 ± 4 % Hemolysis at 250 μM | Horse | Hecp30 Analogs | NA | NA | ||
| 34342438 | 2021 | {nnr:O}P{d}FT{nnr:O}AQWFAIQHISP{nnr:O}TIAM{nnr:O}AINNY{nnr:O}W{nnr:O} | [Orn,1D-Pro2] analog | Free | Free | Linear | Mix | O = L-Ornithine, p = D-Proline | 30 | Antibacterial | 1.1 ± 0.9 % Hemolysis at 250 μM | Horse | Hecp30 Analogs | aqueous = Random coil, SDS micelles (1 mM) = α-Helical | Low hemolytic | ||
| 34342438 | 2021 | {nnr:o}P{d}FT{nnr:O}AQWFAIQHISP{nnr:O}TIAM{nnr:O}AINNY{nnr:O}W{nnr:O} | [D-Orn,1D-Pro2] analog | Free | Free | Linear | Mix | o = D-Ornithine, p = D-Proline | 30 | Antibacterial | 3.6 ± 0.7 % Hemolysis at 250 μM | Horse | Hecp30 Analogs | aqueous = Random coil, SDS micelles (1 mM) = α-Helical | Low hemolytic | ||
| 34738013 | 2021 | FIPLVSGLFSKLL{ct:Amid} | Temporin-FL | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 157.4 μM | Horse | Frog Pelophylax Nigromaculatus | 50%TFE/NH4Ac = Helix | NA | ||
| 34738013 | 2021 | FIPLVSGLFKLL{ct:Amid} | Temporin-FLa | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 74.02 μM | Horse | Temporin-Fl Truncated Analogues | 50%TFE/NH4Ac = Helix | NA | ||
| 34738013 | 2021 | FIPVSGLFKLL{ct:Amid} | Temporin-FLb | Amidation | Free | Linear | L | None | 11 | Antimicrobial, Antibiofilm | 50 % Hemolysis at 356 μM | Horse | Temporin-Fl Truncated Analogues | 50%TFE/NH4Ac = Helix | Low hemolytic | ||
| 34819923 | 2021 | WLRRIKAWLRRIKA{ct:OH} | RR4-OH | OH | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 3.2 ± 1.0 % Hemolysis at 150 μM | Horse | Short Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | WIRRIKKWIRRVHK{ct:Amid} | RR2-NH2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 13.0 ± 1.7 % Hemolysis at 150 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | WLRRIKAWLRRKRK{ct:Amid} | RR3-NH2 | Amidation | Free | Linear | L | None | 15 | Antimicrobial, Antibiofilm | 19.0 ± 3.3 % Hemolysis at 150 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | WLRRIKAWLRRIKA{ct:Amid} | RR4-NH2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 64.3 ± 5.4 % Hemolysis at 150 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | VFWRRIRVWVIR{ct:Amid} | LJK2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 28.4 ± 1.9 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | R{d}I{d}V{d}W{d}V{d}R{d}I{d}R{d}R{d}W{d}F{d}V{d}{ct:Amid} | RIJK2 | Amidation | Free | Linear | D | None | 12 | Antimicrobial, Antibiofilm | 35.1 ± 8.3 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | RIVWVRIRRWFV{ct:Amid} | RJK2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 19.2 ± 3.1 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | KRIVKLILKWLR{ct:Amid} | KR-12-a5 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm, Anti-inflammatory | 79.0 ± 0.6 % Hemolysis at 150 μM | Horse | Ll-37 Derivatives Synthetic Peptide | α-Helical | NA | ||
| 34819923 | 2021 | WKKIRVRLSA{ct:Amid} | SB056 | Amidation | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 1.7 ± 0.2 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | GILGKLWEGVKSIF{ct:Amid} | HP1404 | Amidation | Free | Linear | L | None | 15 | Antimicrobial, Antibiofilm | 100.0 ± 0.5 % Hemolysis at 150 μM | Horse | Scorpion Heterometrus Petersii | NA | NA | ||
| 34819923 | 2021 | ILK{d}KLL{d}K{d}K{d}VKSI{ct:Amid} | HP1404 T1-D | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial, Antibiofilm | 0.3 ± 0.3 % Hemolysis at 150 μM | Horse | Synthetic Peptides | NA | Non-hemolytic | ||
| 34819923 | 2021 | ILK{d}KLL{d}K{d}K{d}VKK{d}I{d}{ct:Amid} | HP1404 T1-E | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 0.8 ± 0.4 % Hemolysis at 150 μM | Horse | Synthetic Peptides | NA | Non-hemolytic | ||
| 34819923 | 2021 | FLFSLIPHAIGGLISAFK{ct:Amid} | AamAP1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.00 ± 1.3 % Hemolysis at 150 μM | Horse | Scorpion Venom Antimicrobial Peptide | NA | NA | ||
| 34819923 | 2021 | FLFSLIPKAIGGLISAFK{ct:Amid} | AamAP-S1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.00 ± 4.9 % Hemolysis at 150 μM | Horse | Aamap1 Analog | NA | NA | ||
| 34819923 | 2021 | FLFSLIPRAIGGLISAFK{ct:Amid} | AamAP-R | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.00 ± 4.3 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid} | Magainin 2 | Amidation | Free | Linear | L | None | 26 | Antimicrobial, Antibiofilm | 35.2 ± 1.1 % Hemolysis at 150 μM | Horse | Synthetic Amp | NA | NA | ||
| 34819923 | 2021 | GIGKFLHSAK{ct:Amid} | Magainin 2(1-10) | Amidation | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0.0 ± 0.4 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Non-hemolytic | ||
| 34819923 | 2021 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 95.1 ± 5.0 % Hemolysis at 150 μM | Horse | Synthetic Amp | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{ct:Amid} | BP525 | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 3.1 ± 1.0 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C3H7CO}{ct:Amid} | BP526 | Amidation | C3H7CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 8.3 ± 0.7 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C5H11CO}{ct:Amid} | BP527 | Amidation | C5H11CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 62.2 ± 4.4 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C11H23CO}{ct:Amid} | BP528 | Amidation | C11H23CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 92.1 ± 5.7 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:HOC11H22CO}{ct:Amid} | BP529 | Amidation | HOC11H22CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 7.2 ± 0.3 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | VRLIVAVRIWRR{ct:Amid} | IDR-1018 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 35.6 ± 4.4 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | KRFRIRVRVIRK{ct:Amid} | HH15 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 2.3 ± 0.3 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | VQWRIRVRVIKK{ct:Amid} | 1026 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 7.6 ± 0.8 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | KQFRIRVRV{ct:Amid} | 1029 | Amidation | Free | Linear | L | None | 9 | Antimicrobial, Antibiofilm | 2.3 ± 0.7 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | VQFRIRVRIVIRK{ct:Amid} | 1036 | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 6.5 ± 0.6 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | KRFRIRVRV{ct:Amid} | 1037 | Amidation | Free | Linear | L | None | 9 | Antimicrobial, Antibiofilm | 2.4 ± 0.4 % Hemolysis at 150 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | FRIRVRV{ct:Amid} | FV7 | Amidation | Free | Linear | L | None | 7 | Antimicrobial, Antibiofilm | 3.7 ± 0.4 % Hemolysis at 150 μM | Horse | Synthetic Peptide | α-Helical | Low hemolytic | ||
| 34819923 | 2021 | RFRRLFRIRVRVLKKI{ct:Amid} | R-FV7-I16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibiofilm | 6.3 ± 0.3 % Hemolysis at 150 μM | Horse | Synthetic Peptide | α-Helical | Low hemolytic | ||
| 34819923 | 2021 | WLRRIKAWLRRIKA-OH{ct:OH} | RR4-OH | OH | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 9.8 ± 3.7 % Hemolysis at 250 μM | Horse | Short Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | WIRRIKKWIRRVHK{ct:Amid} | RR2-NH2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 14.0 ± 1.8 % Hemolysis at 250 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | WLRRIKAWLRRKRK{ct:Amid} | RR3-NH2 | Amidation | Free | Linear | L | None | 15 | Antimicrobial, Antibiofilm | 30.8 ± 4.2 % Hemolysis at 250 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | WLRRIKAWLRRIKA{ct:Amid} | RR4-NH2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 85.0 ± 5.7 % Hemolysis at 250 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | VFWRRIRVWVIR{ct:Amid} | LJK2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 43.9 ± 3.7 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | R{d}I{d}V{d}W{d}V{d}R{d}I{d}R{d}R{d}W{d}F{d}V{d}{ct:Amid} | RIJK2 | Amidation | Free | Linear | D | None | 12 | Antimicrobial, Antibiofilm | 64.4 ± 9.4 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | RIVWVRIRRWFV{ct:Amid} | RJK2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 29.6 ± 2.2 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | KRIVKLILKWLR{ct:Amid} | KR-12-a5 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm, Anti-inflammatory | 96.1 ± 1.8 % Hemolysis at 250 μM | Horse | Ll-37 Derivatives Synthetic Peptide | α-Helical | NA | ||
| 34819923 | 2021 | WKKIRVRLSA{ct:Amid} | SB056 | Amidation | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 1.8 ± 0.3 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | Non-hemolytic | ||
| 34819923 | 2021 | GILGKLWEGVKSIF{ct:Amid} | HP1404 | Amidation | Free | Linear | L | None | 15 | Antimicrobial, Antibiofilm | 100.0 ± 3.9 % Hemolysis at 250 μM | Horse | Scorpion Heterometrus Petersii | NA | NA | ||
| 34819923 | 2021 | ILK{d}KLL{d}K{d}K{d}VKSI{ct:Amid} | HP1404 T1-D | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial, Antibiofilm | 0.8 ± 1.1 % Hemolysis at 250 μM | Horse | Synthetic Peptides | NA | Non-hemolytic | ||
| 34819923 | 2021 | ILK{d}KLL{d}K{d}K{d}VKK{d}I{d}{ct:Amid} | HP1404 T1-E | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 0.7 ± 0.4 % Hemolysis at 250 μM | Horse | Synthetic Peptides | NA | Non-hemolytic | ||
| 34819923 | 2021 | FLFSLIPHAIGGLISAFK{ct:Amid} | AamAP1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.0 ± 4.1 % Hemolysis at 250 μM | Horse | Scorpion Venom Antimicrobial Peptide | NA | NA | ||
| 34819923 | 2021 | FLFSLIPKAIGGLISAFK{ct:Amid} | AamAP-S1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.0 ± 2.1 % Hemolysis at 250 μM | Horse | Aamap1 Analog | NA | NA | ||
| 34819923 | 2021 | FLFSLIPRAIGGLISAFK{ct:Amid} | AamAP-R | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.0 ± 10.5 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid} | Magainin 2 | Amidation | Free | Linear | L | None | 26 | Antimicrobial, Antibiofilm | 54.5 ± 3.7 % Hemolysis at 250 μM | Horse | Synthetic Amp | NA | NA | ||
| 34819923 | 2021 | GIGKFLHSAK{ct:Amid} | Magainin 2(1-10) | Amidation | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0.0 ± 0.2 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | Non-hemolytic | ||
| 34819923 | 2021 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 100.0 ± 4.4 % Hemolysis at 250 μM | Horse | Synthetic Amp | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{ct:Amid} | BP525 | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 3.8 ± 0.8 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C3H7CO}{ct:Amid} | BP526 | Amidation | C3H7CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 20.4 ± 0.7 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C5H11CO}{ct:Amid} | BP527 | Amidation | C5H11CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 73.6 ± 1.1 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C11H23CO}{ct:Amid} | BP528 | Amidation | C11H23CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 96.6 ± 3.1 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:HOC11H22CO}{ct:Amid} | BP529 | Amidation | HOC11H22CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 12.5 ± 0.6 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | VRLIVAVRIWRR{ct:Amid} | IDR-1018 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 43.0 ± 0.2 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | KRFRIRVRVIRK{ct:Amid} | HH15 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 4.5 ± 1.9 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | VQWRIRVRVIKK{ct:Amid} | 1026 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 10.8 ± 0.7 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | KQFRIRVRV{ct:Amid} | 1029 | Amidation | Free | Linear | L | None | 9 | Antimicrobial, Antibiofilm | 3.5 ± 0.7 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | VQFRIRVRIVIRK{ct:Amid} | 1036 | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 11.0 ± 1.6 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | KRFRIRVRV{ct:Amid} | 1037 | Amidation | Free | Linear | L | None | 9 | Antimicrobial, Antibiofilm | 3.3 ± 0.7 % Hemolysis at 250 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | FRIRVRV{ct:Amid} | FV7 | Amidation | Free | Linear | L | None | 7 | Antimicrobial, Antibiofilm | 4.4 ± 0.3 % Hemolysis at 250 μM | Horse | Synthetic Peptide | α-Helical | Low hemolytic | ||
| 34819923 | 2021 | RFRRLFRIRVRVLKKI{ct:Amid} | R-FV7-I16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibiofilm | 8.0 ± 1.3 % Hemolysis at 250 μM | Horse | Synthetic Peptide | α-Helical | Low hemolytic | ||
| 34819923 | 2021 | WLRRIKAWLRRIKA{ct:OH} | RR4-OH | OH | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 17.8 ± 0.3 % Hemolysis at 375 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | WIRRIKKWIRRVHK{ct:Amid} | RR2-NH2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 17.9 ± 0.4 % Hemolysis at 375 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | WLRRIKAWLRRKRK{ct:Amid} | RR3-NH2 | Amidation | Free | Linear | L | None | 15 | Antimicrobial, Antibiofilm | 37.3 ± 4.4 % Hemolysis at 375 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | WLRRIKAWLRRIKA{ct:Amid} | RR4-NH2 | Amidation | Free | Linear | L | None | 14 | Antimicrobial, Antibiofilm | 100.0 ± 5.4 % Hemolysis at 375 μM | Horse | Short Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | VFWRRIRVWVIR{ct:Amid} | LJK2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 72.4 ± 8.9 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | R{d}I{d}V{d}W{d}V{d}R{d}I{d}R{d}R{d}W{d}F{d}V{d}{ct:Amid} | RIJK2 | Amidation | Free | Linear | D | None | 12 | Antimicrobial, Antibiofilm | 71.0 ± 7.1 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | RIVWVRIRRWFV{ct:Amid} | RJK2 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 50.2 ± 5.4 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | KRIVKLILKWLR{ct:Amid} | KR-12-a5 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm, Anti-inflammatory | 100.0 ± 1.7 % Hemolysis at 375 μM | Horse | Ll-37 Derivatives Synthetic Peptide | α-Helical | NA | ||
| 34819923 | 2021 | WKKIRVRLSA{ct:Amid} | SB056 | Amidation | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 2.3 ± 0.7 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | GILGKLWEGVKSIF{ct:Amid} | HP1404 | Amidation | Free | Linear | L | None | 15 | Antimicrobial, Antibiofilm | 100.0 ± 0.7 % Hemolysis at 375 μM | Horse | Scorpion Heterometrus Petersii | NA | NA | ||
| 34819923 | 2021 | ILK{d}KLL{d}K{d}K{d}VKSI{ct:Amid} | HP1404 T1-D | Amidation | Free | Linear | Mix | None | 12 | Antimicrobial, Antibiofilm | 1.3 ± 0.2 % Hemolysis at 375 μM | Horse | Synthetic Peptides | NA | Non-hemolytic | ||
| 34819923 | 2021 | ILK{d}KLL{d}K{d}K{d}VKK{d}I{d}{ct:Amid} | HP1404 T1-E | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 1.5 ± 0.3 % Hemolysis at 375 μM | Horse | Synthetic Peptides | NA | Non-hemolytic | ||
| 34819923 | 2021 | FLFSLIPHAIGGLISAFK{ct:Amid} | AamAP1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.0 ± 4.4 % Hemolysis at 375 μM | Horse | Scorpion Venom Antimicrobial Peptide | NA | NA | ||
| 34819923 | 2021 | FLFSLIPKAIGGLISAFK{ct:Amid} | AamAP-S1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.0 ± 2.9 % Hemolysis at 375 μM | Horse | Aamap1 Analog | NA | NA | ||
| 34819923 | 2021 | FLFSLIPRAIGGLISAFK{ct:Amid} | AamAP-R | Amidation | Free | Linear | L | None | 18 | Antimicrobial, Antibiofilm | 100.0 ± 3.1 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid} | Magainin 2 | Amidation | Free | Linear | L | None | 26 | Antimicrobial, Antibiofilm | 71.1 ± 6.0 % Hemolysis at 375 μM | Horse | Synthetic Amp | NA | NA | ||
| 34819923 | 2021 | GIGKFLHSAK{ct:Amid} | Magainin 2(1-10) | Amidation | Free | Linear | L | None | 10 | Antimicrobial, Antibiofilm | 0.0 ± 0.7 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | Non-hemolytic | ||
| 34819923 | 2021 | ILPWKWPWWPWRR{ct:Amid} | Indolicidin | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 100.0 ± 2.5 % Hemolysis at 375 μM | Horse | Synthetic Amp | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{ct:Amid} | BP525 | Amidation | Free | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 10.0 ± 5.9 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C3H7CO}{ct:Amid} | BP526 | Amidation | C3H7CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 46.8 ± 3.3 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C5H11CO}{ct:Amid} | BP527 | Amidation | C5H11CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 100.0 ± 2.6 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C11H23CO}{ct:Amid} | BP528 | Amidation | C11H23CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 99.1 ± 8.0 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:HOC11H22CO}{ct:Amid} | BP529 | Amidation | HOC11H22CO | Linear | Mix | None | 13 | Antimicrobial, Antibiofilm | 39.0 ± 1.1 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | VRLIVAVRIWRR{ct:Amid} | IDR-1018 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 45.9 ± 4.9 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | KRFRIRVRVIRK{ct:Amid} | HH15 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 4.0 ± 0.4 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | VQWRIRVRVIKK{ct:Amid} | 1026 | Amidation | Free | Linear | L | None | 12 | Antimicrobial, Antibiofilm | 14.5 ± 5.5 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | KQFRIRVRV{ct:Amid} | 1029 | Amidation | Free | Linear | L | None | 9 | Antimicrobial, Antibiofilm | 3.4 ± 0.6 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | VQFRIRVRIVIRK{ct:Amid} | 1036 | Amidation | Free | Linear | L | None | 13 | Antimicrobial, Antibiofilm | 17.3 ± 1.3 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | NA | ||
| 34819923 | 2021 | KRFRIRVRV{ct:Amid} | 1037 | Amidation | Free | Linear | L | None | 9 | Antimicrobial, Antibiofilm | 4.9 ± 0.2 % Hemolysis at 375 μM | Horse | Synthetic Peptide | NA | Low hemolytic | ||
| 34819923 | 2021 | FRIRVRV{ct:Amid} | FV7 | Amidation | Free | Linear | L | None | 7 | Antimicrobial, Antibiofilm | 9.5 ± 1.4 % Hemolysis at 375 μM | Horse | Synthetic Peptide | α-Helical | Low hemolytic | ||
| 34819923 | 2021 | RFRRLFRIRVRVLKKI{ct:Amid} | R-FV7-I16 | Amidation | Free | Linear | L | None | 16 | Antimicrobial, Antibiofilm | 9.7 ± 0.6 % Hemolysis at 375 μM | Horse | Synthetic Peptide | α-Helical | Low hemolytic | ||
| 34508563 | 2021 | FLGALFKVASKLVPAAICSISKKC | Brevinin-1HL | Free | Free | Linear | L | None | 24 | Antimicrobial, Anticancer, Antibiofilm | 50 % Hemolysis at 11.5 ± 0.2 μM | Horse | Broad-Folded Frog, Hylarana Latouchii | aqueous = Random coil, 50% TFE = α-Helical | NA | ||
| 34508563 | 2021 | FFPLIFGALSSILPKIL | Temporin-HLa | Free | Free | Linear | L | None | 17 | Antimicrobial, Anticancer, Antibiofilm | 50 % Hemolysis at 31.4 ± 0.7 μM | Horse | Broad-Folded Frog, Hylarana Latouchii | aqueous = Random coil, 50% TFE = α-Helical | NA | ||
| 34508563 | 2021 | FLQHIIGALSHIF | Temporin-HLb | Free | Free | Linear | L | None | 13 | Antimicrobial, Anticancer, Antibiofilm | 50 % Hemolysis at 18.6 ± 10.0 mM | Horse | Broad-Folded Frog, Hylarana Latouchii | aqueous = Random coil, 50% TFE = α-Helical | Low hemolytic | ||
| 34908502 | 2021 | GMFTNMLKGIGKLAGKAALGAVKTLA{ct:Amid} | Dermaseptin-AC | Amidation | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 50 % Hemolysis at 76.55 μM | Horse | Frog Agalychnis Callidryas | 50% TFE-10 mM NH4Ac solution = α-Helix | NA | ||
| 34908502 | 2021 | GMFTNMLKGIGKLAGKAALGAVKTLA{ct:Amid} | Dermaseptin-AC | Amidation | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 2.73 % Hemolysis at 2 μM | Horse | Frog Agalychnis Callidryas | 50% TFE-10 mM NH4Ac solution = α-Helix | NA | ||
| 34908502 | 2021 | GMFTNMLKGIGKLAGKAALGAVKTLA{ct:Amid} | Dermaseptin-AC | Amidation | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 4.31 % Hemolysis at 4 μM | Horse | Frog Agalychnis Callidryas | 50% TFE-10 mM NH4Ac solution = α-Helix | NA | ||
| 34908502 | 2021 | GMFTNMLKGIGKLAGKAALGAVKTLA{ct:Amid} | Dermaseptin-AC | Amidation | Free | Linear | L | None | 26 | Antibacterial, Antibiofilm | 7.47 % Hemolysis at 8 μM | Horse | Frog Agalychnis Callidryas | 50% TFE-10 mM NH4Ac solution = α-Helix | NA | ||
| 36547631 | 2022 | RICRRRSAGFKGPCVSNKNCAQVCMQEGWGGGNCDGPLRRCKCMRRC | defensin-like protein 1 (D-lp1) | Free | Free | Linear | L | None | 47 | Antifungal, Antibiofilm, Anti-virulence, Anti-Candida | 0.48 % Hemolysis at 0.19 mg/mL | Horse | Sulphur-Rich Defensin Present In Barley Endosperm | NA | Low hemolytic | ||
| 36547631 | 2022 | RICRRRSAGFKGPCVSNKNCAQVCMQEGWGGGNCDGPLRRCKCMRRC | defensin-like protein 1 (D-lp1) | Free | Free | Linear | L | None | 47 | Antifungal, Antibiofilm, Anti-virulence, Anti-Candida | 1.74 % Hemolysis at 0.39 mg/mL | Horse | Sulphur-Rich Defensin Present In Barley Endosperm | NA | Low hemolytic | ||
| 36547631 | 2022 | RICRRRSAGFKGPCVSNKNCAQVCMQEGWGGGNCDGPLRRCKCMRRC | defensin-like protein 1 (D-lp1) | Free | Free | Linear | L | None | 47 | Antifungal, Antibiofilm, Anti-virulence, Anti-Candida | 9.55 % Hemolysis at 0.78 mg/mL | Horse | Sulphur-Rich Defensin Present In Barley Endosperm | NA | Low hemolytic | ||
| 36547631 | 2022 | RICRRRSAGFKGPCVSNKNCAQVCMQEGWGGGNCDGPLRRCKCMRRC | defensin-like protein 1 (D-lp1) | Free | Free | Linear | L | None | 47 | Antifungal, Antibiofilm, Anti-virulence, Anti-Candida | 14.72 % Hemolysis at 1.56 mg/mL | Horse | Sulphur-Rich Defensin Present In Barley Endosperm | NA | Low hemolytic | ||
| 36321228 | 2023 | LFDKIEKVFKRFRKKFKKLF | SK4 | Free | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 0 % Hemolysis at 5 μM | Horse | Hybrid Peptide Resulting From Cecropin A And Bmap-27 | α-Helical | Non-hemolytic | ||
| 36321228 | 2023 | LFDKIEKVFKRFRKKFKKLF | SK4 | Free | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 0 % Hemolysis at 10 μM | Horse | Hybrid Peptide Resulting From Cecropin A And Bmap-27 | α-Helical | Non-hemolytic | ||
| 36321228 | 2023 | LFDKIEKVFKRFRKKFKKLF | SK4 | Free | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 0 % Hemolysis at 20 μM | Horse | Hybrid Peptide Resulting From Cecropin A And Bmap-27 | α-Helical | Non-hemolytic | ||
| 36321228 | 2023 | LFDKIEKVFKRFRKKFKKLF | SK4 | Free | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 0 % Hemolysis at 40 μM | Horse | Hybrid Peptide Resulting From Cecropin A And Bmap-27 | α-Helical | Non-hemolytic | ||
| 36321228 | 2023 | LFDKIEKVFKRFRKKFKKLF | SK4 | Free | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 0 % Hemolysis at 60 μM | Horse | Hybrid Peptide Resulting From Cecropin A And Bmap-27 | α-Helical | Non-hemolytic | ||
| 36321228 | 2023 | LFDKIEKVFKRFRKKFKKLF | SK4 | Free | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 0 % Hemolysis at 80 μM | Horse | Hybrid Peptide Resulting From Cecropin A And Bmap-27 | α-Helical | Non-hemolytic | ||
| 36321228 | 2023 | LFDKIEKVFKRFRKKFKKLF | SK4 | Free | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 0 % Hemolysis at 100 μM | Horse | Hybrid Peptide Resulting From Cecropin A And Bmap-27 | α-Helical | Non-hemolytic | ||
| 25626077 | 2015 | FLFSLIPSVIAGLVSAIRN{ct:Amid} | AaeAP1 | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal | 100 % Hemolysis at 16 μg/ml | Horse | Scorpion Androctonus Aeneas | 21.05 % α-Helix | NA | ||
| 25626077 | 2015 | FLFSLIPSAIAGLVSAIRN{ct:Amid} | AaeAP2 | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal | 100 % Hemolysis at 64 μg/ml | Horse | Scorpion Androctonus Aeneas | 21.05 % α-Helix | NA | ||
| 25626077 | 2015 | FLFKLIPKVIKGLVKAIRK{ct:Amid} | AaeAP1a | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal. Anticancer, Antiproliferative | 100 % Hemolysis at 32 μg/ml | Horse | Aaeap1 Analogues | 31.58% α-Helix | NA | ||
| 25626077 | 2015 | FLFKLIPKAIKGLVKAIRK{ct:Amid} | AaeAP2a | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal. Anticancer, Antiproliferative | 100 % Hemolysis at 64 μg/ml | Horse | Aaeap2 Analogues | 31.58% α-Helix | NA | ||
| 35335979 | 2022 | FVDLKKIANILNSIF{ct:Amid} | Temporin-1CEh | Amidation | Free | Linear | L | None | 15 | Antibacterial, Antibiofilm | 50 % Hemolysis at 152.6 µM | Horse | Rana Chensinensis | α-Helix | NA | ||
| 35335979 | 2022 | FVDLKKIANILNSIF{ct:Amid} | Temporin-1CEh | Amidation | Free | Linear | L | None | 15 | Antibacterial, Antibiofilm | 92.3 % Hemolysis at 256 µM | Horse | Rana Chensinensis | α-Helix | NA | ||
| 35335979 | 2022 | FVDLKKIANIINSIF{ct:Amid} | Temporin-1CEa | Amidation | Free | Linear | L | None | 15 | Antibacterial, Antibiofilm | 50 % Hemolysis at 160 µM | Horse | Synthetic | α-Helix | NA | ||
| 35335979 | 2022 | FVDLKKIANIL{ct:Amid} | T1CEh-t | Amidation | Free | Linear | L | None | 11 | Antibacterial, Antibiofilm | <5 % Hemolysis at 64 µM | Horse | Synthetic | α-Helix | NA | ||
| 35335979 | 2022 | FVDLKKIANII{ct:Amid} | T1CEa-t | Amidation | Free | Linear | L | None | 11 | Antibacterial, Antibiofilm | 0 % Hemolysis at 64 µM | Horse | Synthetic | α-Helix | NA | ||
| 35335979 | 2022 | KKFVDLKKIANIL{ct:Amid} | T1CEh-KK | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 0 % Hemolysis at 64 µM | Horse | Synthetic | α-Helix | NA | ||
| 35335979 | 2022 | KKFVPLKKIANIL{ct:Amid} | T1CEh-KKP | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | ∼1 % Hemolysis at 64 µM | Horse | Synthetic | α-Helix | NA | ||
| 35335979 | 2022 | KKWVPLKKIANIL{ct:Amid} | T1CEh-KKPW | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | <10 % Hemolysis at 256 µM | Horse | Synthetic | α-Helix | NA | ||
| 35335979 | 2022 | KKWVPWKKIANIL{ct:Amid} | T1CEh-KKPWW | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm | 6 % Hemolysis at 256 µM | Horse | Synthetic | α-Helix | NA | ||
| 35335979 | 2022 | KKWVPWKKKWVPWKKIANIL{ct:Amid} | T1CEh-KKPWW2 | Amidation | Free | Branched | L | None | 20 | Antibacterial, Antibiofilm | 63 % Hemolysis at 256 µM | Horse | Synthetic | α-Helix | NA | ||
| 35606468 | 2022 | GLLGKILGAGKKVLCGVSGLC | Nigrocin-PN | Free | Free | Linear | L | None | 21 | Antimicrobial, Anticancer | 0 % Hemolysis at 10 µM | Horse | Pelophylax Nigromaculatus | Random coil | Non-hemolytic | ||
| 35606468 | 2022 | GLLGKILGAGKKVLCGVSGLC | Nigrocin-PN | Free | Free | Linear | L | None | 21 | Antimicrobial, Anticancer | <5 % Hemolysis at 100 µM | Horse | Pelophylax Nigromaculatus | Random coil | Non-hemolytic | ||
| 35606468 | 2022 | GLLGKILGAGKKVLLGVSGLL | Nigrocin-M1 | Free | Free | Linear | L | None | 21 | Antimicrobial, Anticancer | 0 % Hemolysis at 10 µM | Horse | Pelophylax Nigromaculatus | Random coil | Non-hemolytic | ||
| 35606468 | 2022 | GLLGKILGAGKKVLLGVSGLL | Nigrocin-M1 | Free | Free | Linear | L | None | 21 | Antimicrobial, Anticancer | <20 % Hemolysis at 100 µM | Horse | Pelophylax Nigromaculatus | Random coil | Non-hemolytic | ||
| 35606468 | 2022 | GLLGKILGAGKKVL | Nigrocin-M2 | Free | Free | Linear | L | None | 14 | Antimicrobial, Anticancer | 0 % Hemolysis at 10 µM | Horse | Pelophylax Nigromaculatus | Random coil | Non-hemolytic | ||
| 35606468 | 2022 | GLLGKILGAGKKVL | Nigrocin-M2 | Free | Free | Linear | L | None | 14 | Antimicrobial, Anticancer | 0 % Hemolysis at 100 µM | Horse | Pelophylax Nigromaculatus | Random coil | Non-hemolytic | ||
| 35740884 | 2022 | FLPLIIGALSSLLPKIF{ct:Amid} | Temporin-PKE | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Cytotoxic | 50 % Hemolysis at 6.58 µM | Horse | Pelophylax Kl. Esculentus | Random coils | NA | ||
| 35740884 | 2022 | FLPLIIGKLSSLLPKIF{ct:Amid} | Temporin-PKE-2K | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Cytotoxic | 50 % Hemolysis at 19.87 µM | Horse | Synthetic Analogues Of Temporin-Pke | α-Helix | NA | ||
| 35740884 | 2022 | FLPLIIGALSSKLPKIF{ct:Amid} | Temporin-PKE-K12 | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Cytotoxic | 50 % Hemolysis at 122.7 µM | Horse | Synthetic Analogues Of Temporin-Pke | α-Helix | Low hemolytic | ||
| 35740884 | 2022 | FLPKIIGKLSSLLPKIF{ct:Amid} | Temporin-PKE-3K | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Cytotoxic | 50 % Hemolysis at 87.47 µM | Horse | Synthetic Analogues Of Temporin-Pke | α-Helix | Low hemolytic | ||
| 35740884 | 2022 | FLPKIIGKLSSKLPKIF{ct:Amid} | Temporin-PKE-4K | Amidation | Free | Linear | L | None | 17 | Antimicrobial, Cytotoxic | 50 % Hemolysis at 1671 µM | Horse | Synthetic Analogues Of Temporin-Pke | α-Helix | Non-hemolytic | ||
| 35740884 | 2022 | FLPLIIGALSSLLPKI{d}F{ct:Amid} | Temporin-PKE-i | Amidation | Free | Linear | Mix | i = D-Isoleucine | 17 | Antimicrobial, Cytotoxic | 50 % Hemolysis at 68.37 µM | Horse | Synthetic Analogues Of Temporin-Pke | α-Helix | Low hemolytic | ||
| 35740884 | 2022 | FLPLI{d}I{d}GALSSLLPKI{d}F{ct:Amid} | Temporin-PKE-3i | Amidation | Free | Linear | Mix | i = D-Isoleucine | 17 | Antimicrobial, Cytotoxic | 50 % Hemolysis at 64 µM | Horse | Synthetic Analogues Of Temporin-Pke | α-Helix | Low hemolytic | ||
| 35638842 | 2022 | RINSAKDDAAGLQIA-OH{ct:OH} | flg15 | OH | Free | Linear | L | None | 15 | Antimicrobial | 0 ± 0 % Hemolysis at 50 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVL{ct:Amid} | BP13 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 5 ± 0.2 % Hemolysis at 50 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYE-OH{ct:OH} | Pep13 | OH | Free | Linear | L | None | 13 | Antimicrobial | 0 ± 0.6 % Hemolysis at 50 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | YGIHTH{ct:Amid} | PIP1 | Amidation | Free | Linear | L | None | 6 | Antimicrobial | 4 ± 0.8 % Hemolysis at 50 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKL{ct:Amid} | BP16 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 2 ± 1 % Hemolysis at 50 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYL{ct:Amid} | BP100 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 4 ± 0.5 % Hemolysis at 50 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYL{ct:Amid}{ct:Amid} | BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 11 | Antimicrobial | 3 ± 0.6 % Hemolysis at 50 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKIK({nnr:COC3H7})KYL{nt:Acet}{ct:Amid} | BP387 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 13 | Antimicrobial | 4 ± 0.9 % Hemolysis at 50 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK({nnr:COC3H7})L{nt:Acet}{ct:Amid} | BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 11 | Antimicrobial | 0 ± 0 % Hemolysis at 50 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFK{ct:Amid} | KSL-W | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 4 ± 1 % Hemolysis at 50 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLFKKILKKL{ct:Amid} | flg15-BP16 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 2 ± 0.1 % Hemolysis at 50 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLRINSAKDDAAGLQIA{ct:OH} | BP16-flg15 | OH | Free | Linear | L | None | 26 | Antimicrobial | 0 ± 0.3 % Hemolysis at 50 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLFKKILKYL{ct:Amid} | flg15-BP100 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 48 ± 4.1 % Hemolysis at 50 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLRINSAKDDAAGLQIA{ct:OH} | BP100-flg15 | OH | Free | Linear | L | None | 26 | Antimicrobial | 1 ± 0.9 % Hemolysis at 50 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLFKKIK{conj:COC3H7}KYL{nt:Acet}{ct:Amid} | flg15-BP387 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 26 | Antimicrobial | 5 ± 0.4 % Hemolysis at 50 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKIK{conj:COC3H7}KYLRINSAKDDAAGLQIA{nt:Acet}{ct:OH} | BP387-flg15 | OH | Acetylation | Linear | L | COC3H7 = butanoyl | 26 | Antimicrobial | 3 ± 0.3 % Hemolysis at 50 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid} | flg15-BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 26 | Antimicrobial | 7 ± 0.6 % Hemolysis at 50 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK{conj:COC3H7}LRINSAKDDAAGLQIA{nt:Acet}{ct:OH} | BP475-flg15 | OH | Acetylation | Linear | Mix | COC3H7 = butanoyl | 26 | Antimicrobial | 1 ± 1.0 % Hemolysis at 50 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKVVFWVKFK{ct:Amid} | flg15-KSLW | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 0 ± 0.6 % Hemolysis at 50 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKRINSAKDDAAGLQIA{ct:OH} | KSLW-flg15 | OH | Free | Linear | L | None | 25 | Antimicrobial | 4 ± 1.9 % Hemolysis at 50 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLFKKILKKL{ct:Amid} | BP13-BP16 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 86 ± 13.2 % Hemolysis at 50 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLFKLFKKILKVL{ct:Amid} | BP16-BP13 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 100 ± 4.0 % Hemolysis at 50 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLFKKILKYL{ct:Amid} | BP13-BP100 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 100 ± 8.3 % Hemolysis at 50 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLFKLFKKILKVL{ct:Amid} | BP100-BP13 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 100 ± 9.4 % Hemolysis at 50 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLF{d}KKILKYL{ct:Amid} | BP13-BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 100 ± 0.6 % Hemolysis at 50 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYLFKLFKKILKVL{ct:Amid} | BP143-BP13 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 100 ± 6.1 % Hemolysis at 50 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKVVFWVKFK{ct:Amid} | BP13-KSLW | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 80 ± 11.2 % Hemolysis at 50 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKFKLFKKILKVL{ct:Amid} | KSLW-BP13 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 62 ± 8.2 % Hemolysis at 50 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLFKKILKKL{ct:Amid} | Pep13-BP16 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 2 ± 0.6 % Hemolysis at 50 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLVWNQPVRGFKVYE{ct:OH} | BP16-Pep13 | OH | Free | Linear | L | None | 24 | Antimicrobial | 1 ± 0.4 % Hemolysis at 50 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLFKKILKYL{ct:Amid} | Pep13-BP100 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 9 ± 1.0 % Hemolysis at 50 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLVWNQPVRGFKVYE{ct:OH} | BP100-Pep13 | OH | Free | Linear | L | None | 24 | Antimicrobial | 5 ± 0.3 % Hemolysis at 50 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLF{d}KKILKYL{ct:Amid} | Pep13-BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 24 | Antimicrobial | 5 ± 0.5 % Hemolysis at 50 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYLVWNQPVRGFKVYE{ct:OH} | BP143-Pep13 | OH | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 24 | Antimicrobial | 5 ± 1.9 % Hemolysis at 50 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKVVFWVKFK{ct:Amid} | Pep13-KSLW | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 9 ± 2.3 % Hemolysis at 50 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKVWNQPVRGFKVYE{ct:OH} | KSLW-Pep13 | OH | Free | Linear | L | None | 23 | Antimicrobial | 0 ± 0.3 % Hemolysis at 50 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | YGIHTHKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid} | PIP1-BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 17 | Antimicrobial | 4 ± 0.4 % Hemolysis at 50 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK{conj:COC3H7}LYGIHTH{nt:Acet}{ct:Amid} | BP475-PIP1 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 17 | Antimicrobial | 9 ± 1.0 % Hemolysis at 50 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | YGIHTHKKVVFWVKFK{ct:Amid} | PIP1-KSLW | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 7 ± 0.8 % Hemolysis at 50 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKYGIHTH{ct:Amid} | KSLW-PIP1 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 8 ± 1.3 % Hemolysis at 50 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIA{ct:OH} | flg15 | OH | Free | Linear | L | None | 15 | Antimicrobial | 0 ± 0 % Hemolysis at 150 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVL{ct:Amid} | BP13 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 13 ± 2 % Hemolysis at 150 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYE{ct:OH} | Pep13 | OH | Free | Linear | L | None | 13 | Antimicrobial | 0 ± 0.3 % Hemolysis at 150 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | YGIHTH{ct:Amid} | PIP1 | Amidation | Free | Linear | L | None | 6 | Antimicrobial | 0.5 ± 0.3 % Hemolysis at 150 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKL{ct:Amid} | BP16 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 1 ± 0.6 % Hemolysis at 150 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYL{ct:Amid} | BP100 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 4 ± 0.5 % Hemolysis at 150 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYL{ct:Amid} | BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 11 | Antimicrobial | 7 ± 2 % Hemolysis at 150 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKIK({nnr:COC3H7})KYL{ct:Acet} | BP387 | Acetylation | Free | Linear | L | COC3H7 = butanoyl | 13 | Antimicrobial | 4 ± 0.6 % Hemolysis at 150 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK{nnr:COC3H7}L{ct:Acet}{ct:Acet} | BP475 | Acetylation | Free | Linear | Mix | COC3H7 = butanoyl | 11 | Antimicrobial | 11 ± 5 % Hemolysis at 150 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFK{ct:Amid} | KSL-W | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 5 ± 0.2 % Hemolysis at 150 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLFKKILKKL{ct:Amid} | flg15-BP16 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 3 ± 0.2 % Hemolysis at 150 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLRINSAKDDAAGLQIA{ct:OH} | BP16-flg15 | OH | Free | Linear | L | None | 26 | Antimicrobial | 1 ± 0.1 % Hemolysis at 150 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLFKKILKYL{ct:Amid} | flg15-BP100 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 52 ± 4.3 % Hemolysis at 150 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLRINSAKDDAAGLQIA{ct:OH} | BP100-flg15 | OH | Free | Linear | L | None | 26 | Antimicrobial | 1 ± 0.8 % Hemolysis at 150 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLFKKIK{conj:COC3H7}KYL{nt:Acet}{ct:Amid} | flg15-BP387 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 26 | Antimicrobial | 15 ± 1.6 % Hemolysis at 150 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKIK{conj:COC3H7}KYLRINSAKDDAAGLQIA{nt:Acet}{ct:OH} | BP387-flg15 | OH | Acetylation | Linear | L | COC3H7 = butanoyl | 26 | Antimicrobial | 5 ± 0.9 % Hemolysis at 150 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid} | flg15-BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 26 | Antimicrobial | 28 ± 2.3 % Hemolysis at 150 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK{conj:COC3H7}LRINSAKDDAAGLQIA{nt:Acet}{ct:OH} | BP475-flg15 | OH | Acetylation | Linear | Mix | COC3H7 = butanoyl | 26 | Antimicrobial | 0 ± 0.2 % Hemolysis at 150 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKVVFWVKFK{ct:Amid} | flg15-KSLW | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 1 ± 0.4 % Hemolysis at 150 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFK-RINSAKDDAAGLQIA{ct:OH} | KSLW-flg15 | OH | Free | Linear | L | None | 25 | Antimicrobial | 7 ± 3.4 % Hemolysis at 150 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLFKKILKKL{ct:Amid} | BP13-BP16 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 86 ± 1.6 % Hemolysis at 150 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLFKLFKKILKVL{ct:Amid} | BP16-BP13 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 100 ± 2.3 % Hemolysis at 150 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLFKKILKYL{ct:Amid} | BP13-BP100 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 100 ± 5.9 % Hemolysis at 150 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLFKLFKKILKVL{ct:Amid} | BP100-BP13 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 100 ± 5.5 % Hemolysis at 150 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLF{d}KKILKYL{ct:Amid} | BP13-BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 100 ± 3.7 % Hemolysis at 150 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYLFKLFKKILKVL{ct:Amid} | BP143-BP13 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 100 ± 3.6 % Hemolysis at 150 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKVVFWVKFK{ct:Amid} | BP13-KSLW | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 90 ± 7.3 % Hemolysis at 150 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKFKLFKKILKVL{ct:Amid} | KSLW-BP13 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 65 ± 5.9 % Hemolysis at 150 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLFKKILKKL{ct:Amid} | Pep13-BP16 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 3 ± 0.2 % Hemolysis at 150 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLVWNQPVRGFKVYE{ct:OH} | BP16-Pep13 | OH | Free | Linear | L | None | 24 | Antimicrobial | 1 ± 0.3 % Hemolysis at 150 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLFKKILKYL{ct:Amid} | Pep13-BP100 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 25 ± 2.4 % Hemolysis at 150 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLVWNQPVRGFKVYE{ct:Amid} | BP100-Pep13 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 12 ± 1.1 % Hemolysis at 150 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLF{d}KKILKYL{ct:Amid} | Pep13-BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 24 | Antimicrobial | 8 ± 0.3 % Hemolysis at 150 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYLVWNQPVRGFKVYE{ct:OH} | BP143-Pep13 | OH | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 24 | Antimicrobial | 9 ± 0.4 % Hemolysis at 150 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKVVFWVKFK{ct:Amid} | Pep13-KSLW | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 31 ± 3.7 % Hemolysis at 150 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFK-VWNQPVRGFKVYE{ct:OH} | KSLW-Pep13 | OH | Free | Linear | L | None | 23 | Antimicrobial | 2 ± 1.0 % Hemolysis at 150 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | YGIHTHKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid} | PIP1-BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 17 | Antimicrobial | 11 ± 0.5 % Hemolysis at 150 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK{conj:COC3H7}LYGIHTH{nt:Acet}{ct:Amid} | BP475-PIP1 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 17 | Antimicrobial | 18 ± 1.4 % Hemolysis at 150 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | YGIHTHKKVVFWVKFK{ct:Amid} | PIP1-KSLW | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 7 ± 1.1 % Hemolysis at 150 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKYGIHTH{ct:Amid} | KSLW-PIP1 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 3 ± 2.1 % Hemolysis at 150 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIA{ct:OH} | flg15 | OH | Free | Linear | L | None | 15 | Antimicrobial | 0 ± 0 % Hemolysis at 250 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVL{ct:Amid} | BP13 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 27 ± 3 % Hemolysis at 250 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYE{nt:OH}{ct:OH} | Pep13 | OH | OH | Linear | L | None | 13 | Antimicrobial | 2 ± 0.1 % Hemolysis at 250 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | YGIHTH{ct:Amid} | PIP1 | Amidation | Free | Linear | L | None | 6 | Antimicrobial | 0 ± 2 % Hemolysis at 250 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKL{ct:Amid} | BP16 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 1 ± 0.4 % Hemolysis at 250 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYL{ct:Amid} | BP100 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 6 ± 0.3 % Hemolysis at 250 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYL{ct:Amid} | BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 11 | Antimicrobial | 6 ± 0.3 % Hemolysis at 250 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKIK{conj:COC3H7}KYL{nt:Acet}{ct:Amid} | BP387 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 13 | Antimicrobial | 14 ± 0.5 % Hemolysis at 250 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid} | BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 11 | Antimicrobial | 0 ± 0 % Hemolysis at 250 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFK{ct:Amid} | KSL-W | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 6 ± 1 % Hemolysis at 250 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLFKKILKKL{ct:Amid} | flg15-BP16 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 4 ± 0.9 % Hemolysis at 250 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLRINSAKDDAAGLQIA{ct:OH} | BP16-flg15 | OH | Free | Linear | L | None | 26 | Antimicrobial | 0 ± 0.6 % Hemolysis at 250 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIA-KKLFKKILKYL{ct:Amid} | flg15-BP100 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 63 ± 2.4 % Hemolysis at 250 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLRINSAKDDAAGLQIA{ct:OH} | BP100-flg15 | OH | Free | Linear | L | None | 26 | Antimicrobial | 3 ± 0.0 % Hemolysis at 250 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLFKKIK{conj:COC3H7}KYL{nt:Acet}{ct:Amid} | flg15-BP387 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 26 | Antimicrobial | 26 ± 3.5 % Hemolysis at 250 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKIK{conj:COC3H7}KYLRINSAKDDAAGLQIA{nt:Acet}{ct:OH} | BP387-flg15 | OH | Acetylation | Linear | L | COC3H7 = butanoyl | 26 | Antimicrobial | 7 ± 0.2 % Hemolysis at 250 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid} | flg15-BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 26 | Antimicrobial | 43 ± 2.7 % Hemolysis at 250 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK{conj:COC3H7}LRINSAKDDAAGLQIA{nt:Acet}{ct:OH} | BP475-flg15 | OH | Acetylation | Linear | Mix | COC3H7 = butanoyl | 26 | Antimicrobial | 1 ± 0.3 % Hemolysis at 250 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKVVFWVKFK{ct:Amid} | flg15-KSLW | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 1 ± 0.4 % Hemolysis at 250 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKRINSAKDDAAGLQIA{ct:OH} | KSLW-flg15 | OH | Free | Linear | L | None | 25 | Antimicrobial | 8 ± 0.9 % Hemolysis at 250 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLFKKILKKL{ct:Amid} | BP13-BP16 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 87 ± 1.2 % Hemolysis at 250 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLFKLFKKILKVL{ct:Amid} | BP16-BP13 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 100 ± 8.5 % Hemolysis at 250 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLFKKILKYL{ct:Amid} | BP13-BP100 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 99 ± 7.1 % Hemolysis at 250 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLFKLFKKILKVL{ct:Amid} | BP100-BP13 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 98 ± 3.3 % Hemolysis at 250 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLF{d}KKILKYL{ct:Amid} | BP13-BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 100 ± 3.2 % Hemolysis at 250 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYLFKLFKKILKVL{ct:Amid} | BP143-BP13 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 100 ± 7.1 % Hemolysis at 250 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKVVFWVKFK{ct:Amid} | BP13-KSLW | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 100 ± 8.4 % Hemolysis at 250 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKFKLFKKILKVL{ct:Amid} | KSLW-BP13 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 77 ± 12.9 % Hemolysis at 250 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLFKKILKKL{ct:Amid} | Pep13-BP16 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 4 ± 0.3 % Hemolysis at 250 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLVWNQPVRGFKVYE{ct:OH} | BP16-Pep13 | OH | Free | Linear | L | None | 24 | Antimicrobial | 1 ± 0.5 % Hemolysis at 250 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLFKKILKYL{ct:Amid} | Pep13-BP100 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 45 ± 9.0 % Hemolysis at 250 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLVWNQPVRGFKVYE{ct:OH} | BP100-Pep13 | OH | Free | Linear | L | None | 24 | Antimicrobial | 20 ± 2.4 % Hemolysis at 250 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLF{d}KKILKYL{ct:Amid} | Pep13-BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 24 | Antimicrobial | 10 ± 0.6 % Hemolysis at 250 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYLVWNQPVRGFKVYE{ct:OH} | BP143-Pep13 | OH | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 24 | Antimicrobial | 16 ± 1.9 % Hemolysis at 250 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYE-KKVVFWVKFK{ct:Amid} | Pep13-KSLW | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 48 ± 3.8 % Hemolysis at 250 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFK-VWNQPVRGFKVYE{ct:OH} | KSLW-Pep13 | OH | Free | Linear | L | None | 23 | Antimicrobial | 3 ± 0.3 % Hemolysis at 250 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | YGIHTHKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid} | PIP1-BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 17 | Antimicrobial | 18 ± 0.1 % Hemolysis at 250 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK{conj:COC3H7}LYGIHTH{nt:Acet}{ct:Amid} | BP475-PIP1 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 17 | Antimicrobial | 26 ± 2.8 % Hemolysis at 250 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | YGIHTKKVVFWVKFK{ct:Amid} | PIP1-KSLW | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 6 ± 0.4 % Hemolysis at 250 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKYGIHTH{ct:Amid} | KSLW-PIP1 | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 3 ± 1.2 % Hemolysis at 250 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIA{ct:OH} | flg15 | OH | Free | Linear | L | None | 15 | Antimicrobial | 0 ± 0 % Hemolysis at 375 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVL{ct:Amid} | BP13 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 42 ± 3 % Hemolysis at 375 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYE{ct:OH} | Pep13 | OH | Free | Linear | L | None | 13 | Antimicrobial | 0 ± 0.1 % Hemolysis at 375 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | YGIHTH{ct:Amid} | PIP1 | Amidation | Free | Linear | L | None | 6 | Antimicrobial | 1 ± 0.1 % Hemolysis at 375 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKL{ct:Amid} | BP16 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 3 ± 3 % Hemolysis at 375 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYL{ct:Amid} | BP100 | Amidation | Free | Linear | L | None | 11 | Antimicrobial | 11 ± 0.9 % Hemolysis at 375 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYL{ct:Amid} | BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 11 | Antimicrobial | 7 ± 0.3 % Hemolysis at 375 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLFKKIK{conj:COC3H7}KYL{nt:Acet}{ct:Amid} | BP387 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 13 | Antimicrobial | 18 ± 1 % Hemolysis at 375 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid} | BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 11 | Antimicrobial | 0 ± 0 % Hemolysis at 375 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFK{ct:Amid} | KSL-W | Amidation | Free | Linear | L | None | 10 | Antimicrobial | 20 ± 2 % Hemolysis at 375 µM | Horse | Synthetic | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLFKKILKKL{ct:Amid} | flg15-BP16 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 5 ± 0.3 % Hemolysis at 375 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLRINSAKDDAAGLQIA{ct:OH} | BP16-flg15 | OH | Free | Linear | L | None | 26 | Antimicrobial | 1 ± 0.5 % Hemolysis at 375 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLFKKILKYL{ct:Amid} | flg15-BP100 | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 66 ± 9.2 % Hemolysis at 375 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLRINSAKDDAAGLQIA{ct:OH} | BP100-flg15 | OH | Free | Linear | L | None | 26 | Antimicrobial | 6 ± 1.6 % Hemolysis at 375 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLFKKIK{conj:COC3H7}KYL{nt:Acet}{ct:Amid} | flg15-BP387 | Amidation | Acetylation | Linear | L | COC3H7 = butanoyl | 26 | Antimicrobial | 39 ± 2.1 % Hemolysis at 375 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKIK{conj:COC3H7}KYLRINSAKDDAAGLQIA{nt:Acet}{ct:OH} | BP387-flg15 | OH | Acetylation | Linear | L | COC3H7 = butanoyl | 26 | Antimicrobial | 9 ± 2.5 % Hemolysis at 375 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIAKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid} | flg15-BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 26 | Antimicrobial | 46 ± 3.6 % Hemolysis at 375 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK{conj:COC3H7}LRINSAKDDAAGLQIA{nt:Acet}{ct:OH} | BP475-flg15 | OH | Acetylation | Linear | Mix | COC3H7 = butanoyl | 26 | Antimicrobial | 1 ± 0.3 % Hemolysis at 375 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | RINSAKDDAAGLQIA-KKVVFWVKFK{ct:Amid} | flg15-KSLW | Amidation | Free | Linear | L | None | 25 | Antimicrobial | 0 ± 0.3 % Hemolysis at 375 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFK-RINSAKDDAAGLQIA{ct:OH} | KSLW-flg15 | OH | Free | Linear | L | None | 25 | Antimicrobial | 8 ± 2.7 % Hemolysis at 375 µM | Horse | Synthetic; Flg15 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLFKKILKKL{ct:Amid} | BP13-BP16 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 93 ± 2.3 % Hemolysis at 375 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLFKLFKKILKVL{ct:Amid} | BP16-BP13 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 100 ± 2.1 % Hemolysis at 375 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLFKKILKYL{ct:Amid} | BP13-BP100 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 100 ± 4.8 % Hemolysis at 375 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLFKLFKKILKVL{ct:Amid} | BP100-BP13 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 99 ± 3.7 % Hemolysis at 375 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKLF{d}KKILKYL{ct:Amid} | BP13-BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 100 ± 10.6 % Hemolysis at 375 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYLFKLFKKILKVL{ct:Amid} | BP143-BP13 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 22 | Antimicrobial | 100 ± 7.0 % Hemolysis at 375 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | FKLFKKILKVLKKVVFWVKFK{ct:Amid} | BP13-KSLW | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 99 ± 8.4 % Hemolysis at 375 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKFKLFKKILKVL{ct:Amid} | KSLW-BP13 | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 82 ± 10.4 % Hemolysis at 375 µM | Horse | Synthetic; Bp13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLFKKILKKL{ct:Amid} | Pep13-BP16 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 4 ± 0.2 % Hemolysis at 375 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKKLVWNQPVRGFKVYE{ct:OH} | BP16-Pep13 | OH | Free | Linear | L | None | 24 | Antimicrobial | 2 ± 0.4 % Hemolysis at 375 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLFKKILKYL{ct:Amid} | Pep13-BP100 | Amidation | Free | Linear | L | None | 24 | Antimicrobial | 49 ± 9.2 % Hemolysis at 375 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLFKKILKYLVWNQPVRGFKVYE{ct:OH} | BP100-Pep13 | OH | Free | Linear | L | None | 24 | Antimicrobial | 30 ± 3.2 % Hemolysis at 375 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKLF{d}KKILKYL{ct:Amid} | Pep13-BP143 | Amidation | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 24 | Antimicrobial | 17 ± 0.4 % Hemolysis at 375 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKYLVWNQPVRGFKVYE{ct:OH} | BP143-Pep13 | OH | Free | Linear | Mix | lowercase letters correspond to D-amino acids | 24 | Antimicrobial | 29 ± 0.9 % Hemolysis at 375 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | VWNQPVRGFKVYEKKVVFWVKFK{ct:Amid} | Pep13-KSLW | Amidation | Free | Linear | L | None | 23 | Antimicrobial | 60 ± 1.5 % Hemolysis at 375 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKVWNQPVRGFKVYE{ct:OH} | KSLW-Pep13 | OH | Free | Linear | L | None | 23 | Antimicrobial | 5 ± 1.0 % Hemolysis at 375 µM | Horse | Synthetic; Pep13 Conjugates | NA | NA | ||
| 35638842 | 2022 | YGIHTHKKLF{d}KKILKK{conj:COC3H7}L{nt:Acet}{ct:Amid} | PIP1-BP475 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 17 | Antimicrobial | 24 ± 0.5 % Hemolysis at 375 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKLF{d}KKILKK{conj:COC3H7}LYGIHTH{nt:Acet}{ct:Amid} | BP475-PIP1 | Amidation | Acetylation | Linear | Mix | COC3H7 = butanoyl | 17 | Antimicrobial | 39 ± 2.0 % Hemolysis at 375 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | YGIHTHKKVVFWVKFK{ct:Amid} | PIP1-KSLW | Amidation | Free | Linear | L | None | 16 | Antimicrobial | 6 ± 0.4 % Hemolysis at 375 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 35638842 | 2022 | KKVVFWVKFKYGIHTH | KSLW-PIP1 | Free | Free | Linear | L | None | 16 | Antimicrobial | 5 ± 4.9 % Hemolysis at 375 µM | Horse | Synthetic; Pip1 Conjugates | NA | NA | ||
| 36009917 | 2022 | GLWNSIKIAGKKLFVNVLDKIRCKVAGGC | GL-29 | Free | Free | Linear | L | None | 29 | Antimicrobial | 10 % Hemolysis at 5.86 μM | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | GLWNSIKIAGKKLFVNVLDKIRCKVAGGC | GL-29 | Free | Free | Linear | L | None | 29 | Antimicrobial | 50 % Hemolysis at 32 μM | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | GLWNSIKIAGKKLFVNVLDKIR{ct:Amid} | GL-22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | 10 % Hemolysis at 87.304 μM | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | GLWNSIKIAGKKLFVNVLDKIR{ct:Amid} | GL-22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | ∼6 % Hemolysis at 32 μM | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | GLWNSIKIA{ct:Amid} | GL-9 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | No Hemolysis detected | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | LFVNVLDKIR{ct:Amid} | LF-10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | No Hemolysis detected | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | FVNVLDKIR{ct:Amid} | FV-9 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | 10 % Hemolysis at 504.21 μM | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | VNVLDKIR{ct:Amid} | VN-8 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | No Hemolysis detected | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | FVNVLDKI{ct:Amid} | FV-8 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | No Hemolysis detected | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | GLWNSIKIAGKKLFVNVLDKIRCKVAGGC | GL-29 | Free | Free | Linear | L | None | 29 | Antimicrobial | 100 % Hemolysis at 512 μM | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | GLWNSIKIAGKKLFVNVLDKIR{ct:Amid} | GL-22 | Amidation | Free | Linear | L | None | 22 | Antimicrobial | >80 % Hemolysis at 512 μM | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | GLWNSIKIA{ct:Amid} | GL-9 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | <5 % Hemolysis at 512 μM | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | LFVNVLDKIR{ct:Amid} | LF-10 | Amidation | Free | Linear | L | None | 10 | Antimicrobial | ∼10 % Hemolysis at 512 μM | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | FVNVLDKIR{ct:Amid} | FV-9 | Amidation | Free | Linear | L | None | 9 | Antimicrobial | <5 % Hemolysis at 512 μM | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | VNVLDKIR{ct:Amid} | VN-8 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | No Hemolysis detected | Horse | Synthetic | α-Helix | NA | ||
| 36009917 | 2022 | FVNVLDKI{ct:Amid} | FV-8 | Amidation | Free | Linear | L | None | 8 | Antimicrobial | 10 % Hemolysis at 504.21 μM | Horse | Synthetic | α-Helix | NA | ||
| 25485686 | 2015 | TR{d}SG{nnr:x}LR{d}EQ{d}W{d}IT | Lysocin E | Free | Free | Linear | Mix | x = D-N-Methylphenylalanine | 12 | Antibacterial, Antifungal | <1 % Hemolysis at 100μg/mL | Horse | Lysobacter | NA | Non-hemolytic | ||
| 20451254 | 2010 | FLSLIPHIVSGVASIAKHF{ct:Amid} | Phylloseptin-1 (PSN-1) | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antifungal, candidacidal, Antiparasitic, Hemolytic, Antibiofilm | 6.7 % Hemolytic at 5µM | Horse | The Waxy Monkey Frog, Phyllomedusa Sauvagei, South America | Helix | NA | ||
| 22484288 | 2012 | FLFSLIPSAISGLISAF{ct:Amid} | AamAP2 | Amidation | Free | Linear | L | None | 17 | Antibacterial Gram+,Antifungal, candidacidal, Hemolytic | ~50 % Hemolytic at 100µM | Horse | Scorpion Venom, The North African Scorpion, Androctonus Amoreuxi | NA | NA | ||
| 30802593 | 2019 | FIVPSIFLLKKAFCIALKKC | Japonicin-2LF | Free | Free | Linear | L | None | 20 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic, Antibiofilm | >80 % Hemolytic at 64µM | Horse | Fujian Large-Headed Frog Skin Secretion, Limnonectes Fujianensis, China, Asia | Helix | NA | ||
| 37228702 | 2023 | FLPLLAGLAANFLPQIICKIARKC | Brevinin-1-AW | Free | Free | Linear | L | None | 24 | Antibacterial, Anti-MRSA, Hemolytic, Antibiofilm, Anticance | 50 % Hemolytic at 23.96µM | Horse | Skin Secretion, The Wuyi Torrent Frog, Amolops Wuyiensis, China, Asia | Helix | NA | ||
| 37228702 | 2023 | FLPLLAGLAANFLPKIICKIARKC | B1AW-K | Free | Free | Linear | L | None | 24 | Antibacterial, Anti-MRSA, Hemolytic, Antibiofilm, Anticance | 50 % Hemolytic at 10.6µM | Horse | Synthetic Peptide | Helix | NA | ||
| 36138742 | 2022 | FLKIIGKLLSGLL | VM-3K | Free | Free | Linear | L | None | 13 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic, Antibiofilm | 50 % Hemolytic at 11.2µM | Horse | Synthetic Peptide | Helix | NA | ||
| 36138742 | 2022 | FLGIIGKLLSGLL | VM-3G | Free | Free | Linear | L | None | 13 | Antibacterial Gram+, Anti-MRSA, Hemolytic, Antibiofilm | 50 % Hemolytic at 9.7µM | Horse | Synthetic Peptide | Helix | NA | ||
| 36138742 | 2022 | FLWIIGKLLSGLL | VM-3W | Free | Free | Linear | L | None | 13 | Antibacterial Gram+, Anti-MRSA, Hemolytic, Antibiofilm | 50 % Hemolytic at 9.7µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39204443 | 2024 | FLSLIPHAISAVSALAKHL | Phylloseptin-TO2 | Free | Free | Linear | L | None | 19 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer | 50 % Hemolytic at 64µM | Horse | Skin Secretion, Super Tiger Leg Monkey Tree Frog, Phyllomedusa Tomopterna, Central America, South America | Helix | NA | ||
| 39204443 | 2024 | FLSLIPKAISAVSALAKHL | PSTO2 7K | Free | Free | Linear | L | None | 19 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer | 50 % Hemolytic at 32-64µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39204443 | 2024 | FLSLIPKAISAVSALAKKL | PSTO2 18K | Free | Free | Linear | L | None | 19 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer | 50 % Hemolytic at 64µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39204443 | 2024 | FLSLIPKAIKAVSALAKKL | PSTO2 SR (Phylloseptin-TO2 analog) | Free | Free | Linear | L | None | 19 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer | 50 % Hemolytic at 64µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39204443 | 2024 | FLSLIPKAIKAVKALAKKL | PSTO2 SR2 (Phylloseptin-TO2 analog) | Free | Free | Linear | L | None | 19 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer | 50 % Hemolytic at 32µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39138237 | 2024 | FLPFLASLALKIL{ct:Amid} | Temporin-WY2 (Natural AMPs, Leu-rich, frog, amphibians, animals, XXA, UCLL1c) | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm, Anti-MRSA, Hemolytic | 50 % Hemolytic at 32-64µM | Horse | Cutaneous Secretion, The Ranidae Frog, Amolops Wuyiensis, China, Asia | Helix | NA | ||
| 39138237 | 2024 | FLPKLLSALAKIL{ct:Amid} | QUB-1426 (Synthetic AMPs, Temporin-WY2 analog, Leu-rich, XXA, UCLL1c | Amidation | Free | Linear | L | None | 13 | Antibacterial, Antibiofilm, Anti-MRSA, Hemolytic | 50 % Hemolytic at 16-32µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39138237 | 2024 | KKKKKKFLPFLASLALKIL{ct:Amid} | 6K-WY2 (Synthetic AMPs, Temporin-WY2 analog, Lys-rich, Leu-rich, XXA, UCLL1c | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antibiofilm, Anti-MRSA, Hemolytic | 50 % Hemolytic at 32µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39138237 | 2024 | KKKKKKFLPKLLSALAKIL{ct:Amid} | 6K-1426 (Synthetic AMPs, Temporin-WY2 analog, Lys-rich, Leu-rich, XXA, UCLL1c) | Amidation | Free | Linear | L | None | 19 | Antibacterial, Antibiofilm, Anti-MRSA, Hemolytic | 50 % Hemolytic at 32µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39345903 | 2024 | FFPIVAGVAAKVLKKIFCTISKKC | Brevinin-1pl (natural AMPs; frog, amphibians, animals; XXU; 1S=S, UCSS1a; BBL) | Free | Free | Linear | L | None | 24 | Antibacterial, Anticancer, Anti-MRSA, Hemolytic | 50 % Hemolytic at 37.64µM | Horse | Skin Secretions, The Northern Leopard Frog, Rana Pipiens, North America | Helix | NA | ||
| 39345903 | 2024 | FFPKVAGVAAKVLKKIFCTISKKC | [Lys4] brevinine-1pl (brevinine-1pl I4K analog, Synthetic AMPs, XXU; 1S=S, UCSS1a) | Free | Free | Linear | L | None | 24 | Antibacterial, Anti-MRSA, Hemolytic | 50 % Hemolytic at 80.77µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39345903 | 2024 | FFPKVAGVAAKVAKKIFCTISKKC | [Lys4, Ala13] brevinine-1pl (brevinine-1pl I4K,L13A analog, Synthetic AMPs, XXU; 1S=S, UCSS1a) | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic | 50 % Hemolytic at 41.34µM | Horse | Synthetic Peptide | Helix | NA | ||
| 39345903 | 2024 | FFPKVAGVAAKVLKKAFCTISKKC | [Lys4, Ala16] brevinine-1pl (brevinine-1pl I4K,I16A analog, Synthetic AMPs, XXU; 1S=S, UCSS1a | Free | Free | Linear | L | None | 24 | Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic | 50 % Hemolytic at 84.86µM | Horse | Synthetic Peptide | Helix | NA | ||
| 29649486 | 2018 | MNRLIILCLVAATIYSTIALPMKEDISNEERPTSVNEKPVKKSVAVAGAVIQGAALAFQVLDKILTSLGGIGRKIAIGVDNESGMKWAARNVYFYSGTSDTVLPYSVPHSKAFLYGARKTRGSVRGAVGVLAYSMSDGNTLGILFSVPYDYNWYSNWWNIKVYRGYKRANKWMYHDLYYYARPHKGNNEWHEKSLGYGLKSKGFMTSSGQTKLEIRVSRA | Deep-sea actinoporin Cjtox I (DELTA-actitoxin-Cja1a) (DELTA-AITX-Cja1a) | Free | Free | Linear | L | None | 220 | Cytolytic | Hemolytic | Horse | Cribrinopsis Japonica (Deep-Sea Anemone) | NA | NA | ||
| 21624426 | 2011 | FIKELLPHLSGIIDSVANAIK{ct:Amid} | Kasstasin | Amidation | Free | Linear | L | None | 21 | Antimicrobial | 12.8 % Hemolytic at 128µM | Horse | Phlyctimantis Maculatus (Red-Legged Running Frog) (Hylambates Maculatus) | NA | Low hemolytic | ||
| 19101583 | 2008 | ADDKNPLEECFRETDYEEFLEIARNGLKATSNPKRVV | L-amino-acid oxidase (BjarLAAO-I) (LAO) (EC 1.4.3.2) | Free | Free | Linear | L | None | 37 | Antimicrobial | Hemolytic | Horse | Bothrops Jararaca (Jararaca) (Bothrops Jajaraca) | NA | NA | ||
| 27792198 | 2016 | MAFLKKSLFLVLFLGLVNLSICEEEKREEENKEEEDENEALSEVKRGFLEKLKTGAKDFASAFVNSIKGT{ct:Amid} | Frenatin 4.1 [Cleaved into: Frenatin 4.2] | Amidation | Free | Linear | L | None | 70 | Antimicrobial | <5 % Hemolytic at 512ug/ml | Horse | Nyctimystes Infrafrenatus (White-Lipped Tree Frog) (Litoria Infrafrenata) | NA | Non-hemolytic | ||
| 28469603 | 2017 | MAFLKKSLFLVFFLGFVSLSICEEEKRETDEKENEQEDDREERSEEKRLLGMIPVAITAISALSKLG{ct:Amid} | Medusin-PT | Amidation | Free | Linear | L | None | 67 | Antimicrobial | 50 % Hemolytic at 1.814 × 10^6ug/ml | Horse | Phyllomedusa Tarsius (Brownbelly Leaf Frog) (Phyllomedusa Tarsia) | NA | Low hemolytic | ||
| 29649486 | 2017 | MNRLIIVCLVAAMIYSTIALPMKEDISNDERPISVNEEPVKKNAAVAGAVIQGATLTFQVLDRILTVLGDISRKIAIGVDNESGRKWTAKNAYFFSGTSDVVLPYSVPNGKAFLYDGKKTRGPVATGAVGVLAYSMSDGNTLGILFSVPYDYNWYENWWNIKVYSGSKRANKWMYENLYYNASPHKGDNGWHEKSLGYGLKSRGYMASSGQTKLEIRVTRA | Deep sea actinoporin Cjtox II (DELTA-actitoxin-Cja1b) (DELTA-AITX-Cja1b) | Free | Free | Linear | L | None | 221 | Antimicrobial | Hemolytic | Horse | Cribrinopsis Japonica (Deep-Sea Anemone) | NA | NA | ||
| 22232283 | 2011 | MRTLTLLTALLLLALQVQTQSLEETADQVPAQDQPGAEAQDITISFAGDERSAREASKSLIGTASCTCRRAWICRWGERHSGKCIDQKGSTYRLCCRR | Alpha-defensin 1 | Free | Free | Linear | L | None | 98 | Antimicrobial | <3 % Hemolytic at 100µg/ml | Horse | Equus Caballus (Horse) | NA | Non-hemolytic | ||
| 15777955 | 2005 | IGGIISFFKRLF | Grammistin Gs B | Free | Free | Linear | L | None | 12 | Antibacterial | Hemolytic at <10HU/mg | Horse | Grammistes Sexlineatus (Goldenstriped Soapfish) (Perca Sexlineata) | NA | Non-hemolytic | ||
| 15777955 | 2005 | FIGGIISFFKRLF | Grammistin Gs D | Free | Free | Linear | L | None | 13 | Antibacterial | Hemolytic at 79HU/mg | Horse | Grammistes Sexlineatus (Goldenstriped Soapfish) (Perca Sexlineata) | NA | NA | ||
| 15777955 | 2005 | FIGGIISFIKKLF | Grammistin Gs E | Free | Free | Linear | L | None | 13 | Antibacterial | Hemolytic at 63HU/mg | Horse | Grammistes Sexlineatus (Goldenstriped Soapfish) (Perca Sexlineata) | NA | NA | ||
| 15777955 | 2005 | WWRELLKKLAFTAAGHLGSVLAAKQSGW | Grammistin Gs A | Free | Free | Linear | L | None | 28 | Antibacterial | Hemolytic at <10HU/mg | Horse | Grammistes Sexlineatus (Goldenstriped Soapfish) (Perca Sexlineata) | NA | Non-hemolytic | ||
| 15777955 | 2005 | NWRKILGKIAKVAAGLLGSMLAGYQV | Grammistin Gs C | Free | Free | Linear | L | None | 26 | Antibacterial | Hemolytic at <10HU/mg | Horse | Grammistes Sexlineatus (Goldenstriped Soapfish) (Perca Sexlineata) | NA | Non-hemolytic |